<!DOCTYPE html><html lang="en" class="scroll-smooth"><head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Pharmacology Test - Brain And Scalpel</title>
    <link rel="preload" href="assets/background.jpg" as="image">
    <script src="https://cdn.tailwindcss.com"></script>
    <!-- HLS.js for M3U8 support -->
    <script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
    <style>
        
/* Liquid Glass Morphism Universal Theme - Enhanced & Mobile-First */
:root {
  --glass-bg: rgba(0, 0, 0, 0.6);
  --glass-bg-light: rgba(255, 255, 255, 0.1);
  --glass-bg-medium: rgba(255, 255, 255, 0.15);
  --glass-bg-heavy: rgba(255, 255, 255, 0.2);
  --glass-border: rgba(255, 255, 255, 0.2);
  --glass-border-light: rgba(255, 255, 255, 0.1);
  --text-primary: rgba(255, 255, 255, 0.95);
  --text-secondary: rgba(255, 255, 255, 0.7);
  --text-tertiary: rgba(255, 255, 255, 0.5);
  --accent-blue: #60a5fa;
  --accent-purple: #a855f7;
  --accent-green: #34d399;
  --accent-orange: #fb923c;
  --accent-red: #f87171;
  --accent-yellow: #fbbf24;
}

* {
  margin: 0;
  padding: 0;
  box-sizing: border-box;
}

html {
  scroll-behavior: smooth;
}

body {
  margin: 0;
  min-height: 100vh;
  font-family: system-ui, -apple-system, BlinkMacSystemFont, 'Segoe UI', sans-serif;
  position: relative;
  overflow-x: hidden;
  color: var(--text-primary);
  background-color: #000;
}

/* iOS Background Fix */
body::before {
  content: '';
  position: fixed;
  top: 0;
  left: 0;
  height: 100vh;
  width: 100vw;
  z-index: -2;
  background: url("assets/background.jpg") center center / cover no-repeat;
}

body::after {
  content: "";
  position: fixed;
  inset: 0;
  background: rgba(0, 0, 0, 0.4);
  backdrop-filter: blur(10px);
  -webkit-backdrop-filter: blur(10px);
  z-index: -1;
}

/* Glass morphism components */
.glass {
  background: var(--glass-bg);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-light {
  background: var(--glass-bg-light);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid var(--glass-border-light);
  border-radius: 12px;
}

.glass-medium {
  background: var(--glass-bg-medium);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-heavy {
  background: var(--glass-bg-heavy);
  backdrop-filter: blur(25px);
  -webkit-backdrop-filter: blur(25px);
  border: 1px solid var(--glass-border);
  border-radius: 20px;
}

.glass-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.glass-card:hover {
  transform: translateY(-8px);
  background: rgba(255, 255, 255, 0.12);
  border-color: rgba(255, 255, 255, 0.25);
  box-shadow: 0 20px 60px rgba(0, 0, 0, 0.4);
}

.glass-button {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.8), rgba(168, 85, 247, 0.8));
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: white;
  font-weight: 600;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 4px 20px rgba(96, 165, 250, 0.3);
  cursor: pointer;
  border: none;
}

.glass-button:hover {
  transform: translateY(-2px);
  box-shadow: 0 8px 30px rgba(96, 165, 250, 0.4);
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.9), rgba(168, 85, 247, 0.9));
}

.glass-button:disabled {
  opacity: 0.5;
  cursor: not-allowed;
  transform: none;
}

.glass-input {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: var(--text-primary);
  transition: all 0.3s ease;
}

.glass-input:focus {
  outline: none;
  border-color: var(--accent-blue);
  background: rgba(255, 255, 255, 0.12);
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.3);
}

.glass-input::placeholder {
  color: var(--text-tertiary);
}

/* Performance analysis styles */
.performance-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.score-circle {
  position: relative;
  width: 150px;
  height: 150px;
  margin: 0 auto;
}

.score-circle svg {
  transform: rotate(-90deg);
}

.score-circle .circle-bg {
  fill: none;
  stroke: rgba(255, 255, 255, 0.1);
  stroke-width: 8;
}

.score-circle .circle-progress {
  fill: none;
  stroke-width: 8;
  stroke-linecap: round;
  transition: stroke-dasharray 2s cubic-bezier(0.4, 0, 0.2, 1);
}

.score-text {
  position: absolute;
  top: 50%;
  left: 50%;
  transform: translate(-50%, -50%);
  text-align: center;
}

/* Review question styles */
.review-question {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.1);
  border-radius: 16px;
  padding: 20px;
  margin-bottom: 20px;
}

.review-question.correct {
  border-left: 4px solid #22c55e;
}

.review-question.incorrect {
  border-left: 4px solid #ef4444;
}

.review-question.not-attempted {
  border-left: 4px solid #6b7280;
}

/* Gradient backgrounds for accents */
.gradient-blue {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
}

.gradient-purple {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
}

.gradient-green {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
}

.gradient-orange {
  background: linear-gradient(135deg, var(--accent-orange), #f97316);
}

.gradient-red {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
}

.gradient-yellow {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
}

/* Navigation button styles */
.nav-btn-not-attempted {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  color: rgba(255, 255, 255, 0.7);
}

.nav-btn-current {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.4);
}

.nav-btn-correct {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-incorrect {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-bookmarked {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-marked-review {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-answered {
  background: linear-gradient(135deg, #6b7280, #4b5563);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

/* Option button styles - REVISED FOR INLINE FEEDBACK */
.option-button {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.15);
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  position: relative;
  overflow: hidden;
  width: 100%;
  text-align: left;
  padding: 1rem;
  border-radius: 12px;
  color: var(--text-primary);
  cursor: pointer;
  display: flex;
  align-items: center;
  gap: 1rem;
  font-size: 1rem;
}

.option-button:hover {
  background: rgba(255, 255, 255, 0.1);
  border-color: rgba(96, 165, 250, 0.5);
  transform: translateX(8px);
}

.option-button.selected {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.3), rgba(59, 130, 246, 0.3));
  border-color: var(--accent-blue);
  transform: translateX(8px);
}

#optionsContainer.answered .option-button:hover {
    transform: translateX(0); /* Disable hover effect after answering */
}

#optionsContainer.answered .option-button {
    cursor: not-allowed;
    pointer-events: none;
}

#optionsContainer.answered .option-button:not(.correct):not(.incorrect) {
    opacity: 0.5;
}

.option-button.correct {
    background: linear-gradient(135deg, #22c55e, #16a34a);
    border-color: #22c55e;
    color: white;
    transform: translateX(0);
}

.option-button.incorrect {
    background: linear-gradient(135deg, #ef4444, #dc2626);
    border-color: #ef4444;
    color: white;
    transform: translateX(0);
}

.option-letter {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  transition: all 0.3s ease;
  width: 2.5rem;
  height: 2.5rem;
  border-radius: 50%;
  display: flex;
  align-items: center;
  justify-content: center;
  font-weight: bold;
  color: var(--text-primary);
  flex-shrink: 0;
}

.option-button.selected .option-letter {
  background: var(--accent-blue);
  border-color: var(--accent-blue);
  color: white;
}

.option-button.correct .option-letter, .option-button.incorrect .option-letter {
    background: rgba(255, 255, 255, 0.2);
    border-color: rgba(255, 255, 255, 0.3);
}

.option-text {
  flex: 1;
  font-size: 1rem;
  line-height: 1.5;
}

/* Stats bar responsive grid */
.stats-grid {
  display: grid;
  grid-template-columns: repeat(5, 1fr);
  gap: 1rem;
  align-items: center;
  justify-items: center;
}

@media (max-width: 768px) {
  .stats-grid {
    grid-template-columns: repeat(3, 1fr);
    gap: 0.5rem;
  }
 
  .stats-grid > div:nth-child(4),
  .stats-grid > div:nth-child(5) {
    grid-column: span 1;
  }
}

@media (max-width: 480px) {
  .stats-grid {
    grid-template-columns: repeat(2, 1fr);
  }
 
  .stats-grid > div:last-child {
    grid-column: span 2;
    justify-self: center;
  }
}

/* Animations */
@keyframes float {
  0%, 100% { transform: translateY(0px); }
  50% { transform: translateY(-20px); }
}

@keyframes pulse-glow {
  0%, 100% { box-shadow: 0 0 20px rgba(96, 165, 250, 0.3); }
  50% { box-shadow: 0 0 40px rgba(96, 165, 250, 0.6); }
}

@keyframes checkmark {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(180deg); }
  100% { transform: scale(1) rotate(360deg); }
}

@keyframes cross {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(90deg); }
  100% { transform: scale(1) rotate(180deg); }
}

.animate-float {
  animation: float 6s ease-in-out infinite;
}

.animate-pulse-glow {
  animation: pulse-glow 2s ease-in-out infinite;
}

.animate-checkmark {
  animation: checkmark 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

.animate-cross {
  animation: cross 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

/* Custom scrollbar */
::-webkit-scrollbar {
  width: 8px;
}

::-webkit-scrollbar-track {
  background: rgba(255, 255, 255, 0.05);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb {
  background: rgba(255, 255, 255, 0.2);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb:hover {
  background: rgba(255, 255, 255, 0.3);
}

/* --- MOBILE RESPONSIVE STYLES --- */
.quiz-container {
    display: flex;
    flex-direction: column;
    gap: 1.5rem;
}

#mobile-nav-toggle {
    display: none; /* Hidden on desktop */
}

@media (min-width: 1024px) {
    .quiz-container {
        flex-direction: row;
        gap: 2rem;
    }
}

@media (max-width: 1023px) {
    .quiz-sidebar {
        position: fixed;
        top: 0;
        left: 0;
        width: 300px;
        height: 100%;
        z-index: 100;
        transform: translateX(-100%);
        transition: transform 0.3s ease-in-out;
        box-shadow: 10px 0px 30px rgba(0,0,0,0.5);
    }
    .quiz-sidebar.open {
        transform: translateX(0);
    }
    #mobile-nav-toggle {
        display: flex;
        position: fixed;
        bottom: 20px;
        left: 20px;
        z-index: 50;
    }
    .quiz-main-content {
        width: 100%;
    }
}

@media (max-width: 768px) {
    .glass-card, .glass {
        border-radius: 16px;
    }
    h1 { font-size: 2.5rem; }
    #questionText { font-size: 1.125rem; }
    .controls-container {
        flex-direction: column;
        gap: 1rem;
    }
    .controls-container button {
        width: 100%;
    }
}

    </style>
</head>
<body>
    <!-- Mode Selection Modal -->
    <div id="modeModal" class="fixed inset-0 bg-black bg-opacity-70 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-md w-full mx-4 shadow-2xl">
            <h2 class="text-2xl font-bold text-white mb-6 text-center">Choose Study Mode</h2>
            
            <div class="space-y-4">
                <button onclick="selectMode('study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Study Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Interactive learning with immediate feedback</p>
                        </div>
                        <div class="gradient-blue w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 12l2 2 4-4m6 2a9 9 0 11-18 0 9 9 0 0118 0z"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('test')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Test Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Practice test with performance analysis at end</p>
                        </div>
                        <div class="gradient-purple w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 2a1 1 0 000 2h2a1 1 0 100-2H9z"></path>
                                <path fill-rule="evenodd" d="M4 5a2 2 0 012-2v1a1 1 0 001 1h6a1 1 0 001-1V3a2 2 0 012 2v6a2 2 0 01-2 2H6a2 2 0 01-2-2V5zm3 4a1 1 0 000 2h.01a1 1 0 100-2H7zm3 0a1 1 0 000 2h3a1 1 0 100-2h-3z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Study</h3>
                            <p class="text-sm text-white text-opacity-70">Study with time pressure and immediate feedback</p>
                        </div>
                        <div class="gradient-green w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M10 18a8 8 0 100-16 8 8 0 000 16zm1-12a1 1 0 10-2 0v4a1 1 0 00.293.707l2.828 2.829a1 1 0 101.415-1.415L11 9.586V6z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_exam')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Exam</h3>
                            <p class="text-sm text-white text-opacity-70">Real exam simulation with strict timing</p>
                        </div>
                        <div class="gradient-red w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M12.395 2.553a1 1 0 00-1.45-.385c-.345.23-.614.558-.822.88-.214.33-.403.713-.57 1.116-.334.804-.614 1.768-.84 2.734a31.365 31.365 0 00-.613 3.58 2.64 2.64 0 01-.945-1.067c-.328-.68-.398-1.534-.398-2.654A1 1 0 005.05 6.05 6.981 6.981 0 003 11a7 7 0 1011.95-4.95c-.592-.591-.98-.985-1.348-1.467-.363-.476-.724-1.063-1.207-2.03z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
            </div>
        </div>
    </div>

    <!-- Performance Analysis Modal -->
    <div id="performanceModal" class="hidden fixed inset-0 bg-black bg-opacity-80 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-4xl w-full mx-4 shadow-2xl max-h-[90vh] overflow-y-auto">
            <div class="flex items-center justify-between mb-8">
                <h2 class="text-3xl font-bold text-white">Performance Analysis</h2>
                <button onclick="closePerformanceModal()" class="glass-light p-2 rounded-lg text-white hover:bg-white hover:bg-opacity-20">
                    <svg class="w-6 h-6" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M4.293 4.293a1 1 0 011.414 0L10 8.586l4.293-4.293a1 1 0 111.414 1.414L11.414 10l4.293 4.293a1 1 0 01-1.414 1.414L10 11.414l-4.293 4.293a1 1 0 01-1.414-1.414L8.586 10 4.293 5.707a1 1 0 010-1.414z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
            
            <!-- Score Overview -->
            <div class="grid grid-cols-1 md:grid-cols-3 gap-6 mb-8">
                <div class="performance-card p-6 text-center">
                    <div class="score-circle mb-4">
                        <svg width="150" height="150" class="mx-auto">
                            <circle class="circle-bg" cx="75" cy="75" r="65"></circle>
                            <circle id="scoreCircle" class="circle-progress" cx="75" cy="75" r="65" stroke="#22c55e" stroke-dasharray="0 408"></circle>
                        </svg>
                        <div class="score-text">
                            <div class="text-3xl font-bold text-white" id="accuracyScore">0%</div>
                            <div class="text-sm text-white text-opacity-70">Accuracy</div>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Results Summary</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Questions:</span>
                            <span class="text-white font-semibold" id="totalQuestionsResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-green-400">Correct:</span>
                            <span class="text-green-400 font-semibold" id="correctResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-red-400">Incorrect:</span>
                            <span class="text-red-400 font-semibold" id="incorrectResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-gray-400">Not Attempted:</span>
                            <span class="text-gray-400 font-semibold" id="notAttemptedResult">0</span>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Time Analysis</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Time:</span>
                            <span class="text-white font-semibold" id="totalTimeResult">0:00</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Avg per Question:</span>
                            <span class="text-white font-semibold" id="avgTimeResult">0:00</span>
                        </div>
                    </div>
                </div>
            </div>
            
            <!-- Action Buttons -->
            <div class="flex justify-center space-x-4 mb-8">
                <button onclick="reviewQuestions()" class="glass-button px-8 py-3 text-lg">
                    Review All Questions
                </button>
                <button onclick="retakeQuiz()" class="glass-light px-8 py-3 text-lg text-white hover:bg-white hover:bg-opacity-20">
                    Retake Quiz
                </button>
            </div>
            
            <!-- Question Review Section -->
            <div id="questionReviewSection" class="hidden">
                <h3 class="text-2xl font-bold text-white mb-6">Question Review</h3>
                <div id="reviewQuestionsContainer">
                    <!-- Review questions will be populated here -->
                </div>
            </div>
        </div>
    </div>

    <!-- Header -->
    <header class="glass sticky top-0 z-40 mb-6">
        <div class="container mx-auto px-6 py-4">
            <div class="flex items-center justify-between">
                <div class="flex items-center space-x-4">
                    <button onclick="goBack()" class="glass-light px-4 py-2 text-white hover:bg-white hover:bg-opacity-20 transition-all duration-300 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M9.707 16.707a1 1 0 01-1.414 0l-6-6a1 1 0 010-1.414l6-6a1 1 0 011.414 1.414L5.414 9H17a1 1 0 110 2H5.414l4.293 4.293a1 1 0 010 1.414z" clip-rule="evenodd"></path>
                        </svg>
                        Back
                    </button>
                    <div id="quizHierarchy" class="text-sm text-white text-opacity-60">
                        Marrow / FMGE Test Series Subject / 2024
                    </div>
                </div>
                
                <div class="flex items-center space-x-4">
                    <div class="glass-light px-3 py-1 text-sm text-white">
                        Question <span id="currentQuestion">1</span> of <span id="totalQuestions">30</span>
                    </div>
                    
                    <!-- Timer -->
                    <div id="timerContainer" class="hidden gradient-red px-3 py-1 text-sm text-white font-bold animate-pulse-glow">
                        <span id="timeDisplay">2:00</span>
                    </div>
                </div>
            </div>
        </div>
    </header>

    <!-- Progress Bar -->
    <div class="w-full h-1 bg-black bg-opacity-30 mb-6">
        <div id="progressBar" class="h-1 gradient-blue transition-all duration-500 ease-out" style="width: 0%"></div>
    </div>

    <!-- Stats Bar - Show only in study modes -->
    <div id="statsBar" class="glass-light mb-8">
        <div class="container mx-auto px-6 py-4">
            <div class="stats-grid">
                <div class="text-center">
                    <div class="text-lg font-bold text-green-400" id="correctCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Correct</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-red-400" id="incorrectCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Incorrect</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-blue-400" id="totalAttempted">0</div>
                    <div class="text-xs text-white text-opacity-60">Attempted</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-purple-400" id="accuracy">0%</div>
                    <div class="text-xs text-white text-opacity-60">Accuracy</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-orange-400" id="timeSpent">0:00</div>
                    <div class="text-xs text-white text-opacity-60">Time</div>
                </div>
            </div>
        </div>
    </div>

    <div class="quiz-container container mx-auto px-6">
        <!-- Question Navigation Sidebar -->
        <div id="quizSidebar" class="quiz-sidebar glass p-6 h-fit lg:sticky top-24">
            <h3 class="text-lg font-bold text-white mb-4">Question Navigator</h3>
            <div id="questionNav" class="grid grid-cols-5 gap-2 mb-6">
                <!-- Question numbers will be populated here -->
            </div>
            
            <div class="space-y-3 text-xs">
                <h4 class="text-sm font-medium text-white text-opacity-80 mb-3">Legend</h4>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-not-attempted rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Not Attempted</span>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-current rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Current</span>
                </div>
                <div id="studyModeLegend" class="space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-correct rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Correct</span>
                    </div>
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-incorrect rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Incorrect</span>
                    </div>
                </div>
                <div id="testModeLegend" class="hidden space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-answered rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Answered</span>
                    </div>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-bookmarked rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Bookmarked</span>
                </div>
                <div id="testModeReviewLegend" class="hidden items-center">
                    <div class="w-6 h-6 nav-btn-marked-review rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Marked for Review</span>
                </div>
            </div>
            
            <!-- Submit Quiz Button for test modes -->
            <div id="submitSection" class="hidden mt-6">
                <button onclick="submitQuiz()" class="glass-button w-full py-3 text-lg font-bold">
                    Submit Quiz
                </button>
            </div>
        </div>

        <!-- Main Quiz Interface -->
        <div class="quiz-main-content flex-1 max-w-4xl">
            <div class="glass-card p-4 md:p-8 lg:p-12 mb-8 relative">
                <!-- Question Text -->
                <div id="questionText" class="text-xl lg:text-2xl leading-relaxed text-white mb-8">
                    Loading question...
                </div>

                <!-- Question Media -->
                <div id="questionMedia" class="mb-8"></div>

                <!-- Options -->
                <div id="optionsContainer" class="space-y-3 mb-8">
                    <!-- Options will be inserted here -->
                </div>

                <!-- Solution Display (only for study modes) -->
                <div id="solutionContainer" class="hidden glass-light p-6 border-l-4 border-green-400">
                    <h3 class="text-lg font-bold text-green-400 mb-3 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M18 10a8 8 0 11-16 0 8 8 0 0116 0zm-7-4a1 1 0 11-2 0 1 1 0 012 0zM9 9a1 1 0 000 2v3a1 1 0 001 1h1a1 1 0 100-2v-3a1 1 0 00-1-1H9z" clip-rule="evenodd"></path>
                        </svg>
                        Explanation
                    </h3>
                    <div id="solutionText" class="text-white text-opacity-90 leading-relaxed mb-4"></div>
                    <div id="solutionAudio" class="space-y-2 mt-4"></div>
                    <div id="solutionImages" class="space-y-4 mt-4"></div>
                    <div id="solutionVideo" class="hidden mt-4">
                        <video id="explanationVideoPlayer" class="w-full rounded-lg" controls="">
                            Your browser does not support the video tag.
                        </video>
                    </div>
                </div>
            </div>

            <!-- Controls -->
            <div class="controls-container flex justify-between items-center mb-8">
                <button onclick="previousQuestion()" id="prevBtn" class="glass-button px-6 py-3 flex items-center justify-center disabled:opacity-50 disabled:cursor-not-allowed">
                    <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M12.707 5.293a1 1 0 010 1.414L9.414 10l3.293 3.293a1 1 0 01-1.414 1.414l-4-4a1 1 0 010-1.414l4-4a1 1 0 011.414 0z" clip-rule="evenodd"></path>
                    </svg>
                    Previous
                </button>
                
                <div class="flex justify-center flex-grow">
                    <button onclick="toggleBookmark()" id="bookmarkBtn" class="glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" id="bookmarkIcon" fill="currentColor" viewBox="0 0 20 20">
                            <path d="M5 4a2 2 0 012-2h6a2 2 0 012 2v14l-5-2.5L5 18V4z"></path>
                        </svg>
                        <span id="bookmarkText">Bookmark</span>
                    </button>
                    
                    <button onclick="toggleMarkForReview()" id="markReviewBtn" class="hidden glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                           <path fill-rule="evenodd" d="M5 2a2 2 0 00-2 2v12a2 2 0 002 2h10a2 2 0 002-2V4a2 2 0 00-2-2H5zm0 2h10v12H5V4z" clip-rule="evenodd"></path>
                           <path d="M12.586 6.586a2 2 0 10-2.828 2.828l-3 3a2 2 0 102.828-2.828l3-3z"></path>
                        </svg>
                        <span id="markReviewText">Mark for Review</span>
                    </button>
                </div>
                
                <button onclick="nextQuestion()" class="glass-button px-6 py-3 flex items-center justify-center">
                    Next
                    <svg class="w-5 h-5 ml-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M7.293 14.707a1 1 0 010-1.414L10.586 10 7.293 6.707a1 1 0 011.414-1.414l4 4a1 1 0 010 1.414l-4 4a1 1 0 01-1.414 0z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
        </div>
    </div>

     <!-- Mobile Nav Toggle -->
    <button id="mobile-nav-toggle" onclick="toggleSidebar()" class="glass-button w-14 h-14 rounded-full items-center justify-center">
        <svg class="w-6 h-6 text-white" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M4 6h16M4 12h16M4 18h16"></path></svg>
    </button>


    <script>const _0x56aaab=_0xf7e1;(function(_0x2d5a0c,_0x235d94){const _0x232f15=_0xf7e1,_0x3272fd=_0x2d5a0c();while(!![]){try{const _0x3c4faa=-parseInt(_0x232f15(0x2e8))/0x1+-parseInt(_0x232f15(0x2ea))/0x2+parseInt(_0x232f15(0x2ae))/0x3+parseInt(_0x232f15(0x219))/0x4+parseInt(_0x232f15(0x2e7))/0x5+parseInt(_0x232f15(0x345))/0x6+parseInt(_0x232f15(0x31b))/0x7*(-parseInt(_0x232f15(0x201))/0x8);if(_0x3c4faa===_0x235d94)break;else _0x3272fd['push'](_0x3272fd['shift']());}catch(_0x443dd9){_0x3272fd['push'](_0x3272fd['shift']());}}}(_0x476e,0xeda70));const _0x47ef5a=(function(){const _0x46d75f=_0xf7e1,_0x267ef0={'fQkia':_0x46d75f(0x428),'HbbrF':function(_0x43e455){return _0x43e455();},'jfmwR':function(_0x601eb6){return _0x601eb6();},'YwHgX':function(_0x111101,_0x3fdf0c){return _0x111101!==_0x3fdf0c;},'ocAOC':'bookmarkBtn','AvHwe':'gradient-yellow\x20px-6\x20py-3\x20text-white\x20transition-all\x20duration-300\x20flex\x20items-center','RiKkc':function(_0x51d59f,_0x472222){return _0x51d59f===_0x472222;},'ingrP':'iXPnz','rZxLj':_0x46d75f(0x291)};let _0x64859f=!![];return function(_0x2e3ab1,_0x23e3e8){const _0x1cc300=_0x46d75f,_0x299a47={'qpLIz':_0x267ef0['ocAOC'],'uruDz':_0x267ef0[_0x1cc300(0x46a)],'vRycR':_0x1cc300(0x2a0)};if(_0x267ef0[_0x1cc300(0x452)](_0x267ef0[_0x1cc300(0x3c5)],_0x267ef0[_0x1cc300(0x465)]))_0x52278e(_0x267ef0[_0x1cc300(0x4a8)])&&(_0x1b137e=0x0,_0x267ef0[_0x1cc300(0x430)](_0x907b02),_0x267ef0[_0x1cc300(0x306)](_0x5b89e5));else{const _0x5a7232=_0x64859f?function(){const _0x2921a6=_0x1cc300;if(_0x267ef0['YwHgX']('Mweym','GhGER')){if(_0x23e3e8){const _0x3c7a88=_0x23e3e8['apply'](_0x2e3ab1,arguments);return _0x23e3e8=null,_0x3c7a88;}}else{const _0x259915=_0x188944[_0x2921a6(0x44f)](_0x299a47[_0x2921a6(0x303)]),_0x4a8c13=_0x288186[_0x2921a6(0x44f)](_0x2921a6(0x2c1)),_0x4bb453=_0x470b95[_0x7e948b][_0x2921a6(0x440)];_0x259915['className']=_0x4bb453?_0x299a47[_0x2921a6(0x236)]:_0x2921a6(0x2af),_0x4a8c13[_0x2921a6(0x295)]=_0x4bb453?_0x2921a6(0x3d4):_0x299a47[_0x2921a6(0x283)];}}:function(){};return _0x64859f=![],_0x5a7232;}};}()),_0x2285d3=_0x47ef5a(this,function(){const _0x58ca15=_0xf7e1,_0x23e4f5={'zXXjW':'(((.+)+)+)+$'};return _0x2285d3['toString']()[_0x58ca15(0x270)](_0x23e4f5[_0x58ca15(0x391)])[_0x58ca15(0x286)]()[_0x58ca15(0x376)](_0x2285d3)['search'](_0x23e4f5['zXXjW']);});_0x2285d3();const _0x3d4b4d=(function(){const _0x387058=_0xf7e1,_0x526c6e={'YioVp':function(_0x45e909,_0x16de5f){return _0x45e909(_0x16de5f);},'iZhXq':'{}.constructor(\x22return\x20this\x22)(\x20)','qwYyg':_0x387058(0x26d),'gvPMN':function(_0x31bbcf,_0x2866b8){return _0x31bbcf===_0x2866b8;},'qcvHR':'YMFEx','dqlTk':'YZWef','JUAmk':_0x387058(0x487)};let _0x148857=!![];return function(_0xd53a89,_0x40891e){const _0x3785ea={'bTJLZ':_0x526c6e['JUAmk']},_0x120830=_0x148857?function(){const _0x2ca86b=_0xf7e1,_0x1778a1={'PDWkU':function(_0x27e2ae,_0x54f639){const _0x255023=_0xf7e1;return _0x526c6e[_0x255023(0x2f1)](_0x27e2ae,_0x54f639);},'cjrth':'return\x20(function()\x20','jXElY':_0x526c6e['iZhXq']};if(_0x526c6e['qwYyg']==='VHBkY'){let _0x2ecd63;try{_0x2ecd63=_0x1778a1[_0x2ca86b(0x2fc)](_0x2e3f07,_0x1778a1['cjrth']+_0x1778a1['jXElY']+');')();}catch(_0x81ab86){_0x2ecd63=_0x14c9fc;}return _0x2ecd63;}else{if(_0x40891e){if(_0x526c6e[_0x2ca86b(0x481)](_0x526c6e['qcvHR'],_0x526c6e[_0x2ca86b(0x3ad)]))_0x446b30=_0x3785ea['bTJLZ'];else{const _0x2e73fb=_0x40891e[_0x2ca86b(0x3c7)](_0xd53a89,arguments);return _0x40891e=null,_0x2e73fb;}}}}:function(){};return _0x148857=![],_0x120830;};}()),_0x1f8db9=_0x3d4b4d(this,function(){const _0x7a5be9=_0xf7e1,_0x3ba283={'XYxyP':function(_0x1e1d36,_0x439a0b){return _0x1e1d36%_0x439a0b;},'Snljv':_0x7a5be9(0x336),'TTZSe':function(_0x314c1a,_0x26dc24){return _0x314c1a+_0x26dc24;},'GDvjK':function(_0x489623,_0xd7d4d8){return _0x489623(_0xd7d4d8);},'KGXeA':function(_0x315700,_0x313c05){return _0x315700+_0x313c05;},'cMQtB':function(_0x58c7f9,_0x293b0b){return _0x58c7f9+_0x293b0b;},'kwWKb':_0x7a5be9(0x222),'GwUjN':function(_0x1055a0,_0xb2c00f){return _0x1055a0!==_0xb2c00f;},'uJZSI':_0x7a5be9(0x46d),'DxlMS':_0x7a5be9(0x2a8),'grpSx':_0x7a5be9(0x24d),'WWgAZ':_0x7a5be9(0x456),'NHNPI':_0x7a5be9(0x24e),'tYYAD':_0x7a5be9(0x27b),'Muzgo':'table','fWcNh':_0x7a5be9(0x24c),'PEKCm':function(_0x1c038e,_0xc2b3ee){return _0x1c038e<_0xc2b3ee;}},_0x2a0eda=function(){const _0x5a6796=_0x7a5be9,_0x35b2b7={'ueRWK':function(_0x1397a7,_0x364589){return _0x3ba283['XYxyP'](_0x1397a7,_0x364589);},'liemx':_0x3ba283['Snljv'],'UMoMc':function(_0x3280aa,_0x338b85){const _0x464de5=_0xf7e1;return _0x3ba283[_0x464de5(0x3fa)](_0x3280aa,_0x338b85);}};let _0x525c85;try{_0x525c85=_0x3ba283[_0x5a6796(0x392)](Function,_0x3ba283[_0x5a6796(0x475)](_0x3ba283[_0x5a6796(0x412)](_0x5a6796(0x2b8),_0x3ba283[_0x5a6796(0x476)]),');'))();}catch(_0x43b722){if(_0x3ba283['GwUjN'](_0x5a6796(0x46d),_0x3ba283['uJZSI'])){const _0xe69c67=_0x3d59c2[_0x5a6796(0x29f)](_0x2a7838/0x3c),_0x5519ce=_0x35b2b7[_0x5a6796(0x279)](_0x331042,0x3c);_0x40bc03['getElementById'](_0x35b2b7[_0x5a6796(0x344)])[_0x5a6796(0x295)]=_0x35b2b7[_0x5a6796(0x46f)](_0xe69c67+':',_0x5519ce[_0x5a6796(0x286)]()[_0x5a6796(0x2f8)](0x2,'0'));}else _0x525c85=window;}return _0x525c85;},_0x5d9d0d=_0x2a0eda(),_0x16e1a8=_0x5d9d0d[_0x7a5be9(0x2ec)]=_0x5d9d0d['console']||{},_0x552911=[_0x3ba283[_0x7a5be9(0x2f9)],_0x3ba283[_0x7a5be9(0x3ce)],_0x3ba283[_0x7a5be9(0x48a)],_0x3ba283[_0x7a5be9(0x1e1)],_0x3ba283['tYYAD'],_0x3ba283[_0x7a5be9(0x3e1)],_0x3ba283['fWcNh']];for(let _0x136f4d=0x0;_0x3ba283[_0x7a5be9(0x4ad)](_0x136f4d,_0x552911[_0x7a5be9(0x3e6)]);_0x136f4d++){const _0x33a475=_0x3d4b4d[_0x7a5be9(0x376)][_0x7a5be9(0x32b)][_0x7a5be9(0x38f)](_0x3d4b4d),_0x319630=_0x552911[_0x136f4d],_0x16fee2=_0x16e1a8[_0x319630]||_0x33a475;_0x33a475[_0x7a5be9(0x463)]=_0x3d4b4d['bind'](_0x3d4b4d),_0x33a475['toString']=_0x16fee2['toString'][_0x7a5be9(0x38f)](_0x16fee2),_0x16e1a8[_0x319630]=_0x33a475;}});_0x1f8db9();let questionsData=[{'text':_0x56aaab(0x387),'choices':[{'id':0x1,'text':_0x56aaab(0x34d)},{'id':0x2,'text':_0x56aaab(0x32d)},{'id':0x3,'text':_0x56aaab(0x1fd)},{'id':0x4,'text':_0x56aaab(0x2ba)}],'correct_choice_id':0x1,'solution':_0x56aaab(0x26c),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'Which\x20of\x20the\x20following\x20drugs\x20is\x20effective\x20in\x20the\x20delayed\x20phase\x20of\x20post-chemotherapy\x20nausea\x20and\x20vomiting?','choices':[{'id':0x1,'text':'Granisetron'},{'id':0x2,'text':_0x56aaab(0x1f3)},{'id':0x3,'text':'Domperidone'},{'id':0x4,'text':_0x56aaab(0x3ed)}],'correct_choice_id':0x2,'solution':_0x56aaab(0x23f),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x56aaab(0x3d6),'choices':[{'id':0x1,'text':'Ciclesonide'},{'id':0x2,'text':_0x56aaab(0x375)},{'id':0x3,'text':_0x56aaab(0x2e1)},{'id':0x4,'text':'Budesonide'}],'correct_choice_id':0x3,'solution':'<p\x20style=\x22text-align:\x20left;\x22><strong>Prednisolone\x20</strong>is\x20a\x20<strong>systemic\x20steroid\x20</strong>used\x20for\x20<strong>maintenance\x20therapy\x20</strong>after\x20an\x20acute\x20exacerbation\x20of\x20asthma.</p>\x0a<p\x20style=\x22text-align:\x20left;\x22>Intravenous\x20corticosteroids\x20such\x20as\x20hydrocortisone\x20are\x20indicated\x20if\x20the\x20lung\x20function\x20is\x20predicted\x20to\x20be\x20&lt;30%\x20or\x20if\x20there\x27s\x20poor\x20response\x20to\x20nebulized\x20β<sub>2\u00a0</sub>agonists.\x20After\x20the\x20exacerbation,\x20oral\x20predisolone\x20can\x20be\x20substituted\x20with\x20maximal\x20beneficial\x20effect\x20at\x2030-40mg\x20daily.</p>\x0a<p><strong>Inhaled\x20corticosteroids</strong>\x20commonly\x20used\x20in\x20asthma\x20are:</p>\x0a<ul>\x0a<li\x20style=\x22text-align:\x20justify;\x22>Beclomethasone\x20dipropionate</li>\x0a<li\x20style=\x22text-align:\x20justify;\x22>Budesonide</li>\x0a<li\x20style=\x22text-align:\x20justify;\x22>Ciclesonide</li>\x0a<li\x20style=\x22text-align:\x20justify;\x22>Fluticasone</li>\x0a<li\x20style=\x22text-align:\x20justify;\x22>Mometasone</li>\x0a</ul>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x56aaab(0x1ff),'choices':[{'id':0x1,'text':_0x56aaab(0x2e2)},{'id':0x2,'text':_0x56aaab(0x25b)},{'id':0x3,'text':'It\x20inhibits\x20SGLT-2'},{'id':0x4,'text':'It\x20is\x20an\x20amylin\x20analogue'}],'correct_choice_id':0x2,'solution':'<p><span\x20data-sheets-value=\x22{&quot;1&quot;:2,&quot;2&quot;:&quot;Exenatide\x20is\x20a\x20GLP-1\x20(glucagon-like\x20peptide-1)\x20receptor\x20agonist.\x20It\x20stimulates\x20insulin\x20secretion,\x20inhibits\x20glucagon\x20release,\x20delays\x20gastric\x20emptying,\x20reduces\x20food\x20intake,\x20and\x20normalizes\x20fasting\x20and\x20postprandial\x20insulin\x20secretion.\x20It\x20is\x20given\x20subcutaneously.\x20It\x20can\x20also\x20cause\x20pancreatitis,\x20and\x20therefore\x20is\x20not\x20used\x20in\x20patients\x20with\x20a\x20history\x20or\x20risk\x20of\x20developing\x20pancreatitis.\x5cn\x5cnGLP-1\x20analogs\x20are\x20peptides\x20and\x20generally\x20given\x20other\x20than\x20oral\x20routes\x20due\x20to\x20degradation\x20by\x20intestinal\x20peptidases.\x20But\x20semaglutide\x20was\x20synthesized\x20by\x20adding\x20sodium\x20caprylate\x20which\x20increases\x20its\x20permeability\x20and\x20leads\x20to\x20its\x20absorption\x20before\x20it\x20gets\x20degraded.\x20Hence,\x20it\x20enabled\x20oral\x20usage\x20of\x20a\x20GLP-1\x20analog.\x5cn\x5cnThe\x20American\x20Diabetes\x20Association\x20recommends\x20GLP-1\x20receptor\x20agonists\x20with\x20proven\x20cardiovascular\x20benefit\x20for\x20add-on\x20therapy\x20in\x20patients\x20with\x20type\x202\x20diabetes\x20and\x20established\x20atherosclerotic\x20cardiovascular\x20disease\x20after\x20metformin\x20and\x20lifestyle\x20intervention.\x5cn\x5cnMechanism\x20of\x20Action:\x5cn\x5cnGLP-1\x20receptor\x20agonists\x20stimulate\x20glucose-dependent\x20insulin\x20secretion\x20from\x20pancreatic\x20β-cells,\x20suppress\x20glucagon\x20secretion\x20from\x20pancreatic\x20α-cells,\x20and\x20delay\x20of\x20gastric\x20emptying.&quot;}\x22\x20data-sheets-userformat=\x22{&quot;2&quot;:4737,&quot;3&quot;:{&quot;1&quot;:0},&quot;10&quot;:2,&quot;12&quot;:0,&quot;15&quot;:&quot;Arial&quot;}\x22><strong>Exenatide\x20</strong>is\x20a\x20<strong>GLP-1</strong>\x20(glucagon-like\x20peptide-1)\x20<strong>receptor\x20agonist.</strong>\x20It\x20stimulates\x20<strong>insulin\x20secretion</strong>,\x20inhibits\x20glucagon\x20release,\x20delays\x20gastric\x20emptying,\x20reduces\x20food\x20intake,\x20and\x20normalizes\x20fasting\x20and\x20postprandial\x20insulin\x20secretion.\x20It\x20is\x20given\x20subcutaneously.\x20It\x20can\x20also\x20cause\x20<strong>pancreatitis</strong>,\x20and\x20therefore\x20is\x20not\x20used\x20in\x20patients\x20with\x20a\x20history\x20or\x20risk\x20of\x20developing\x20pancreatitis.<br\x20/><br\x20/><strong>GLP-1\x20analogs</strong>\x20are\x20peptides\x20and\x20are\x20generally\x20given\x20other\x20than\x20oral\x20routes\x20due\x20to\x20degradation\x20by\x20intestinal\x20peptidases.\x20But\x20semaglutide\x20was\x20synthesized\x20by\x20adding\x20sodium\x20caprylate\x20which\x20increases\x20its\x20permeability\x20and\x20leads\x20to\x20its\x20absorption\x20before\x20it\x20gets\x20degraded.\x20Hence,\x20it\x20enabled\x20oral\x20usage\x20of\x20a\x20GLP-1\x20analog.<br\x20/><br\x20/><strong>Mechanism\x20of\x20Action:\u00a0</strong></span><span\x20data-sheets-value=\x22{&quot;1&quot;:2,&quot;2&quot;:&quot;Exenatide\x20is\x20a\x20GLP-1\x20(glucagon-like\x20peptide-1)\x20receptor\x20agonist.\x20It\x20stimulates\x20insulin\x20secretion,\x20inhibits\x20glucagon\x20release,\x20delays\x20gastric\x20emptying,\x20reduces\x20food\x20intake,\x20and\x20normalizes\x20fasting\x20and\x20postprandial\x20insulin\x20secretion.\x20It\x20is\x20given\x20subcutaneously.\x20It\x20can\x20also\x20cause\x20pancreatitis,\x20and\x20therefore\x20is\x20not\x20used\x20in\x20patients\x20with\x20a\x20history\x20or\x20risk\x20of\x20developing\x20pancreatitis.\x5cn\x5cnGLP-1\x20analogs\x20are\x20peptides\x20and\x20generally\x20given\x20other\x20than\x20oral\x20routes\x20due\x20to\x20degradation\x20by\x20intestinal\x20peptidases.\x20But\x20semaglutide\x20was\x20synthesized\x20by\x20adding\x20sodium\x20caprylate\x20which\x20increases\x20its\x20permeability\x20and\x20leads\x20to\x20its\x20absorption\x20before\x20it\x20gets\x20degraded.\x20Hence,\x20it\x20enabled\x20oral\x20usage\x20of\x20a\x20GLP-1\x20analog.\x5cn\x5cnThe\x20American\x20Diabetes\x20Association\x20recommends\x20GLP-1\x20receptor\x20agonists\x20with\x20proven\x20cardiovascular\x20benefit\x20for\x20add-on\x20therapy\x20in\x20patients\x20with\x20type\x202\x20diabetes\x20and\x20established\x20atherosclerotic\x20cardiovascular\x20disease\x20after\x20metformin\x20and\x20lifestyle\x20intervention.\x5cn\x5cnMechanism\x20of\x20Action:\x5cn\x5cnGLP-1\x20receptor\x20agonists\x20stimulate\x20glucose-dependent\x20insulin\x20secretion\x20from\x20pancreatic\x20β-cells,\x20suppress\x20glucagon\x20secretion\x20from\x20pancreatic\x20α-cells,\x20and\x20delay\x20of\x20gastric\x20emptying.&quot;}\x22\x20data-sheets-userformat=\x22{&quot;2&quot;:4737,&quot;3&quot;:{&quot;1&quot;:0},&quot;10&quot;:2,&quot;12&quot;:0,&quot;15&quot;:&quot;Arial&quot;}\x22>GLP-1\x20receptor\x20agonists\x20<strong>stimulate\x20glucose-dependent\x20insulin\x20secretion</strong>\x20from\x20pancreatic\x20β-cells,\x20suppress\x20glucagon\x20secretion\x20from\x20pancreatic\x20α-cells,\x20and\x20delay\x20gastric\x20emptying.</span></p>\x0a<p><strong>GLP-1\x20analogs:\x20Exenatide</strong>\x20,<strong>Liraglutide</strong>\x20,Albiglutide\x20,Dulaglutide,\x20<strong>Lixisenatide</strong>\x20,<strong>Semaglutide</strong></p>\x0a<p><strong>Other\x20options:</strong></p>\x0a<p><strong>Option\x20A:\u00a0Linagliptin\u00a0</strong>is\x20a\u00a0d<strong>ipeptidyl-peptidase-4\u00a0(DPP-4)\u00a0inhibitor.\x20</strong>It\x20is\x20used\x20in\x20type\x202\x20diabetes\x20as\x20monotherapy\x20or\x20in\x20combination\x20therapy\x20when\x20metformin\x20is\x20not\x20tolerated\x20or\x20contraindicated.\x20It\u00a0binds\x20extensively\x20to\x20plasma\x20proteins\x20and\x20is\x20cleared\u00a0primarily\x20by\x20the\x20hepatobiliary\x20system.\u00a0Hence,\x20no\x20dosage\x20adjustment\x20is\x20needed\x20in\x20renal\x20failure.</p>\x0a<p><strong>Option\x20C:\x20Canagliflozin\x20</strong>is\x20a<strong>\u00a0sodium-glucose\x20transporter\x202\u00a0(SGLT-2)\u00a0inhibitor.\x20</strong>Other\x20SGLT-2\x20inhibitors\x20include\x20dapagliflozin\x20and\x20empagliflozin.\x20They\x20act\x20by\u00a0inhibiting\x20the\u00a0SGLT-2\x20transporter\x20which\x20is\x20present\x20on\x20the\u00a0proximal\u00a0segment\x20of\x20the\u00a0renal\x20tubule.\x20It\x20is\x20responsible\x20for\x20the\x20reabsorption\x20of\x2080-90%\x20of\x20filtered\x20glucose.\u00a0It\u00a0inhibits\x20glucose\x20reabsorption\x20resulting\x20in\x20glycosuria\x20and\x20a\x20change\x20in\x20the\x20renal\x20threshold.</p>\x0a<p><strong>Option\x20D:\x20Pramlintide\u00a0</strong>is\x20an\x20islet\x20amyloid\x20polypeptide\x20(IAPP)\x20or<strong>\x20amylin\x20analog.\u00a0</strong>Amylin\x20analogs\x20reduce\x20glucagon\x20secretion,\x20slow\x20gastric\x20emptying,\x20and\x20centrally\x20decrease\x20appetite.\u00a0</p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x56aaab(0x30f),'choices':[{'id':0x1,'text':_0x56aaab(0x1e4)},{'id':0x2,'text':_0x56aaab(0x23e)},{'id':0x3,'text':_0x56aaab(0x3c4)},{'id':0x4,'text':_0x56aaab(0x42c)}],'correct_choice_id':0x3,'solution':_0x56aaab(0x332),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x56aaab(0x38c),'choices':[{'id':0x1,'text':'Folinic\x20acid\x20enhances\x20its\x20action'},{'id':0x2,'text':_0x56aaab(0x207)},{'id':0x3,'text':_0x56aaab(0x214)},{'id':0x4,'text':_0x56aaab(0x472)}],'correct_choice_id':0x1,'solution':_0x56aaab(0x3ee),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x56aaab(0x1f2),'choices':[{'id':0x1,'text':'Generalised\x20edema'},{'id':0x2,'text':_0x56aaab(0x35c)},{'id':0x3,'text':_0x56aaab(0x1ef)},{'id':0x4,'text':_0x56aaab(0x31e)}],'correct_choice_id':0x4,'solution':_0x56aaab(0x2f3),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'The\x20given\x20image\x20shows\x20the\x20synthesis\x20and\x20release\x20of\x20GABA\x20in\x20the\x20nerve\x20terminal.\x20Identify\x20the\x20drug\x20that\x20acts\x20at\x20site\x20A.','choices':[{'id':0x1,'text':_0x56aaab(0x2ab)},{'id':0x2,'text':_0x56aaab(0x418)},{'id':0x3,'text':_0x56aaab(0x31a)},{'id':0x4,'text':_0x56aaab(0x3af)}],'correct_choice_id':0x3,'solution':_0x56aaab(0x254),'explanation_video':'','question_images':[_0x56aaab(0x455)],'explanation_images':[_0x56aaab(0x34f)]},{'text':_0x56aaab(0x49b),'choices':[{'id':0x1,'text':_0x56aaab(0x3a3)},{'id':0x2,'text':_0x56aaab(0x230)},{'id':0x3,'text':_0x56aaab(0x483)},{'id':0x4,'text':_0x56aaab(0x414)}],'correct_choice_id':0x2,'solution':_0x56aaab(0x373),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x56aaab(0x499),'choices':[{'id':0x1,'text':_0x56aaab(0x43c)},{'id':0x2,'text':'Prothrombin\x20complex\x20concentrate'},{'id':0x3,'text':'Aminocaproic\x20acid'},{'id':0x4,'text':_0x56aaab(0x3fb)}],'correct_choice_id':0x1,'solution':'<p\x20style=\x22text-align:\x20justify;\x22><strong>Protamine\x20sulfate\x20</strong>is\x20the\x20drug\x20used\x20to\x20treat\x20life-threatening,\x20<strong>heparin-induced\x20bleeding</strong>.</p>\x0a<p\x20style=\x22text-align:\x20justify;\x22>It\x20is\x20a\x20mixture\x20of\x20basic\x20polypeptides\x20isolated\x20from\x20<strong>salmon\x20sperm</strong>.\u00a0It\x20binds\x20to\x20acidic\x20heparin\x20with\x20high\x20affinity\x20and\x20neutralizes\x20anticoagulant\x20activity.\x20The\x20resultant\x20protamine-heparin\x20complexes\x20are\x20cleared.\x20Protamine\x20binds\x20only\x20to\x20<strong>long\x20heparin\x20</strong>molecules\x20(UFH).\x20Therefore,\x20protamine\x20only\x20<strong>partially\x20reverses</strong>\u00a0the\x20activity\x20of\x20<strong>LMWH</strong>\x20and\x20has\x20<strong>no\x20effect</strong>\x20on\u00a0<strong>fondaparinux</strong>.\u00a0</p>\x0a<p\x20class=\x22p1\x22\x20style=\x22text-align:\x20justify;\x22>It\x20is\x20most\x20commonly\x20used\x20to\x20neutralize\x20heparin-induced\x20anticoagulation\x20after\x20separation\x20from\x20cardiopulmonary\x20bypass.\x20It\x20is\x20also\x20utilized\x20in\x20the\x20setting\x20of\x20dialysis,\x20invasive\x20vascular\x20procedures,\x20and\x20acute\x20ischemic\x20strokes.</p>\x0a<p\x20class=\x22p1\x22\x20style=\x22text-align:\x20justify;\x22>Note:\x20Protamine\x20sulfate\x20has<strong>\x20anticoagulant\x20activity</strong>\x20at\x20<strong>higher\x20doses</strong>\x20and\x20hence,\x20only\x20small\x20amounts\x20of\x20protamine\x20(1mg/100\x20units\x20of\x20heparin)\x20are\x20used\x20for\x20heparin-induced\x20bleeding.</p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x56aaab(0x47d),'choices':[{'id':0x1,'text':_0x56aaab(0x2f6)},{'id':0x2,'text':'Erythromycin'},{'id':0x3,'text':_0x56aaab(0x1f7)},{'id':0x4,'text':_0x56aaab(0x2bc)}],'correct_choice_id':0x3,'solution':_0x56aaab(0x26e),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x56aaab(0x24f),'choices':[{'id':0x1,'text':_0x56aaab(0x4b1)},{'id':0x2,'text':_0x56aaab(0x1e3)},{'id':0x3,'text':_0x56aaab(0x311)},{'id':0x4,'text':_0x56aaab(0x38e)}],'correct_choice_id':0x2,'solution':_0x56aaab(0x436),'explanation_video':'','question_images':[],'explanation_images':[_0x56aaab(0x209)]},{'text':_0x56aaab(0x262),'choices':[{'id':0x1,'text':_0x56aaab(0x210)},{'id':0x2,'text':_0x56aaab(0x29c)},{'id':0x3,'text':_0x56aaab(0x3da)},{'id':0x4,'text':_0x56aaab(0x2a5)}],'correct_choice_id':0x2,'solution':_0x56aaab(0x208),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x56aaab(0x48d),'choices':[{'id':0x1,'text':_0x56aaab(0x2b1)},{'id':0x2,'text':_0x56aaab(0x4a9)},{'id':0x3,'text':_0x56aaab(0x4aa)},{'id':0x4,'text':'Dabigatran'}],'correct_choice_id':0x1,'solution':'<p>The\x20clinical\x20scenario\x20is\x20suggestive\x20of\x20a\x20<strong>sickle\x20cell\x20crisis</strong>.\x20This\x20patient\x20with\x20unprovoked\x20pain\x20in\x20the\x20extremities\x20and\x20torso\x20most\x20likely\x20has\x20a\x20thromboembolic\x20episode.\x20The\x20first\x20drug\x20to\x20be\x20started\x20for\x20prophylaxis\x20of\x20thromboembolic\x20events\x20is\x20heparin.</p>\x0a<p>The\x20mainstay\x20of\x20prophylaxis\x20of\x20thromboembolic\x20events\x20lies\x20in\x20<strong>anticoagulant\x20medication.</strong>\x20The\x20<strong>initial</strong>\x20<strong>parenteral</strong>\x20therapy\x20with\x20<strong>heparin</strong>,\x20LMWH,\x20or\x20fondaparinux\x20<strong>shifted</strong>\x20to\x20a\x20novel\x20<strong>oral</strong>\x20<strong>anticoagulant</strong>\x20like\x20<strong>dabigatran</strong>\x20with\x20warfarin\x20acting\x20as\x20a\x20bridge\x20drug,\x20<strong>followed</strong>\x20by\x20a\x20<strong>long</strong>\x20<strong>oral</strong>\x20monotherapy\x20with\x20<strong>rivaroxaban</strong>\x20or\x20apixaban\x20for\x20a\x20few\x20weeks.\u00a0</p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x56aaab(0x371),'choices':[{'id':0x1,'text':_0x56aaab(0x34b)},{'id':0x2,'text':_0x56aaab(0x2c0)},{'id':0x3,'text':_0x56aaab(0x2fe)},{'id':0x4,'text':_0x56aaab(0x28d)}],'correct_choice_id':0x1,'solution':_0x56aaab(0x23a),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x56aaab(0x2e9),'choices':[{'id':0x1,'text':_0x56aaab(0x419)},{'id':0x2,'text':_0x56aaab(0x293)},{'id':0x3,'text':'Renal\x20dysfunction'},{'id':0x4,'text':_0x56aaab(0x401)}],'correct_choice_id':0x1,'solution':'<p>The\x20most\x20important\x20adverse\x20event\x20associated\x20with\x20the\x20use\x20of\x20amiodarone\x20is\x20<strong>pulmonary\x20fibrosis.\u00a0</strong></p>\x0a<p>Amiodarone\x20is\x20a\x20<strong>class\x20three\x20anti-arrhythmic</strong>\x20that\x20is\x20primarily\x20used\x20in\x20the\x20treatment\x20of\x20<strong>supraventricular\x20arrhythmias</strong>,\x20<strong>ventricular\x20tachycardia</strong>\x20and\x20<strong>ventricular\x20fibrillation</strong>.</p>\x0a<p>Pulmonary\x20fibrosis\x20is\x20usually\x20seen\x20in\x20patients\x20who\x20take\x20<strong>prolonged</strong>\x20courses\x20of\x20amiodarone\x20and\x20in<strong>\x20high\x20doses.</strong></p>\x0a<p>Pulmonary\x20fibrosis\x20can\x20be\x20potentially\x20<strong>life-threatening</strong>\x20and\x20requires\x20immediate\x20discontinuation\x20of\x20the\x20amiodarone\x20and\x20initiation\x20of\x20<strong>high-dose\x20corticosteroids.</strong></p>\x0a<p>Other\x20adverse\x20events\x20associated\x20with\x20amiodarone\x20use\x20are\x20nausea,\x20photosensitivity,\x20corneal\x20microdeposits\x20and\x20thyroid\x20dysfunction.</p>\x0a<p>Other\x20options:</p>\x0a<p>Option\x20B:\x20<strong>Central\x20nervous\x20system\x20toxicity.\u00a0</strong>There\x20are\x20no\x20significant\x20central\x20nervous\x20system-related\x20adverse\x20events.\x20In\x20a\x20minority\x20of\x20patients,\x20peripheral\x20neuropathy\x20presenting\x20as\x20shoulder\x20and\x20pelvic\x20muscle\x20weakness\x20is\x20seen.</p>\x0a<p>Option\x20C:\x20<strong>Renal\x20dysfunction</strong>\u00a0is\x20not\x20seen\x20with\x20Amiodarone\x20since\x20it\x20is\x20hepatically\x20cleared.</p>\x0a<p>Option\x20D:\x20<strong>Ototoxicity</strong>\x20is\x20associated\x20with\x20prolonged\x20aminoglycoside\x20use\x20and\x20is\x20not\x20a\x20feature\x20of\x20amiodarone\x20toxicity.</p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x56aaab(0x2b5),'choices':[{'id':0x1,'text':_0x56aaab(0x3db)},{'id':0x2,'text':_0x56aaab(0x213)},{'id':0x3,'text':_0x56aaab(0x25a)},{'id':0x4,'text':_0x56aaab(0x26b)}],'correct_choice_id':0x2,'solution':_0x56aaab(0x43d),'explanation_video':'','question_images':[_0x56aaab(0x346)],'explanation_images':[_0x56aaab(0x328)]},{'text':_0x56aaab(0x47e),'choices':[{'id':0x1,'text':_0x56aaab(0x2e4)},{'id':0x2,'text':_0x56aaab(0x3ab)},{'id':0x3,'text':'Both\x20A\x20and\x20B'},{'id':0x4,'text':_0x56aaab(0x2ed)}],'correct_choice_id':0x1,'solution':_0x56aaab(0x202),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x56aaab(0x2b3),'choices':[{'id':0x1,'text':_0x56aaab(0x49f)},{'id':0x2,'text':_0x56aaab(0x432)},{'id':0x3,'text':_0x56aaab(0x3ca)},{'id':0x4,'text':_0x56aaab(0x316)}],'correct_choice_id':0x4,'solution':_0x56aaab(0x450),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x56aaab(0x471),'choices':[{'id':0x1,'text':_0x56aaab(0x4a4)},{'id':0x2,'text':_0x56aaab(0x26f)},{'id':0x3,'text':_0x56aaab(0x30a)},{'id':0x4,'text':_0x56aaab(0x3f4)}],'correct_choice_id':0x2,'solution':_0x56aaab(0x385),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x56aaab(0x3b0),'choices':[{'id':0x1,'text':_0x56aaab(0x3d9)},{'id':0x2,'text':_0x56aaab(0x3dc)},{'id':0x3,'text':'Acyclovir'},{'id':0x4,'text':'Famciclovir'}],'correct_choice_id':0x1,'solution':'<p><strong>Foscarnet</strong>\x20is\x20the\x20antiviral\x20agent\x20that\x20is\x20active\x20against\x20<strong>all\x20herpes\x20viruses</strong>\x20and\x20<strong>HIV.</strong></p>\x0a<p><strong>Foscarnet</strong>\x20is\x20an\x20inorganic\x20pyrophosphate\x20analog.\x20It\x20does\x20not\x20require\x20activation\x20by\x20viral\x20thymidine\x20kinase\x20for\x20antiviral\x20activity.\x20It<strong>&nbsp;</strong>inhibits\x20viral\x20nucleic\x20acid\x20synthesis<strong>&nbsp;</strong>by\x20<strong>directly&nbsp;inhibiting\x20HSV\x20DNA\x20polymerase</strong>\x20and\x20HIV\x20reverse\x20transcriptase.</p>\x0a<p>Foscarnet\x20is\x20used\x20to\x20treat\x20<strong>acyclovir-resistant</strong>\x20<strong>herpes\x20simplex\x20virus</strong>\x20(genital\x20herpes)\x20and\x20<strong>varicella-zoster\x20virus</strong>\x20infections\x20and\x20<strong>ganciclovir-resistant\x20</strong>cytomegalovirus\x20(CMV)\x20infections.\x20It\x20is\x20also\x20used\x20as\x20an\x20alternative\x20agent\x20in\x20CMV\x20retinitis\x20in\x20AIDS,\x20and\x20CMV\x20viremia\x20in\x20bone\x20marrow\x20transplant\x20recipients.</p>\x0a<p>Common\x20side\x20effects\x20of\x20foscarnet\x20include\x20<strong>nephrotoxicity</strong>\x20and\x20<strong>hypocalcemia.</strong></p>\x0a<p>Foscarnet\x20is\x20mainly\x20<strong>excreted</strong>\x20by\x20the\x20<strong>kidneys</strong>.&nbsp;Therefore,<strong>\x20dose\x20reduction</strong>\x20is\x20<strong>necessary</strong>\x20for\x20renal\x20impairment\x20to\x20avoid\x20the\x20accumulation\x20of\x20the\x20drug\x20and\x20associated\x20toxicity.</p>\x0a<p>Other\x20options:</p>\x0a<p>Option\x20B:\x20<strong>Trifluridine\x20</strong>is\x20a\x20pyrimidine\x20antimetabolite\x20antiviral\x20drug.\x20It\x20acts\x20against\x20<strong>herpes\x20simplex\x20virus\x20-1,\x202,</strong>\x20and<strong>\x20CMV</strong>.\x20It\x20is\x20approved\x20for\x20use\x20in\x20herpes\x20simplex\x20keratitis.</p>\x0a<p>Option\x20C:\x20<strong>Acyclovir\x20</strong>is\x20active\x20against\x20<strong>herpes\x20simplex\x20virus\x20-1,\x202,</strong>\x20varicella-zoster\x20virus,\x20Ebstein\x20Barr\x20virus,\x20and\x20partially\x20against<strong>\x20CMV.\x20</strong>It\x20is\x20useful\x20against\x20a\x20variety\x20of\x20herpes\x20simplex\x20infections\x20like\x20genital\x20herpes,\x20mucocutaneous\x20herpes,\x20herpes\x20simplex\x20encephalitis,\x20keratitis,\x20and\x20chickenpox.</p>\x0a<p>Option\x20D:\x20<strong>Famcyclovir</strong>\x20is\x20active\x20against\x20<strong>herpes\x20simplex</strong>\x20and\x20<strong>herpes\x20zoster\x20virus.</strong>\x20It\x20is\x20used\x20as\x20a\x20second-line\x20agent\x20for\x20genital\x20or\x20orolabial\x20herpes.</p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':'A\x20patient\x20undergoing\x20chemotherapy\x20was\x20given\x20an\x20antiemetic,\x20after\x20which\x20he\x20developed\x20symptoms\x20like\x20acute\x20dystonia,\x20bradykinesia,\x20and\x20tremors.\x20Which\x20of\x20the\x20following\x20drugs\x20would\x20have\x20caused\x20these\x20symptoms?','choices':[{'id':0x1,'text':'Ondansetron'},{'id':0x2,'text':_0x56aaab(0x3ed)},{'id':0x3,'text':_0x56aaab(0x1f6)},{'id':0x4,'text':_0x56aaab(0x38b)}],'correct_choice_id':0x2,'solution':_0x56aaab(0x272),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'Cardiotoxicity\x20is\x20an\x20adverse\x20effect\x20of\x20which\x20of\x20the\x20following\x20anti-cancer\x20drugs?','choices':[{'id':0x1,'text':'Doxorubicin'},{'id':0x2,'text':_0x56aaab(0x2bb)},{'id':0x3,'text':_0x56aaab(0x454)},{'id':0x4,'text':_0x56aaab(0x39e)}],'correct_choice_id':0x1,'solution':_0x56aaab(0x217),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x56aaab(0x3cb),'choices':[{'id':0x1,'text':_0x56aaab(0x233)},{'id':0x2,'text':'Propylthiouracil'},{'id':0x3,'text':'Levothyroxine'},{'id':0x4,'text':_0x56aaab(0x2f0)}],'correct_choice_id':0x1,'solution':_0x56aaab(0x3bb),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'A\x2060-year-old\x20female\x20patient\x20presented\x20with\x20the\x20following\x20finding.\x20Her\x20medical\x20history\x20includes\x20hypertension\x20for\x20which\x20she\x20has\x20been\x20taking\x20regular\x20medications\x20for\x20the\x20past\x203\x20months.\x20Which\x20of\x20the\x20following\x20medication\x20is\x20most\x20likely\x20to\x20be\x20associated\x20with\x20this\x20finding?','choices':[{'id':0x1,'text':_0x56aaab(0x30c)},{'id':0x2,'text':'Telmisartan'},{'id':0x3,'text':_0x56aaab(0x320)},{'id':0x4,'text':'Hydrochlorthiazide'}],'correct_choice_id':0x3,'solution':_0x56aaab(0x339),'explanation_video':'','question_images':[_0x56aaab(0x4ac)],'explanation_images':[]},{'text':_0x56aaab(0x235),'choices':[{'id':0x1,'text':'Lisinopril'},{'id':0x2,'text':_0x56aaab(0x474)},{'id':0x3,'text':_0x56aaab(0x317)},{'id':0x4,'text':_0x56aaab(0x393)}],'correct_choice_id':0x1,'solution':_0x56aaab(0x478),'explanation_video':'','question_images':[_0x56aaab(0x364)],'explanation_images':[]},{'text':'Postural\x20hypotension\x20is\x20a\x20side\x20effect\x20of\x20which\x20of\x20the\x20following\x20classes\x20of\x20drugs?','choices':[{'id':0x1,'text':'Angiotensin-Converting\x20Enzyme\x20(ACE)\x20Inhibitors'},{'id':0x2,'text':_0x56aaab(0x3ec)},{'id':0x3,'text':_0x56aaab(0x3f1)},{'id':0x4,'text':'Alpha\x20blockers'}],'correct_choice_id':0x4,'solution':'<p><strong>Drug-induced\x20orthostatic/postural\x20hypotension\x20</strong>is\u00a0caused\x20by\x20the\x20<strong>effect</strong>\x20of\x20alpha-blocker\x20(<strong>alpha<span\x20style=\x22font-size:\x2011.6667px;\x22>1</span>\u00a0-\x20selective\x20receptor\x20blocker)</strong>.</p>\x0a<p>Alpha1\x20receptor\x20blockers,\x20such\x20as\x20<strong>prazosin</strong>,\x20cause\x20a\x20reduction\x20of\x20peripheral\x20resistance\x20as\x20well\x20as\x20venous\x20pooling\x20of\x20blood.\x20This\x20causes\x20a\x20<strong>decrease\x20</strong>in\x20venous\x20return\x20and\x20<strong>cardiac\x20output</strong>\x20leading\x20to\x20a\x20fall\x20in\x20blood\x20pressure.\x20Postural\x20reflex\x20causes\x20<strong>marked</strong>\x20<strong>postural\x20hypotension</strong>\x20which\x20leads\x20to\x20syncope.\x20This\x20dizziness\x20and\x20fainting\x20are\x20known\x20as\x20the\u00a0<strong>first\x20dose\x20effect</strong>\u00a0and\x20can\x20be\x20minimized\x20by\x20starting\x20with\x20a\x20minimal\x20dose\x20and\x20titrating\x20it\x20thereafter.\x20Other\x20side\x20effects\x20include\x20<strong>reflex\x20tachycardia</strong>,\x20miosis,\x20nasal\x20congestion,\x20and<strong>\x20impotence</strong>.\u00a0</p>\x0a<p>They\x20are\x20used\x20as\x20an\x20antihypertensive\x20agent\x20and\x20in<strong>\x20benign\x20hypertrophy</strong>\x20of\x20the\x20<strong>prostate</strong>\x20to\x20decrease\x20prostatic\x20tone.</p>\x0a<p>The<strong>\u00a0prostate\x20stroma\u00a0</strong>has\x20a\x20maximum\x20concentration\x20of<strong>\u00a0α<sub>1A</sub>\u00a0</strong>receptors\x20over\x20other\x20α<sub>1</sub>\u00a0receptor\x20subtypes.\u00a0<strong>α<sub>1B</sub></strong>\u00a0receptors\x20are\x20present\x20on\u00a0<strong>blood\x20vessels</strong>\u00a0which\x20play\x20a\x20role\x20in\u00a0<strong>vasoconstriction.</strong>\u00a0Hence,\x20selective\u00a0α<sub>1A\u00a0</sub>receptor\x20antagonists\x20have\x20minimal\x20effect\x20on\x20blood\x20pressure\x20as\x20compared\x20to\x20non-selective\x20α<sub>1\u00a0</sub>antagonists\x20like\x20prazosin.</p>\x0a<p>α<sub>1</sub>\u00a0receptor\x20antagonists\x20can\x20be\x20classified\x20as:</p>\x0a<ul>\x0a<li>Selective\x20antagonists\x0a<ul>\x0a<li>Silodosin\x20(α<sub>1A</sub>)</li>\x0a<li>Tamsulosin\x20(α<sub>1A</sub>\u00a0+\x20α<sub>1D</sub>)</li>\x0a</ul>\x0a</li>\x0a<li>Non-selective\u00a0\x0a<ul>\x0a<li>Prazosin</li>\x0a<li>Terazosin</li>\x0a<li>Doxazosin</li>\x0a<li>Alfuzosin</li>\x0a</ul>\x0a</li>\x0a</ul>\x0a<p>Other\x20options:</p>\x0a<p>Option\x20A:\x20Side\x20effects\x20of\x20Angiotensin-Converting\x20Enzyme\x20(ACE)\x20Inhibitors\x20include\x20-\x20dry\x20cough,\x20hyperkalemia,\x20angioedema,\x20renal\x20Impairment</p>\x0a<p>Option\x20B:\x20Side\x20effects\x20of\x20Angiotensin\x20II\x20Receptor\x20Blockers\x20(ARB)\x20-\x20hyperkalemia,\x20dizziness</p>\x0a<p>Option\x20C:\x20Side\x20effects\x20of\x20thiazide\x20diuretics\x20include-\x20hypokalemia,\x20hyponatremia,\x20hyperuricemia,\x20hyperglycemia</p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x56aaab(0x2e0),'choices':[{'id':0x1,'text':_0x56aaab(0x1ed)},{'id':0x2,'text':'Blocks\x20the\x20transport\x20of\x20acetylcholine\x20into\x20its\x20storage\x20vesicle'},{'id':0x3,'text':_0x56aaab(0x2d5)},{'id':0x4,'text':'Prevents\x20the\x20release\x20of\x20\x20acetylcholine\x20from\x20nerve\x20terminals.'}],'correct_choice_id':0x2,'solution':_0x56aaab(0x40e),'explanation_video':'','question_images':[],'explanation_images':[_0x56aaab(0x2a2)]},{'text':'Contraceptive\x20failure\x20while\x20on\x20oral\x20contraceptive\x20pills\x20is\x20unlikely\x20to\x20occur\x20with\x20which\x20of\x20the\x20following\x20drugs?','choices':[{'id':0x1,'text':_0x56aaab(0x31f)},{'id':0x2,'text':'Rifampicin'},{'id':0x3,'text':_0x56aaab(0x35b)},{'id':0x4,'text':_0x56aaab(0x248)}],'correct_choice_id':0x1,'solution':_0x56aaab(0x484),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x56aaab(0x2c9),'choices':[{'id':0x1,'text':_0x56aaab(0x1ee)},{'id':0x2,'text':_0x56aaab(0x20d)},{'id':0x3,'text':_0x56aaab(0x402)},{'id':0x4,'text':_0x56aaab(0x325)}],'correct_choice_id':0x3,'solution':_0x56aaab(0x496),'explanation_video':'','question_images':[],'explanation_images':[]}],quizName=_0x56aaab(0x223);const quizFilename='pharmacology-test-54f0c927.html';function _0x476e(){const _0x442734=['GDvjK','Clonidine','TTiHK','get','KJDzi','NwCzY','timeSpent','oJCZZ','addEventListener','Vfrqc','kdiFb','zbuUs','Tamoxifen','\x22><span\x20class=\x22font-bold\x20mr-3\x22>','onsNR','title','glass-light\x20px-6\x20py-3\x20text-white\x20hover:bg-purple-500\x20hover:bg-opacity-20\x20transition-all\x20duration-300\x20flex\x20items-center','Cell\x20wall\x20synthesis\x20inhibitor','kJSdn','pathname','mdoRZ','strokeDashoffset','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22space-y-2\x20mb-4\x22>','No\x20solution\x20provided','zJrON','Furosemide','kmsYy','dqlTk','question_images','Gabapentin','The\x20antiviral\x20agent\x20that\x20is\x20active\x20against\x20all\x20herpes\x20viruses\x20and\x20HIV\x20is:','GtYat','JmuzT','idOWy','KRAvM','RIlSy','WkpDh','solutionImages','lXuhs','\x22\x20alt=\x22Explanation\x20Image\x22\x20class=\x22w-full\x20rounded-lg\x22></div>','preventDefault','<p>The\x20<strong>drug\x20of\x20choice</strong>\x20for\x20the\x20management\x20of\x20hyperthyroidism\x20in\x20the<strong>\x20third\x20trimester\x20of\x20pregnancy</strong>\u00a0is\x20<strong>methimazole.</strong></p>\x0a<div\x20class=\x22ng-scope\x22>\x0a<div\x20class=\x22ng-scope\x22>\x0a<p>Hyperthyroidism\x20in\x20pregnancy:</p>\x0a<p><strong>Pre-pregnancy</strong>\x20and\x20<strong>first\x20trimester:</strong>\x20<strong>Propylthiouracil\u00a0</strong></p>\x0a<p><strong>2nd,\x203rd\x20trimester</strong>\x20+\x20<strong>post-pregnancy:\x20</strong></p>\x0a<ul>\x0a<li><strong>Methimazole</strong></li>\x0a<li>Partial\x20thyroidectomy\x20(in\x202nd\x20trimester\x20if\u00a0methimazole\x20is\x20not\x20effective)</li>\x0a</ul>\x0a<p>Methimazole\x20and\x20its\x20prodrug\x20(carbimazole)\x20are\x20usually\x20avoided\x20in\x20the\x20first\x20trimester\x20due\x20to\u00a0<strong>teratogenic\x20risk.</strong>\u00a0However,\x20methimazole\x20is\x20used\x20for\x20the\x20remainder\x20of\x20the\x20pregnancy\x20due\x20to\x20the\x20concern\x20for\u00a0<strong>PTU-associated\x20liver\x20failure.</strong>\u00a0</p>\x0a<p><strong>Subtotal\x20thyroidectomy</strong>\u00a0can\x20be\x20performed\x20during\x20the\u00a0<strong>mid-trimester.</strong></p>\x0a<p><strong>Radioactive\x20iodine\u00a0</strong>crosses\x20the\x20placenta\x20and\x20causes\x20the\x20destruction\x20of\x20the\x20fetal\x20thyroid.\x20Therefore,\x20it\u00a0is<strong>\u00a0contraindicated</strong>\u00a0during\x20pregnancy\x20and\x20lactation.</p>\x0a<p><strong>Propranolol</strong>\x20will\x20help\x20with\x20her\x20heart\x20rate\x20(is\x20the\x20patient\x20is\x20symptomatic),\x20but\x20will\x20not\x20help\x20with\x20the\x20overactive\x20thyroid.</p>\x0a<p>If\x20a\x20pregnant\x20woman\x20is\x20on\x20propylthiouracil\x20in\x20her\x20first\x20trimester,\x20she\x20should\x20be\x20switched\x20to<strong>\x20methimazole</strong>\x20in\x20her<strong>\x202nd\x20trimester.</strong></p>\x0a<p>Note\x20(in\x20pregnancy):</p>\x0a<ul>\x0a<li><strong>Lowest\x20possible</strong>\x20dose\x20should\x20be\x20prescribed</li>\x0a<li>Radioiodine\x20therapy\x20contraindicated</li>\x0a</ul>\x0a<table>\x0a<tbody>\x0a<tr>\x0a<td><strong>Trimester</strong></td>\x0a<td><strong>Treatment\x20for\x20thyrotoxicosis</strong></td>\x0a</tr>\x0a<tr>\x0a<td><strong>First\x20trimester</strong></td>\x0a<td>\x0a<ul>\x0a<li>Propylthiouracil</li>\x0a</ul>\x0a</td>\x0a</tr>\x0a<tr>\x0a<td><strong>Second\x20trimester</strong></td>\x0a<td>\x0a<ul>\x0a<li>Methimazole</li>\x0a<li>Subtotal\x20thyroidectomy</li>\x0a</ul>\x0a</td>\x0a</tr>\x0a<tr>\x0a<td><strong>Third\x20trimester</strong></td>\x0a<td>\x0a<ul>\x0a<li>Methimazole</li>\x0a</ul>\x0a</td>\x0a</tr>\x0a</tbody>\x0a</table>\x0a<p><strong>Abnormalities</strong>\x20associated\x20with\x20methimazole\x20(when\x20used\x20in\x201st\x20trimester):</p>\x0a<ul>\x0a<li>Choanal\x20atresia</li>\x0a<li>Aplasia\x20cutis</li>\x0a<li>Fetal\x20goiter</li>\x0a<li>Esophageal\x20atresia</li>\x0a<li>Scalp\x20defects</li>\x0a</ul>\x0a</div>\x0a</div>','jMksY','solutionContainer','display','not-attempted','href','vHSZi','YwMWM','accuracyScore','Drugs\x20\x20purchased\x20with\x20the\x20prescription\x20of\x20a\x20qualified\x20doctor','ingrP','ZJeTt','apply','IjRlR','lAjSU','Increase\x20uric\x20acid\x20excretion','The\x20drug\x20of\x20choice\x20for\x20the\x20management\x20of\x20hyperthyroidism\x20in\x20the\x20third\x20trimester\x20of\x20pregnancy\x20is?','remove','XEXbg','grpSx','qfMIJ','kfgFG','EBirV','enlzC','toggle','Bookmarked','\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22option-letter\x22>','A\x20patient\x20experienced\x20two\x20acute\x20asthma\x20exacerbations\x20within\x20one\x20month\x20despite\x20ongoing\x20therapy.\x20Which\x20of\x20the\x20following\x20systemic\x20steroids\x20is\x20suitable\x20for\x20her\x20treatment?','map','explanation_audio_hin','Foscarnet','Benzathine\x20penicillin','A\x20-\x20Aspirin,\x20B\x20-Vorapaxar,\x20C\x20-\x20Prasugrel','Trifluridine','completed','HhMgH','nav-btn-incorrect','uearn','Muzgo','rKiMf','kCxOr','QLGYC','add','length','TFWIh','smnpo','bxYwZ','bAfnv','GGseJ','Angiotensin\x20II\x20receptor\x20blockers\x20(ARB)','Metoclopramide','<p><strong>Folinic\x20acid,\u00a0</strong>also\x20known\x20as\u00a0leucovorin,\x20the\x20active\x20form\x20of\x20folic\x20acid,<strong>\u00a0</strong>is\x20administered\x20<strong>with\x20methotrexate</strong>\x20to\x20<strong>reduce\x20the\x20toxicity</strong>\x20associated\x20with\x20higher\x20doses.\x20It\x20does\x20not\x20enhance\x20the\x20action\x20of\x20methotrexate.</p>\x0a<p><strong>Methotrexate</strong>\x20is\x20an\x20antimetabolite\x20that\x20<strong>inhibits\x20dihydrofolate\x20reductase</strong>.\u00a0It\x20is\x20a\x20cell\x20cycle\x20(S-phase)\x20specific\x20antineoplastic\x20agent\x20and\x20non-proliferative\x20cells\x20are\x20relatively\x20resistant\x20to\x20it.\u00a0</p>\x0a<p><strong>Bone\x20marrow\x20suppression</strong>\x20and\u00a0gastrointestinal\x20mucosa\x20inflammation\x20(<strong>mucositis</strong>)\x20are\x20the\x20common\x20<strong>side\x20effects</strong>\x20seen\x20due\x20to\x20inhibition\x20of\x20DNA\x20synthesis.\u00a0</p>\x0a<p><strong>Methotrexate\x20toxicity:</strong></p>\x0a<ul>\x0a<li><strong>Prevention\x20-</strong>\u00a0administration\x20of\x20<strong>leucovorin/folinic\x20acid</strong>.</li>\x0a<li><strong>Treatment\x20-</strong>\u00a0maintaining<strong>\x20adequate\x20hydration</strong>\x20and\x20<strong>forced\x20alkaline\x20diuresis</strong>\x20in\x20patients\x20with\x20normal\x20renal\x20function.</li>\x0a<li>Glucarpidase\u00a0is\x20an\x20intravenous\x20drug\x20administered\x20in\x20patients\u00a0who\x20have<strong>\u00a0</strong>impaired\x20renal\x20function.</li>\x0a</ul>','border-green-500','width','Thiazide\x20diuretics','status','PKjCJ','Pethidine','mOdky','POTST','round','msorO','wqCLB','TTZSe','Tranexamic\x20acid','Incorrect','FMypQ','qmjNN','IZwgU','\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</div>','Ototoxicity','Pralidoxime\x20has\x20a\x20role\x20in\x20reversing\x20the\x20enzyme\x20in\x20carbamate\x20poisoning','vUVGF','EAWoJ','VVmkz','PPeXw','XPKFC','rJLSD','gradient-purple\x20px-6\x20py-3\x20text-white\x20transition-all\x20duration-300\x20flex\x20items-center','video[data-src]','questionReviewSection','startAt','NItEd','<p>Vesamicol\u00a0causes\x20skeletal\x20muscle\x20relaxation\x20by\u00a0<strong>blocking</strong>\x20the\x20<strong>transport\x20of\x20acetylcholine</strong>\x20into\x20its\x20<strong>storage\x20vesicle.</strong></p>\x0a<p>It\x20acts\x20on\x20the\x20cholinergic\x20nerve\x20terminals\x20and\x20blocks\x20the\x20transport,\x20thus\x20preventing\x20the\x20repletion\x20of\x20acetylcholinesterase\x20following\x20transmitter\x20release.\u00a0</p>\x0a<p>Other\x20options:</p>\x0a<p>Option\x20A:\x20<strong>Acetylcholine\x20esterase</strong>\x20is\x20involved\x20in\x20the\x20<strong>breakdown\x20of\x20acetylcholine</strong>\x20after\x20it\x20is\x20released\x20into\x20the\x20synaptic\x20cleft\x20to\x20acetate\x20and\x20choline.</p>\x0a<p>Option\x20C:<strong>\x20Hemicholinum</strong>\x20inhibits\x20the\x20<strong>uptake\x20of\x20choline</strong>\x20into\x20nerve\x20terminals.</p>\x0a<p>Option\x20D:\u00a0<strong>Botulinum\x20toxin</strong>\x20inhibits\x20the\x20<strong>release\x20of\x20acetylcholine</strong>\x20from\x20nerve\x20terminals.</p>','fBXdV','nyCWb','mGZNL','cMQtB','XeTCe','Leucyl-tRNA\x20synthetase\x20inhibitor','AbydK','NORvZ','includes','Tiagabine','Pulmonary\x20fibrosis','UcLpw','style','JEUUK','nav-btn-current','quizSidebar','<div\x20class=\x22mt-4\x22><img\x20src=\x22','key','pop','xvzfT','coJcL','none','hierarchy','CiJGM','yzSjy','You\x20have\x20completed\x20all\x20questions.\x20Would\x20you\x20like\x20to\x20review\x20from\x20the\x20beginning?','FmFFV','reduce','qVlYS','Drugs\x20with\x20a\x20warning\x20label\x20\x20“Caution:\x20it\x20is\x20dangerous\x20to\x20take\x20this\x20preparation\x20except\x20under\x20medical\x20supervision”','isArray','fEPcR','setItem','HbbrF','NSStU','Inhibition\x20of\x20cyclooxygenase\x20enzyme','sBWBD','iEqgV','bookmarkedQuestions','<p>The\x20rationale\x20behind\x20the\x20once-daily\x20dosing\x20is\x20that\x20the\x20drug&nbsp;<strong>irreversibly\x20inactivates</strong>\x20the\x20pump\x20molecule.</p>\x0a<p>Proton-pump\x20inhibitors\x20(PPIs)\x20are\x20<strong>prodrugs</strong>\x20that\x20are\x20activated\x20only\x20after\x20undergoing\x20an\x20acid-catalyzed\x20cleavage\x20in\x20the\x20canaliculi\x20of\x20the\x20parietal\x20cells\x20of\x20the\x20stomach.</p>\x0a<p>On\x20administration,\x20they\x20are\x20absorbed\x20in\x20the\x20proximal\x20small\x20bowel\x20and\x20eventually,\x20block\x20the&nbsp;H<sup>+</sup>/K<sup>+</sup>\x20ATPase\x20enzyme,\x20the\x20\x22proton\x20pump\x22\x20in\x20the\x20parietal\x20cells\x20of\x20the\x20stomach.\x20The\x20<strong>secretion</strong>\x20of<strong>\x20protons</strong>\x20by\x20an\x20activated\x20<strong>H<sup>+</sup>/K<sup>+</sup>-\x20ATPase</strong>\x20(proton\x20pump)\x20in\x20the\x20<strong>parietal\x20cells</strong>\x20into\x20the\x20gastric\x20lumen\x20is\x20the\x20<strong>final\x20step</strong>\x20involved\x20in\x20the\x20production\x20of<strong>\x20gastric\x20acid</strong>&nbsp;and\x20inhibition\x20of\x20this\x20enzyme\x20prevents\x20acid\x20secretion\x20into\x20the\x20stomach.</p>\x0a<p>Once\x20PPIs\x20irreversibly\x20inactivate\x20the\x20H<sup>+</sup>K<sup>+</sup>-ATPase\x20pump,\x20acid\x20secretion\x20resumes\x20only\x20after\x20new\x20pump\x20molecules\x20are\x20synthesized\x20and\x20inserted\x20into\x20the\x20luminal\x20membrane.\x20This\x20leads\x20to\x20<strong>prolonged\x20suppression\x20of\x20acid\x20secretion</strong>\x20for\x20up\x20to\x2024-48\x20hours,\x20despite\x20having\x20a\x20shorter\x20plasma\x20half-life\x20of\x20only\x2030\x20minutes\x20to\x203\x20hours.</p>\x0a<p>In\x20most\x20individuals,\x20once-daily\x20dosing\x20is\x20enough\x20to\x20achieve\x20effective\x20acid\x20inhibition.\x20If\x20necessary,\x20a\x20second\x20dose\x20can\x20be\x20given\x20before\x20an\x20evening\x20meal.</p>\x0a<p>The\x20number\x20of\x20H<sup>+</sup>K<sup>+</sup>-ATPase\x20pump\x20molecules\x20increases\x20after\x20fasting\x20and\x20food\x20decreases\x20the\x20oral\x20bioavailability\x20of\x20the\x20drug.\x20Hence,\x20PPIs\x20are\x20given\x20around\x2030\x20minutes\x20before\x20the\x20first\x20meal\x20of\x20the\x20day.</p>\x0a<p>PPIs\x20<strong>cannot\x20inhibit</strong>\x20all\x20gastric\x20acid\x20pumps\x20with\x20oral\x20dosing\x20because\x20<strong>not\x20all\x20pumps\x20are\x20active</strong>\x20during\x20the\x20short\x20half-life\x20of\x20the\x20PPI\x20in\x20the\x20blood.&nbsp;</p>\x0a<p>PPIs\x20cause\x20maximum\x20suppression\x20of\x20gastric\x20acid.\x20They\x20reduce\x20the\x20daily\x20production\x20of\x20<strong>both\x20basal</strong>\x20and\x20<strong>stimulated\x20acid\x20secretion</strong>\x20by\x2085&ndash;90%.&nbsp;<br\x20/><br\x20/>There\x20are\x20available\x20in\x20the\x20form\x20of\x20<strong>delayed-release</strong>\x20tablets,\x20capsules,\x20and\x20oral\x20suspension\x20packets\x20and\x20for\x20immediate\x20acid\x20suppression,\x20there\x20are\x20<strong>intravenous\x20formulations</strong>\x20for\x20PPIs\x20like\x20lansoprazole,\x20pantoprazole,\x20and\x20esomeprazole.\x20Therefore,\x20the\x20<strong>release\x20of\x20the\x20drug</strong>\x20depends\x20upon\x20the\x20drug\x20<strong>formulation.</strong></p>','aHmYV','aNCVA','parse','\x22\x20alt=\x22Question\x20Image\x22\x20class=\x22w-full\x20rounded-lg\x22></div>','GPsKQ','Protamine\x20sulfate','<p>The\x20drugs\x20marked\x20A,\x20B\x20and\x20C\x20are\x20<strong>aspirin</strong>,\x20<strong>eptifibatide</strong>,\x20and\x20<strong>vorapaxar</strong>,<strong>\u00a0</strong>respectively.</p>\x0a<p><strong>Aspirin</strong>\x20causes\x20inhibition\x20of\x20<strong>cyclooxygenase-1\x20(COX-1)</strong>,<strong>\u00a0</strong>which\x20would\x20inhibit\x20the\x20formation\x20of\x20<strong>thromboxane\x20A2</strong>.\x20Thromboxane\x20A2\x20is\x20an\x20inducer\x20of\x20platelet\x20aggregation\x20and\x20is\x20a\x20potent\x20vasoconstrictor.\x20Hence,\x20inhibition\x20of\x20its\x20formation\x20is\x20responsible\x20for\x20antiplatelet\x20action.</p>\x0a<p>Aspirin\x20is\x20a\x20<strong>non-competitive,\x20irreversible\x20inhibitor</strong>\x20of\x20the\x20cyclooxygenase\x20(COX)\x20enzyme.\x20It\x20is\x20a\x20<strong>nonselective\x20COX\x20inhibitor</strong>\x20and\x20inhibits\x20both\x20COX-1\x20and\x20COX-2.\u00a0</p>\x0a<p>Abciximab,\x20tirofiban,\x20and\x20<strong>eptifibatide</strong>\x20act\x20by\u00a0<strong>blocking\x20Gp\x20IIb/IIIa\x20receptors</strong>.\x20They\x20are\x20mainly\x20used\x20during\u00a0<strong>percutaneous\x20coronary\x20intervention</strong>\u00a0for\x20acute\x20coronary\x20syndrome.\x20They\x20carry\x20a\u00a0<strong>high\x20risk\x20of\x20bleeding</strong>\u00a0and\x20can\x20cause\u00a0<strong>thrombocytopenia</strong>.</p>\x0a<p><strong>Vorapaxar\u00a0</strong>primarily\x20inhibits\x20platelet\x20aggregation\x20caused\x20by\u00a0<strong>thrombin.\u00a0</strong>PAR-1\x20activation\x20by\x20thrombin\x20contributes\x20to\x20platelet\x20aggregation.\x20Vorapaxar\x20is\x20a\x20competitive\x20antagonist\x20of\x20protease-activated\x20receptor-1\x20(PAR-1).\x20Vorapaxar\x20is\u00a0<strong>indicated\x20in\x20combination</strong>\u00a0with\x20aspirin\x20and/or\x20clopidogrel\x20to\x20reduce\x20thromboembolic\x20events\x20in\x20patients\x20with\x20MI\x20or\x20peripheral\x20vascular\x20disease.</p>\x0a<p><strong>Prasugrel\u00a0</strong>is\x20an<strong>\u00a0irreversible\x20P2Y12\u00a0inhibitor\x20</strong>and\x20lasts\x20for\x20the\x20entire\x20lifetime\x20of\x20a\x20platelet.</p>\x0a<div\x20class=\x22page\x22\x20title=\x22Page\x20606\x22>\x0a<div\x20class=\x22section\x22>\x0a<div\x20class=\x22layoutArea\x22>\x0a<div\x20class=\x22column\x22>\x0a<p>Prasugrel\x20is\x20a\u00a0<strong>prodrug</strong>\u00a0that\x20is\x20used\x20in\x20patients\x20with\x20acute\x20coronary\x20syndrome\x20who\x20have\x20undergone\u00a0<strong>percutaneous\x20coronary\x20intervention.</strong>\u00a0It<strong>\u00a0reduces</strong>\u00a0the\x20rate\x20of\u00a0<strong>thrombotic\x20cardiovascular\x20events</strong>\u00a0in\x20such\x20patients.\u00a0</p>\x0a</div>\x0a</div>\x0a</div>\x0a</div>','ivQhX','DRlRQ','bookmarked','TXqCp','jmJsy','Vilog','kixnA','quizHierarchy','div','joefy','wuOoN','XyQPL','location','ayDEU','<div\x20class=\x22glass-light\x20p-4\x20mb-4\x22><img\x20src=\x22','reviewQuestionsContainer','totalQuestionsResult','getElementById','<p\x20style=\x22text-align:\x20justify;\x22><strong>Allopurinol\x20</strong>is\x20recommended\x20as\x20the\x20<strong>first-line</strong>\x20urate-lowering\x20agent\x20in\x20all\x20patients\x20with\x20<strong>chronic</strong>\x20gout.\x20It\x20is\x20a<strong>\u00a0purine\x20antimetabolite\x20</strong>and\x20an<strong>\x20inhibitor\x20of\x20the\x20xanthine\x20oxidase\x20</strong>enzyme.</p>\x0a<p\x20style=\x22text-align:\x20justify;\x22>It\x20prevents\x20the\x20conversion\x20of\x20hypoxanthine\x20and\x20xanthine\x20to\x20uric\x20acid\x20<strong>reducing\x20plasma\x20uric\x20acid</strong>\x20levels.\x20Allopurinol\x20is\x20also\x20a\x20substrate\x20for\x20xanthine\x20oxidase.\x20The\x20<strong>metabolite\x20</strong>of\x20allopurinol\x20called<strong>\x20oxypurinol</strong>\x20is\x20a\x20<strong>non-competitive\x20inhibitor\x20</strong>of\x20xanthine\x20oxidase.\u00a0\u00a0</p>\x0a<p\x20style=\x22text-align:\x20justify;\x22><strong>Febuxostat\u00a0</strong>is\x20a\x20uric\x20acid\x20synthesis\x20inhibitor\x20that\x20acts\x20by<strong>\u00a0inhibiting\u00a0</strong>the\x20enzyme<strong>\u00a0xanthine\x20oxidase</strong>\u00a0and\x20it\x20is\x20indicated\x20in\x20gout\x20management.</p>\x0a<p\x20style=\x22text-align:\x20justify;\x22>Both\x20Febuxostat\x20and\x20Allopurinol\x20are\x20Xanthine\x20Oxidase\x20inhibitors,\x20of\x20which\x20Allopurinol\x20is\x20a\x20hypoxanthine\x20analog.</p>\x0a<p>Drugs\x20used\x20in\x20the<strong>\x20management\x20of\x20gout</strong>\x20can\x20be\x20classified\x20as:</p>\x0a<p>Drugs\x20that\u00a0<strong>relieve\x20inflammation\x20and\x20pain</strong>-\x20These\x20drugs\x20are\x20useful\x20in\x20the\x20management\x20of\u00a0<strong>acute\x20attacks\x20of\x20gout</strong>.\x20They\x20are:</p>\x0a<ul>\x0a<li><strong>NSAIDs:</strong>\u00a0They\x20mainly\x20exert\x20their\x20antiinflammatory\x20action\x20by\u00a0<strong>inhibiting\x20cyclooxygenase\x20enzyme</strong>\u00a0(COX).\u00a0This\x20enzyme\x20converts\x20arachidonic\x20acid\x20to\u00a0prostanoids,\x20thromboxane\x20A2,\x20and\x20other\x20prostaglandins</li>\x0a<li><strong>Colchicine:</strong>\u00a0It\x20arrests\x20the\x20cell\x20division\x20by\x20interfering\x20with\x20microtubule\x20and\x20spindle\x20formation.\x20This\x20results\x20in\x20decreased\x20neutrophil\x20recruitment\x20decreased\x20neutrophil\x20motility\x20and\x20decreased\x20release\x20of\x20chemotactic\x20factors.\u00a0</li>\x0a<li><strong>Glucocorticoids:</strong>\u00a0These\x20drugs\x20bind\x20to\x20the\x20nuclear\x20receptors\x20and\x20decrease\x20the\x20transcription\x20of\x20genes\x20for\u00a0COX-2,\x20inducible\x20NOS\x20(NOS2),\x20inflammatory\x20cytokines,\x20collagenase,\x20etc,\x20that\x20are\x20responsible\x20for\x20inflammation.</li>\x0a</ul>\x0a<p>Drugs\x20that\u00a0<strong>inhibit\x20urate\x20formation</strong>-\x20These\x20drugs\x20inhibit\x20urate\x20formation\x20by\x20inhibiting\x20the\x20enzyme\x20xanthine\x20oxidase.\x20Eg.\x20allopurinol\x20and\x20febuxostat.\u00a0The\x20most\x20common\x20adverse\x20effect\x20of\x20allopurinol\x20is\u00a0<strong>hypersensitivity\x20reactions</strong>.\u00a0<strong>Oxypurinol</strong>\u00a0is\x20a\x20metabolite\x20of\x20allopurinol\x20and\x20inhibits\x20xanthine\x20oxidase\x20thus\x20reducing\x20uric\x20acid\x20production.\x20It\x20is\x20an\u00a0<strong>orphan\x20drug</strong>\u00a0and\x20is\x20used\x20in\x20patients\x20intolerant\x20to\x20allopurinol.\u00a0\u00a0</p>\x0a<p><strong>Other\x20options:</strong></p>\x0a<p><strong>Option\x20A:</strong>\x20Pegloticase\x20and\x20rasburicase\x20catalyze\x20the\x20enzymatic\x20oxidation\x20of\x20uric\x20acid\x20into\x20allantoin.\x20This\x20product\x20is\x20soluble\x20and\x20inactive.\u00a0</p>\x0a<p><strong>Option\x20B:</strong>\u00a0<strong>NSAIDs:</strong>\u00a0They\x20mainly\x20exert\x20their\x20antiinflammatory\x20action\x20by\u00a0<strong>inhibiting\x20cyclooxygenase\x20enzyme</strong>\u00a0(COX).\u00a0This\x20enzyme\x20converts\x20arachidonic\x20acid\x20to\u00a0prostanoids,\x20thromboxane\x20A2,\x20and\x20other\x20prostaglandins</p>\x0a<p><strong>Option\x20C:\x20U</strong>ricosuric\x20drugs:\x20These\x20drugs<strong>\x20increase\x20the\x20excretion\x20of\x20uric\x20acid.</strong>\x20Important\x20ones\x20are:</p>\x0a<ul>\x0a<li><strong>Probenecid-</strong>\u00a0it\u00a0inhibits\x20the\x20reabsorption\x20of\x20uric\x20acid\x20by\x20inhibiting\x20organic\x20acid\x20transporter\x20(OATs),\x20principally\x20URAT-1.</li>\x0a<li><strong>Benzbromarone</strong>-\x20It\x20increases\x20uric\x20acid\x20secretion\x20by\u00a0reversibly\x20inhibiting\x20urate–anion\x20exchanger\x20in\x20the\x20proximal\x20tubule</li>\x0a<li><strong>Lesinurad</strong>-\x20It\u00a0inhibits\x20the\x20URAT-1\x20and\x20OAT-4\x20transporters,\x20thereby\x20reducing\x20renal\x20uric\x20acid\x20reabsorption.</li>\x0a</ul>','BUGGU','RiKkc','timed_exam','Cyclophosphamide','https://cdn1.dailyrounds.org/uploads/f834ef19d22443a591b20771ab352c7d.JPEG','info','w-8\x20h-8\x20text-sm\x20font-medium\x20rounded\x20','RcsBA','isSupported','timerContainer','incorrectResult','tvtlk','jGYVw','SKoAI','question_video','SWJym','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</button>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20','stringify','__proto__','DOMContentLoaded','rZxLj','removeItem','qhevW','CzxLY','DTvpQ','AvHwe','true','block','wfwlA','markReviewBtn','UMoMc','fdOTd','Which\x20among\x20the\x20following\x20is\x20the\x20most\x20potent\x20opioid\x20analgesic\x20from\x20the\x20options\x20given\x20below?','It\x20targets\x20the\x20S-phase\x20of\x20the\x20cell\x20cycle','GREFr','Nifedipine','KGXeA','kwWKb','markReviewText','<p>The\x20image\x20shows\x20edema\x20over\x20the\x20lips\x20and\x20face\x20and\x20its\x20occurrence\x20following\x20intake\x20of\x20an\x20antihypertensive\x20is\x20suggestive\x20of\x20<strong>drug-induced\x20angioedema</strong>.\x20<strong>Lisinopril,\x20an\x20angiotensin-converting\x20enzyme\x20inhibitor\x20(ACE\x20inhibitor),\x20</strong>is\x20most\x20likely<strong>\u00a0</strong>responsible\x20for\x20this\x20condition.</p>\x0a<p>Angioedema\x20with\x20ACE\x20inhibitors:</p>\x0a<p>In\x20very\x20few\x20patients(0.1%-0.5%),\x20ACE\x20inhibitors\x20cause\x20rapid\x20swelling\u00a0in\x20the\x20nose,\x20throat,\x20mouth,\x20glottis,\x20larynx,\x20lips,\x20or\x20tongue.\u00a0Once\x20the\u00a0drug\x20is\x20stopped\u00a0symptoms\x20improve\x20drastically\x20over\x20hours.\x20Angioedema\x20of\x20the\x20intestine\x20can\x20occur\x20very\x20rarely.\u00a0</p>\x0a<p><strong>ACE\x20inhibitor-associated\x20angioedema</strong>\u00a0is\x20a\u00a0<strong>class\x20effect</strong>,\x20and\x20patients\x20who\x20develop\x20this\x20adverse\x20event\x20should\u00a0not\x20be\x20prescribed\u00a0any\x20other\x20drugs\x20within\x20the\x20ACE\x20inhibitor\x20class.</p>\x0a<p>Other\x20adverse\x20effects\x20of\x20ACE\x20inhibitors:</p>\x0a<ul>\x0a<li>A\x20sudden\x20fall\x20in\x20blood\x20pressure\x20can\x20occur\x20following\x20the\x20first\x20dose\x20of\x20ACE\x20inhibitors.</li>\x0a<li>It\x20can\x20produce\x20a\x20bothersome\x20<strong>dry\x20cough</strong>\x20due\x20to\x20the\x20accumulation\x20of\x20bradykinin,\x20substance\x20P,\x20or\x20prostaglandins\x20in\x20the\x20lungs.\x20The\x20cough\x20usually\x20disappears\x20within\x204\x20days\x20of\x20the\x20stoppage\x20of\x20the\x20drug.</li>\x0a<li>Hyperkalemia\x20due\x20to\x20K+\x20retention\x20can\x20occur.</li>\x0a<li>Acute\x20renal\x20failure\x20can\x20occur\x20with\x20ACE\x20inhibitors\x20in\x20patients\x20with\u00a0<strong>bilateral\x20renal\x20artery\x20stenosis</strong>,\x20stenosis\x20of\x20the\x20artery\x20to\x20a\x20single\x20remaining\x20kidney,\x20heart\x20failure,\u00a0or\x20volume\x20depletion\x20due\x20to\u00a0diarrhea\x20or\x20diuretics.</li>\x0a<li>It\x20should\x20be\x20discontinued\x20in\x20pregnant\x20women\x20as\x20it\x20can\x20cause\x20<strong>developmental\x20defects</strong>.</li>\x0a<li>It\x20can\x20also\x20cause\x20maculopapular\x20skin\x20rash\x20in\x20some\x20cases.</li>\x0a</ul>\x0a<p>Other\x20options:</p>\x0a<p>Option\x20B:\x20<strong>Nifedipine</strong>\x20is\x20a\x20calcium\x20channel\x20blocker.\x20Common\x20adverse\x20effects\x20include\x20<strong>headache,</strong>\x20<strong>flushing</strong>,\x20and\x20dizziness.\x20Peripheral\x20edema\x20(pedal\x20edema)\x20may\x20rarely\x20occur.</p>\x0a<p>Option\x20C:\x20<strong>Atenolol</strong>\x20is\x20a\x20beta-1\x20selective\x20antagonist.\x20<strong>Bradycardia</strong>,\x20fatigue,\x20and\x20cold\x20extremities\x20are\x20common\x20adverse\x20effects.\x20CNS\x20side\x20effects\x20like\x20nightmares\x20and\x20depression\x20are\x20less\x20frequent\x20with\x20atenolol\x20than\x20other\x20beta-blockers.</p>\x0a<p>Option\x20D:\x20<strong>Clonidine</strong>\x20is\x20an\x20alpha-2\x20adrenergic\x20agonist.\x20The\x20main\x20adverse\x20effects\x20of\x20clonidine\x20are\x20<strong>dry\x20mouth</strong>\x20and\x20<strong>sedation</strong>.\x20Bradycardia\x20and\x20sexual\x20dysfunction\x20are\x20other\x20effects.</p>','Qlopa','gradient-yellow\x20px-6\x20py-3\x20text-white\x20transition-all\x20duration-300\x20flex\x20items-center','QFQRU','zXwTl','A\x20patient\x20on\x20long-term\x20anticoagulation\x20therapy\x20with\x20warfarin,\x20would\x20need\x20an\x20increase\x20in\x20dosage\x20when\x20coadministered\x20with\x20which\x20of\x20the\x20following\x20drugs?','Gynecomastia\x20is\x20an\x20adverse\x20effect\x20of\x20which\x20of\x20the\x20following\x20drugs?','getItem','filter','gvPMN','CuHCk','DNA\x20gyrase\x20inhibitor','<p><strong>Contraceptive\x20failure</strong>\x20in\x20patients\x20on\x20the\x20oral\x20contraceptive\x20pill\x20is\x20<strong>unlikely</strong>\x20to\x20occur\x20with\x20<strong>valproate.</strong>\x20It\x20is\x20an\x20<strong>enzyme\x20inhibitor</strong>\x20that\x20inhibits\x20the\x20degradation\x20of\x20OCPs\x20and\x20<strong>increases</strong>\x20their\x20<strong>duration</strong>\x20of\x20<strong>action.</strong></p>\x0a<p>Rifampicin,\x20phenytoin,\x20and\x20phenobarbitone\x20are\x20enzyme\x20inducers\x20and\x20can\x20cause\x20increased\x20metabolism\x20of\x20OCPs\x20leading\x20to\x20contraceptive\x20failure.</p>\x0a<table\x20style=\x22height:\x20150px;\x22\x20width=\x22453\x22>\x0a<tbody>\x0a<tr>\x0a<td\x20style=\x22width:\x20180.547px;\x20text-align:\x20center;\x22><strong>Enzyme\x20inducers</strong></td>\x0a<td\x20style=\x22width:\x20256.453px;\x20text-align:\x20center;\x22><strong>Enzyme\x20inhibitors</strong></td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x20180.547px;\x22>\x0a<p>Mnemonic:\x20CRAP\x20GPS</p>\x0a<ul>\x0a<li><strong>C</strong>arbamezepine</li>\x0a<li><strong>R</strong>ifampicin</li>\x0a<li><strong>A</strong>lcohol\x20(chronic)</li>\x0a<li><strong>P</strong>henytoin</li>\x0a<li><strong>G</strong>riseofulvin</li>\x0a<li><strong>P</strong>henobarbitone</li>\x0a<li><strong>S</strong>ulfonylureas</li>\x0a</ul>\x0a</td>\x0a<td\x20style=\x22width:\x20256.453px;\x22>\x0a<p>Mnemonic:&nbsp;RED\x20VICK</p>\x0a<ul>\x0a<li><strong>R</strong>itonavir</li>\x0a<li><strong>E</strong>rythromycin</li>\x0a<li><strong>D</strong>iltiazem</li>\x0a<li><strong>V</strong>erapamil,&nbsp;Valproate</li>\x0a<li><strong>I</strong>traconazole</li>\x0a<li><strong>C</strong>larithromycin,&nbsp;Cimetidine</li>\x0a<li><strong>K</strong>etoconazole</li>\x0a</ul>\x0a</td>\x0a</tr>\x0a</tbody>\x0a</table>','ugqIg','ETynb','nav-btn-marked-review','\x20-\x20Brain\x20And\x20Scalpel','aZShZ','WWgAZ','gmFbW','WPFIw','A\x2035-year-old\x20female,\x20a\x20known\x20case\x20of\x20sickle\x20disease\x20came\x20with\x20complaints\x20of\x20unprovoked\x20pain\x20in\x20the\x20extremities\x20and\x20torso.\x20A\x20thromboembolic\x20episode\x20was\x20suspected.\x20What\x20is\x20the\x20first\x20drug\x20to\x20be\x20started\x20for\x20prophylaxis\x20of\x20thromboembolic\x20events\x20in\x20this\x20patient?','PDBko','ftmxv','test','cWLpR','cLfEj','answered','hidden','VSPhk','<p>The&nbsp;clinical\x20scenario\x20is\x20suggestive\x20of&nbsp;<strong>organophosphate</strong>&nbsp;poisoning.\x20Pralidoxime\x20is\x20used\x20to\x20counter\x20the&nbsp;<strong>nicotinic</strong>&nbsp;effects\x20of\x20organophosphates.\x20It&nbsp;<strong>reactivates</strong>&nbsp;the&nbsp;<strong>acetylcholinesterase,&nbsp;</strong>which&nbsp;had\x20been\x20deactivated\x20in\x20organophosphate\x20poisoning.&nbsp;</p>\x0a<p><strong>Atropine</strong>&nbsp;is\x20useful\x20in&nbsp;<strong>organophosphate\x20poisoning</strong>&nbsp;because\x20it\x20is\x20a\x20competitive\x20antagonist\x20of\x20acetylcholine.&nbsp;An\x20acetylcholinesterase\x20enzyme\x20has\x20an\x20active\x20and\x20anionic\x20site.\x20The&nbsp;<strong>organophosphates</strong>&nbsp;<strong>bind\x20to</strong>&nbsp;the\x20<strong>active</strong>&nbsp;<strong>site\x20of\x20AChEs</strong>&nbsp;(acetylcholine\x20esterases)\x20and<strong>&nbsp;deactivate</strong>&nbsp;it.\x20This\x20results\x20in\x20excessive\x20Ach\x20causing\x20excessive\x20muscarinic\x20activity.\x20It\x20has\x20relatively\x20insignificant\x20action\x20on\x20nicotinic\x20receptors.&nbsp;</p>\x0a<p>Organophosphates\x20and\x20carbamates\x20are\x20powerful\x20acetylcholinesterase&nbsp;inhibitors.\x20While\x20carbamates\x20bind\x20reversibly,\x20organophosphates\x20bind\x20irreversibly.&nbsp;&nbsp;</p>\x0a<p>The\x20predominant\x20initial\x20signs\x20are\x20of&nbsp;<strong>muscarinic</strong>&nbsp;excess\x20which\x20includes:&nbsp;<strong>(DUMBBELSS)</strong></p>\x0a<ul>\x0a<li><strong>Diarrhea</strong></li>\x0a<li><strong>U</strong>rination</li>\x0a<li><strong>M</strong>iosis</li>\x0a<li><strong>B</strong>ronchospasm</li>\x0a<li><strong>B</strong>radycardia</li>\x0a<li><strong>E</strong>mesis</li>\x0a<li><strong>L</strong>acrimation</li>\x0a<li><strong>S</strong>alivation</li>\x0a<li><strong>S</strong>weating</li>\x0a</ul>\x0a<p><strong>Nicotinic\x20manifestations</strong>&nbsp;include\x20twitching\x20of\x20eyelids,\x20tongue,\x20and\x20facial\x20muscles\x20which\x20then\x20leads\x20to\x20paralysis.&nbsp;<strong>CNS\x20stimulation</strong>&nbsp;results\x20in\x20headaches,\x20tremors,\x20ataxia,\x20coma,\x20and\x20death.&nbsp;</p>\x0a<p>Patients\x20who\x20present\x20with\x20organophosphate\x20and\x20carbamate\x20poisoning\x20require\x20early\x20endotracheal\x20intubation\x20to\x20avoid\x20respiratory\x20depression,\x20which\x20is\x20a\x20common\x20complication.\x20Succinylcholine\x20is\x20avoided\x20due\x20to\x20its\x20metabolism\x20by\x20acetylcholinesterase\x20which\x20leads\x20to\x20prolonged\x20neuromuscular\x20blockade.&nbsp;</p>','quizPerformanceData','stats','A\x20patient\x20scheduled\x20for\x20a\x20CABG\x20procedure\x20receives\x20preoperative\x20heparin\x20for\x20anticoagulation.\x20During\x20the\x20surgery,\x20the\x20patient\x20starts\x20bleeding\x20massively\x20and\x20there\x20is\x20a\x20drop\x20in\x20BP.\x20Which\x20of\x20the\x20following\x20would\x20you\x20use\x20to\x20manage\x20this\x20patient?','MoQbB','What\x20is\x20the\x20mechanism\x20of\x20action\x20of\x20doxycycline?','vvnOy','replace','AhoxF','Converts\x20uric\x20acid\x20into\x20allantoi','\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20','question_audio','vrYjS','bookmarkBtn','Morphine','kMPbo','OOxui','name','fQkia','Warfarin','Aspirin','custom_quiz.html','https://cdn1.dailyrounds.org/uploads/0a404cea4a154c8d89713520faedfb97.JPEG','PEKCm','LzUey','WgeSo','jaADA','The\x20drug\x20can\x20inhibit\x20all\x20gastric\x20pumps.','\x22\x20controls\x20class=\x22w-full\x22></audio></div>','JhSbg','hfLox','RcBIU','<div\x20class=\x22p-3\x20rounded-lg\x20border\x20','frLnY','YQuhl','NHNPI','BnncZ','The\x20drug\x20irreversibly\x20inactivates\x20the\x20pump\x20molecule.','Biologicals\x20and\x20special\x20products\x20like\x20insulin,\x20toxin\x20and\x20antitoxins','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22option-text\x22>','forEach','solutionText','wIsRk','userHistory','nav-btn-correct','timed_study','BLiSZ','Breakdown\x20of\x20acetylcholine\x20after\x20its\x20release\x20into\x20the\x20synaptic\x20cleft','Carbamates\x20bind\x20to\x20acetylcholinesterases\x20reversibly','Acute\x20pulmonary\x20edema','AOiyW','RrJlG','High-ceiling\x20diuretics\x20are\x20used\x20in\x20the\x20treatment\x20of\x20all\x20of\x20the\x20following\x20conditions\x20except:','Aprepitant','bWBZN','ooojE','Meclizine','Rifampicin','Mark\x20for\x20Review','incorrectAnswers','mieqw','gray','OcSRA','Succimer','IbRuW','What\x20is\x20the\x20mechanism\x20of\x20action\x20of\x20exenatide,\x20that\x20is\x20used\x20in\x20the\x20treatment\x20of\x20type\x202\x20diabetes\x20mellitus?','PLUQj','976MrjqUY','<p><strong>Spironolactone\x20has\x20an\x20additional\x20affinity\x20towards\x20progesterone\x20and\x20androgen\x20receptors</strong>\x20resulting\x20in\x20gynecomastia,\x20loss\x20of\x20libido,\x20menstrual\x20irregularities,\x20and\x20other\x20adverse\x20effects.</p>\x0a<p><strong>Eplerenone</strong>\x20has\x20a\x20lower\x20affinity\x20to\x20progesterone\x20and\x20androgen\x20receptors\x20due\x20to\x20its\x209,11\x20epoxide\x20group.\x20The\x20incidence\x20of\x20gynecomastia\x20and\x20other\x20effects\x20are\x20minimal\x20with\x20eplerenone.</p>\x0a<p>Other\x20options:\x20Amiloride\x20and\x20furosemide\x20are\x20not\x20associated\x20with\x20gynecomastia\u00a0</p>','Marrow','rtAAx','<div\x20class=\x22mt-4\x22><video\x20id=\x22review-video-','SVjzH','It\x20inhibits\x20dihydrofolate\x20reductase','<p><strong>Cloxacillin&nbsp;</strong>is\x20penicillinase-resistant\x20penicillin.</p>\x0a<p>Penicillinase\x20is\x20a\x20<strong>beta-lactamase</strong>\x20enzyme\x20that\x20<strong>inactivates\x20penicillin</strong>&nbsp;by\x20destroying\x20the\x20beta-lactam\x20ring.\x20This\x20enzyme\x20is\x20produced\x20by\x20<strong>most\x20staphylococci</strong>,\x20some\x20gonococci\x20strains,\x20Bacillus\x20subtilis,\x20E.coli,\x20Hemophilus\x20influenza\x20etc..,</p>\x0a<p>Penicillinase-resistant\x20penicillins\x20are\x20not\x20inactivated\x20by\x20penicillinase.\x20But,\x20they\x20are\x20less\x20efficient\x20than\x20penicillin\x20G\x20against\x20penicillin-sensitive\x20pathogens.\x20They\x20are\x20used\x20to\x20treat\x20staphylococcal\x20infections\x20that\x20are<strong>\x20sensitive\x20to\x20methicillin.&nbsp;</strong>Penicillinase-resistant\x20penicillins\x20are:</p>\x0a<ul>\x0a<li>Cloxacillin</li>\x0a<li>Dicloxacillin</li>\x0a<li>Flucloxacillin</li>\x0a<li>Methicillin</li>\x0a<li>Nafcillin</li>\x0a</ul>\x0a<p>Other\x20options:</p>\x0a<p>Option\x20A:\x20<strong>Penicillin\x20V</strong>\x20is\x20an\x20acid-resistant\x20penicillin\x20preparation\x20that\x20is\x20administered\x20orally.\x20But\x20it\x20has\x20limited\x20use\x20against\x20penicillinase-producing\x20organisms.</p>\x0a<p>Option\x20C:<strong>\x20Benzathine\x20penicillin\x20G\x20</strong>and\x20procaine\x20penicillin\x20G\x20are\x20repository\x20preparations\x20of\x20penicillin\x20G\x20and\x20are\x20long-acting.\x20They\x20are\x20given\x20as\x20deep\x20I.M.\x20injections.\x20<strong>Benzathine\x20penicillin</strong>\x20has\x20the\x20longest\x20half-life\x20and\x20is\x20administered\x20every\x202-4\x20weeks.\x20It\x20is\x20sensitive\x20to\x20penicillinase.&nbsp;</p>\x0a<p>Option\x20D:<strong>\x20Ampicillin</strong>&nbsp;is\x20an\x20extended-spectrum\x20penicillin\x20but\x20is\x20not\x20resistant\x20to\x20beta-lactamases.</p>','https://cdn1.dailyrounds.org/uploads/79f8d7a356254942ac77ef98dbd915b6x912x630.PNG','navBtn_','solutionVideo','</span><span>','Atropine\x20is\x20used\x20as\x20an\x20antidote\x20for\x20OP\x20poisoning','XbHtO','efSWX','Penicillin\x20V','TXRTG','hcmfs','A\x20-\x20Aspirin,\x20B\x20-\x20Eptifibatide,\x20C\x20-\x20Vorapaxar','Non-proliferative\x20cells\x20are\x20resistant\x20to\x20it','totalAttempted','oYBBr','<p><strong>Cardiotoxicity</strong>\x20is\x20a\x20unique\x20adverse\x20effect\x20of\x20<strong>doxorubicin</strong>.\x20It\x20is\x20an\x20<strong>anthracycline\x20group</strong>\x20of\x20anticancer\x20antibiotics.</p>\x0a<p><strong>Anthracyclines:</strong></p>\x0a<p>They\x20work\x20by\x20interacting\x20with\x20DNA\x20directly\x20and\u00a0<strong>affecting\x20transcription\x20and\x20replication</strong>.\x20They\x20have\x20the\x20potential\x20to\u00a0<strong>create\x20free\x20radicals</strong>\u00a0which\x20cause\u00a0<strong>irreversible\x20cardiotoxicity</strong>\u00a0and\u00a0<strong>cardiomyopathy</strong>\u00a0which\x20is\x20dose-dependent.</p>\x0a<p>Adverse\x20effects:</p>\x0a<ul>\x0a<li><strong>Cardiomyopathy</strong>\u00a0is\x20the\x20most\x20common\x20adverse\x20effect\x20and\x20it\x20can\x20be\x20either<strong>\u00a0acute,</strong>\u00a0in\x20the\x20form\x20of\u00a0<strong>myocardial\x20damage(\x22pericarditis-myocarditis\x20syndrome\x22),</strong>\u00a0or\x20a\u00a0<strong>chronic</strong>\u00a0form\x20of\u00a0<strong>dose-dependent\x20cardiomyopathy</strong>\u00a0leading\x20to\x20heart\x20failure.</li>\x0a<li>Alopecia,\x20anemia,\x20amenorrhea,\x20leukopenia,\x20nausea,\x20vomiting.</li>\x0a<li>Mucositis,\x20diarrhea,\x20thrombocytopenia.</li>\x0a<li>Less\x20common:\x20acute\x20lymphoid\x20leukemia,acute\x20myelogenous\x20leukemia,atrioventricular\x20block,esophagitis,hyperpigmentation,myelodysplastic\x20syndrome</li>\x0a</ul>\x0a<p><strong>Anthracycline-induced\x20cardiomyopathy</strong>\x20takes\x20two\x20forms:</p>\x0a<ul>\x0a<li><strong>Acute:</strong>\u00a0pericarditis-myocarditis\x20syndrome,\u00a0arrhythmias,\x20ST\x20and\x20T\x20wave\x20changes\x20in\x20ECG.</li>\x0a<li><strong>Chronic:</strong>\x20dilated\x20cardiomyopathy.</li>\x0a</ul>\x0a<p><span\x20data-sheets-value=\x22{&quot;1&quot;:2,&quot;2&quot;:&quot;ANTI-CANCER\x20DRUGS\x20AND\x20THEIR\x20TOXICITIES\x5cn\x5cnDRUG\x5ctTOXICITY\x5cnCyclophosphamide\x20&amp;\x20Ifosfamide\x5ctHemorrhagic\x20cystitis,\x20SIADH\x5cnBusulfan\x5ctPulmonary\x20fibrosis\x5cnProcarbazine\x5ct\x5cnSecondary\x20leukemias\x5cn\x5cnDisulfiram-like\x20reaction\x5cn\x5cnCisplatin\x5ct\x5cnNephrotoxicity\x5cn\x5cnNeurotoxicity\x5cn\x5cnOtotoxicity\x5cn\x5cnCapecitabine\x5ctDiarrhea,\x20hand-foot\x20syndrome,\x5cnmyelosuppression\x5cnCytarabine\x5ctCerebellar\x20ataxia\x5cnIrinotecan\x5ctDiarrhea\x5cnBleomycin\x5ctPulmonary\x20fibrosis\x5cnAnthracyclines\x5ctCardiotoxicity\x5cnMitomycin\x5ctHemolytic-uremic\x20syndrome\x5cnCladribine\x5ctMyelosuppression,\x20nausea\x5cnand\x20vomiting,\x20and\x5cnimmunosuppression\x5cn&quot;}\x22\x20data-sheets-userformat=\x22{&quot;2&quot;:4737,&quot;3&quot;:{&quot;1&quot;:0},&quot;10&quot;:2,&quot;12&quot;:0,&quot;15&quot;:&quot;Arial&quot;}\x22>Anti-cancer\x20drugs\x20and\x20their\x20toxicities:</span></p>\x0a<table>\x0a<tbody>\x0a<tr>\x0a<td><strong>Drug</strong></td>\x0a<td><strong>Toxicity</strong></td>\x0a</tr>\x0a<tr>\x0a<td><strong>Cyclophosphamide\u00a0</strong>&amp;\x20Ifosfamide</td>\x0a<td>Hemorrhagic\x20cystitis,\x20SIADH</td>\x0a</tr>\x0a<tr>\x0a<td>Busulfan</td>\x0a<td>Pulmonary\x20fibrosis</td>\x0a</tr>\x0a<tr>\x0a<td>Procarbazine</td>\x0a<td>\x0a<p>Secondary\x20leukemias</p>\x0a<p>Disulfiram-like\x20reaction</p>\x0a</td>\x0a</tr>\x0a<tr>\x0a<td>Cisplatin</td>\x0a<td>\x0a<p>Nephrotoxicity</p>\x0a<p>Neurotoxicity</p>\x0a<p>Ototoxicity</p>\x0a</td>\x0a</tr>\x0a<tr>\x0a<td>Capecitabine</td>\x0a<td>Diarrhea,\x20hand-foot\x20syndrome,<br\x20/>myelosuppression</td>\x0a</tr>\x0a<tr>\x0a<td>Cytarabine</td>\x0a<td>Cerebellar\x20ataxia</td>\x0a</tr>\x0a<tr>\x0a<td>Irinotecan</td>\x0a<td>Diarrhea</td>\x0a</tr>\x0a<tr>\x0a<td>Bleomycin</td>\x0a<td>Pulmonary\x20fibrosis</td>\x0a</tr>\x0a<tr>\x0a<td><strong>Anthracyclines</strong></td>\x0a<td><strong>Cardiotoxicity</strong></td>\x0a</tr>\x0a<tr>\x0a<td>Mitomycin</td>\x0a<td>Hemolytic-uremic\x20syndrome</td>\x0a</tr>\x0a<tr>\x0a<td><strong>Cladribine</strong></td>\x0a<td>Myelosuppression,\x20nausea<br\x20/>and\x20vomiting,\x20and<br\x20/>immunosuppression</td>\x0a</tr>\x0a<tr>\x0a<td><strong>Tamoxifen</strong></td>\x0a<td>Endometrial\x20cancer,\x20osteoporosis</td>\x0a</tr>\x0a</tbody>\x0a</table>\x0a<p>\u00a0</p>','SNyMQ','4626048qVVrFg','zboWk','ZrcUP','AjBdP','bpuCw','XbNwy','XCXQM','\x22\x20class=\x22w-full\x20rounded-lg\x22\x20controls></video></div>','ZrZCp','{}.constructor(\x22return\x20this\x22)(\x20)','Pharmacology\x20Test','<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>English\x20Explanation:</p><audio\x20src=\x22','notAttemptedResult','LDDUB','questionMedia','jloWt','.m3u8','Igedi','wTGDg','bgSHg','PfUal','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20','classList','Protein\x20synthesis\x20inhibitor','green','incomplete','Methimazole','push','A\x20patient\x20started\x20on\x20an\x20antihypertensive\x20presented\x20with\x20the\x20following\x20picture.\x20Which\x20of\x20the\x20following\x20drugs\x20is\x20the\x20most\x20likely\x20cause?','uruDz','uUIIb','qekxx','Jhltu','<p><strong>Tamsulosin</strong>\x20acts\x20by\x20<strong>selective&nbsp;&alpha;<sub>1&nbsp;</sub>receptor&nbsp;antagonism</strong>.</p>\x0a<p>Tamsulosin&nbsp;is<strong>&nbsp;a\x20uroselective\x20&alpha;<sub>1&nbsp;</sub>blocker\x20that&nbsp;</strong>acts\x20by\x20decreasing\x20the\x20tone\x20of\x20prostatic/\x20bladder\x20neck\x20muscles.\x20This\x20reduces\x20the\x20<strong>dynamic\x20obstruction</strong>\x20and\x20increases\x20the\x20urinary\x20flow\x20rate.\x20It\x20is\x20used\x20in\x20the\x20treatment\x20of\x20BPH\x20and\x20<strong>acute\x20urinary\x20retention</strong>.\x20It\x20is\x20taken<strong>\x20once\x20a\x20day</strong>\x20and\x20preferred\x20in\x20cases\x20with\x20postural\x20hypotension\x20as\x20it\x20has\x20very\x20little\x20effect\x20on\x20BP.</p>\x0a<p><strong>Retrograde\x20ejaculation&nbsp;</strong>and\x20floppy\x20iris\x20during\x20cataract\x20surgery\x20are\x20the\x20side\x20effects\x20of\x20this\x20drug.</p>\x0a<p>&nbsp;\x20Other\x20&alpha;<sub>1&nbsp;</sub>antagonists\x20used\x20in\x20BPH\x20include</p>\x0a<ul>\x0a<li>Terazosin&nbsp;</li>\x0a<li>Doxazosin&nbsp;</li>\x0a<li><strong>Alfuzosin</strong>&nbsp;</li>\x0a</ul>\x0a<p>Other\x20options:</p>\x0a<p>Option\x20B:&nbsp;<strong>&nbsp;Selective</strong>\x20<strong>&alpha;1</strong>\x20receptor\x20<strong>agonists\x20</strong>such\x20as\x20<strong>phenylephrine\x20</strong>are&nbsp;used\x20as\x20<strong>nasal\x20decongestants</strong>\x20and\x20also\x20as\x20a\x20<strong>mydriatic\x20agent</strong>.&nbsp;<strong>Midodrine&nbsp;</strong>has\x20been\x20used\x20to\x20treat\x20patients\x20with\x20autonomic\x20insufficiency\x20and\x20<strong>postural\x20hypotension</strong>.&nbsp;</p>\x0a<p>Option\x20C:&nbsp;<strong>Nonselective\x20&alpha;</strong>\x20receptor\x20<strong>antagonism</strong>\x20can\x20be\x20seen\x20in\x20drugs\x20such\x20as&nbsp;<strong>phenoxybenzamine</strong>\x20and\x20<strong>phentolamine</strong>.\x20They\x20are\x20administered\x20prior\x20to\x20the\x20surgical\x20removal\x20of\x20<strong>pheochromocytoma\x20</strong>to\x20control\x20the\x20episodes\x20of\x20severe\x20hypertension.\x20They\x20have\x20also\x20been\x20used\x20to\x20manage\x20the\x20<strong>cheese\x20reaction</strong>\x20occurring\x20in\x20patients\x20who\x20take\x20MAO\x20inhibitors.</p>\x0a<p>Option\x20D:&nbsp;<strong>Selective</strong>\x20<strong>&alpha;2</strong>&nbsp;receptor\x20<strong>agonists\x20</strong>such\x20as\x20<strong>clonidine\x20</strong>have\x20been\x20used\x20in\x20treating\x20hypertension.&nbsp;</p>','disabled','correctResult','JWsfY','Bacterial\x20vaccines','<p><strong>Aprepitant\x20</strong>is\x20the\x20drug\x20preferred\x20for\x20<strong>delayed\x20onset\x20vomiting\x20after\x20cancer\x20chemotherapy</strong>.</p>\x0a<p><strong>Nausea\x20and\x20vomiting</strong>\x20associated\x20with\x20<strong>chemotherapy</strong>\x20occur\x20in<strong>\x20two\x20phases</strong>:</p>\x0a<ul>\x0a<li><strong>The</strong>\x20<strong>acute</strong>\x20<strong>phase</strong>\x20is\x20seen\x20<strong>within\x2024\x20hours</strong>\x20and\x20occurs\x20in\x20almost\x20<strong>all\x20patients</strong>\x20receiving\x20chemotherapy.\x20In\x20response\x20to\x20chemotherapeutic\x20agents,\x20the\x20<strong>enterochromaffin</strong>\x20<strong>cells</strong>\x20in\x20the\x20small\x20intestine\x20secrete\x20<strong>serotonin</strong>,\x20which\x20acts\x20on\x20the\x205HT3\x20receptors\x20and\x20causes\x20vomiting.\x20This\x20phase\x20is\x20treated\x20by\x20<strong>5HT3\x20antagonists\u00a0</strong>such\x20as\x20ondansetron,\x20granisetron,\x20and\x20palanosetron.\x0a<div\x20class=\x22page\x22\x20title=\x22Page\x20941\x22>\u00a0</div>\x0a</li>\x0a<li><strong>The</strong>\x20<strong>delayed</strong>\x20<strong>phase</strong>\x20is\x20seen\x20on\x20<strong>days\x202-5</strong>\x20and\x20occurs\x20only\x20in\x20<strong>some\x20patients</strong>.\x20It\x20occurs\x20in\x20response\x20to\x20stimulation\x20of\x20<strong>NK-1</strong>\x20receptors\x20by\x20<strong>substance\x20P</strong>.\x20<strong>5HT3\x20antagonists\x20are\x20not\x20effective</strong>\x20against\x20the\x20delayed\x20phase,\x20and\x20<strong>NK-1\x20receptor\x20antagonists</strong>\u00a0<strong>are\x20used</strong>\x20in\x20these\x20patients.\u00a0</li>\x0a</ul>\x0a<p><strong>NK-1\x20receptor\x20antagonists</strong>\x20include\x20<strong>aprepitant</strong>\x20and\x20its\x20parenteral\x20formulation,\x20<strong>fosaprepitant</strong>,\x20<strong>rolapitant,</strong>\x20and\x20<strong>netupitant</strong>.\x20These\x20drugs\x20are\x20usually\x20administered\x20in\x20combination\x20with\x205HT3\x20antagonists\x20and\x20dexamethasone\x20for\x20highly\x20emetogenic\x20chemotherapy.\x20A\x20<strong>fixed-dose\x20combination\x20of\x20netupitant\x20and\x20palanosetron</strong>\x20has\x20been\x20<strong>approved</strong>\x20to\x20cover\x20both\x20the\x20acute\x20and\x20delayed\x20phase\x20of\x20post-chemotherapy\x20nausea\x20and\x20vomiting.</p>','vQFiH','-600\x20text-white\x22>','CRtiX','correctAnswers','jjFLN','Doicm','<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>Hinglish:</p><audio\x20src=\x22','createElement','Phenobarbitone','pjrIU','HoanJ','3|4|1|0|2|5','trace','warn','error','While\x20working\x20as\x20a\x20resident\x20in\x20a\x20hospital,\x20you\x20are\x20asked\x20by\x20the\x20consultant\x20to\x20prescribe\x20a\x20certain\x20proton-pump\x20inhibitor\x20(PPI).\x20It\x20should\x20be\x20given\x20only\x20orally\x20once\x20daily\x20before\x20breakfast,\x20even\x20though\x20it\x20has\x20a\x20half-life\x20of\x20no\x20more\x20than\x203\x20hours.\x20What\x20is\x20the\x20rationale\x20behind\x20this\x20once-daily\x20dosing?','dJZcm','tXLKN','fmSRq','strokeDasharray','<p>The\x20drug\x20that\x20acts\x20at\x20the\x20site\x20\x27A\x27\x20is\x20<strong>baclofen.</strong></p>\x0a<p>Baclofen\x20is\x20a\u00a0<strong>centrally-acting\x20muscle\x20relaxant.\u00a0</strong>It\x20is\x20an\x20analog\x20of\x20the\x20<strong>inhibitory\x20transmitter\x20GABA</strong>\x20and\x20acts\x20as\x20a\x20selective\u00a0<strong>GABA<sub>B</sub></strong>\u00a0receptor\x20agonist.\x20It\x20also\x20acts\x20at\x20the\x20spinal\x20cord\x20where\x20it\x20decreases\x20excitatory\x20transmitter\x20release\x20of\x20excitatory\x20neurotransmitter\x20release.</p>\x0a<p>Baclofen\x20is\x20used\x20for\x20the\x20treatment\x20of\u00a0<strong>spasticity</strong>\u00a0in\x20<strong>multiple\x20sclerosis</strong>,\x20amyotrophic\x20lateral\x20sclerosis,\x20<strong>spinal\x20injuries</strong>,\x20and\x20flexor\x20spasm.\x20In\x20these\x20conditions,\x20baclofen\x20is\x20the\x20preferred\x20drug\x20for\x20symptomatic\x20relief.</p>\x0a<p>It\x20can\x20also\x20be\x20administered\x20intrathecally\x20around\x20the\x20spinal\x20cord\x20through\x20a\x20catheter\x20placed\x20surgically.\x20Side\x20effects\x20of\x20baclofen\x20include\x20drowsiness,\x20mental\x20confusion,\x20weakness,\x20and\x20ataxia.</p>','modeModal','choices','BuhwU','EeUpY','Option\x20','A\x20-\x20Aspirin,\x20B\x20-\x20Eptifibatide,\x20C\x20-\x20Prasugrel','It\x20is\x20a\x20GLP\x201\x20analogue','jxyxd','knjBS','INhxJ','MuUSf','now','<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>Hinglish\x20Explanation:</p><audio\x20src=\x22','Which\x20of\x20the\x20following\x20is\x20a\x20penicillinase-resistant\x20penicillin?','flex','nMkSJ','querySelectorAll','axNAJ','rpGMl','KfBEA','gyPqO','ycrdK','A\x20-\x20Aspirin,\x20B\x20-\x20Prasugrel,\x20C\x20-\x20Eptifibatide','<p><strong>Acetaminophen</strong>\x20is\x20not\x20an\x20orphan\x20drug.\x20It\x20is\x20an\x20essential\x20drug.</p>\x0a<p>Orphan\x20drugs\x20are\x20<strong>drugs\x20for\x20rare\x20diseases</strong>.</p>\x0a<p>Orphan\x20drugs\x20are\x20for\x20the\x20treatment\x20or\x20prevention\x20of\x20rare\x20diseases\x20with\x20little\x20commercial\x20value\x20for\x20pharmaceutical\x20companies.\x20Therefore,\x20special\x20incentives\x20are\x20given\x20by\x20the\x20government\x20for\x20the\x20pharmaceutical\x20companies\x20for\x20the\x20development\x20and\x20marketing\x20of\x20orphan\x20drugs.</p>\x0a<p>Few\x20examples\x20of\x20orphan\x20drugs:</p>\x0a<ul>\x0a<li><strong>Miltefosine</strong></li>\x0a<li><strong>Sodium\x20nitrite</strong></li>\x0a<li><strong>Succimer</strong></li>\x0a<li>Rifabutin</li>\x0a<li>Liposomal\x20amphotericin\x20B</li>\x0a<li>Fomepizole</li>\x0a</ul>','PufOa','<p>A\x20patient\x20on\x20long-term\x20anticoagulation\x20therapy\x20with\x20<strong>warfarin</strong>\x20would\x20need\x20an\x20<strong>increased\x20in\x20dosage&nbsp;</strong>when\x20coadministered\x20with\x20<strong>rifampicin</strong>.&nbsp;This\x20is\x20because\x20<strong>rifampicin</strong>\x20is\x20a\x20potent\x20<strong>microsomal\x20enzyme\x20inducer&nbsp;</strong>and\x20can\x20decrease\x20the\x20effect\x20of\x20warfarin.</p>\x0a<p>Warfarin\x20is\x20cleared\x20<strong>hepatically</strong>\x20primarily\x20via\x20the\x20CYP2C9\x20enzyme.</p>\x0a<p>Rifampicin\x20induces\x20<strong>CYP3A</strong>\x20and\x20<strong>CYP2D6</strong>\x20enzymes.&nbsp;</p>\x0a<p>Enzyme\x20inducers:</p>\x0a<ul>\x0a<li>CYP3A\x0a<ul>\x0a<li>Carbamazepine</li>\x0a<li>Phenobarbitone\x20(CYP2B1)</li>\x0a<li>Rifampicin\x20(CYP2D6)</li>\x0a<li>Phenytoin</li>\x0a<li>Glucocorticoids</li>\x0a</ul>\x0a</li>\x0a<li>CYP2E1\x0a<ul>\x0a<li>Isoniazid</li>\x0a<li>Chronic\x20alcoholism</li>\x0a</ul>\x0a</li>\x0a</ul>\x0a<p>Note:&nbsp;Isoniazid\x20is\x20an\x20inducer\x20for\x20CYP2E1\x20but\x20an\x20inhibitor\x20for\x20CYP3A4</p>\x0a<p>&nbsp;</p>\x0a<table\x20style=\x22height:\x20150px;\x22\x20width=\x22453\x22>\x0a<tbody>\x0a<tr>\x0a<td\x20style=\x22width:\x20180.547px;\x20text-align:\x20center;\x22><strong>Enzyme\x20inducers</strong></td>\x0a<td\x20style=\x22width:\x20256.453px;\x20text-align:\x20center;\x22><strong>Enzyme\x20inhibitors</strong></td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x20180.547px;\x22>\x0a<p>Mnemonic:\x20CRAP\x20GPS</p>\x0a<ul>\x0a<li><strong>C</strong>arbamezepine</li>\x0a<li><strong>R</strong>ifampicin</li>\x0a<li><strong>A</strong>lcohol\x20(chronic)</li>\x0a<li><strong>P</strong>henytoin</li>\x0a<li><strong>G</strong>riseofulvin</li>\x0a<li><strong>P</strong>henobarbitone</li>\x0a<li><strong>S</strong>ulfonylureas</li>\x0a</ul>\x0a</td>\x0a<td\x20style=\x22width:\x20256.453px;\x22>\x0a<p>Mnemonic:&nbsp;RED\x20VICK</p>\x0a<ul>\x0a<li><strong>R</strong>itonavir</li>\x0a<li><strong>E</strong>rythromycin</li>\x0a<li><strong>D</strong>iltiazem</li>\x0a<li><strong>V</strong>erapamil,&nbsp;Valproate</li>\x0a<li><strong>I</strong>traconazole</li>\x0a<li><strong>C</strong>larithromycin,&nbsp;Cimetidine</li>\x0a<li><strong>K</strong>etoconazole</li>\x0a</ul>\x0a</td>\x0a</tr>\x0a</tbody>\x0a</table>','Fentanyl','search','solution','<p>In\x20the\x20above\x20scenario,\x20the\x20patient\x20has\x20developed&nbsp;<strong>extrapyramidal</strong>\x20adverse\x20effects\x20like\x20<strong>acute\x20dystonia,</strong>\x20<strong>bradykinesia</strong>,\x20and<strong>\x20tremors.\x20</strong>This\x20is\x20likely\x20due\x20to<strong>&nbsp;</strong>the&nbsp;<strong>antagonist</strong>\x20action\x20on\x20<strong>dopamine\x20receptors</strong>\x20by\x20<strong>metoclopramide.</strong></p>\x0a<p>Metoclopramide\x20is\x20a\x20<strong>prokinetic</strong>\x20and\x20<strong>antiemetic.</strong>\x20It\x20has\x20the\x20following\x20<strong>pharmacological\x20actions:</strong></p>\x0a<ul>\x0a<li><strong>Dopamine</strong>\x20receptor\x20<strong>antagonist</strong>&nbsp;</li>\x0a<li>Serotonin\x20(<strong>5HT4</strong>)\x20receptor\x20<strong>agonist</strong>&nbsp;</li>\x0a<li>Serotonin\x20(<strong>5HT3</strong>)\x20<strong>antagonist</strong></li>\x0a<li><strong>Sensitization</strong>\x20of\x20<strong>muscarinic\x20receptors</strong>\x20on\x20<strong>smooth\x20muscle.</strong>\x20This\x20results\x20in\x20<strong>increased</strong>\x20lower\x20<strong>esophageal\x20sphincter\x20tone</strong>\x20and\x20stimulates\x20gastric\x20antral\x20contractions.</li>\x0a</ul>\x0a<p>Metoclopramide\x20acts\x20on\x20both\x20the\x20gastrointestinal\x20system\x20and\x20central\x20nervous\x20system.\x20It\x20is\x20used\x20as\x20an\x20upper\x20antiemetic\x20for\x20many\x20types\x20of\x20vomiting,\x20especially\x20migraine,\x20drug-induced,\x20and<strong>\x20chemotherapy-induced</strong>.\x20It\x20is\x20also\x20used\x20as\x20a\x20prokinetic\x20in\x20<strong>gastroparesis</strong>\x20to\x20increase\x20gastric\x20emptying.</p>\x0a<p>Adverse\x20effects\x20of\x20metoclopramide\x20are\x20mainly\x20extrapyramidal\x20effects,\x20and\x20these\x20include\x20<strong>acute\x20dystonia,\x20Parkinson</strong><strong>-like</strong>\x20symptoms\x20(tremors,\x20bradykinesia,\x20rigidity),\x20tardive\x20dyskinesia,<strong>\x20galactorrhea\x20</strong>due\x20to\x20hyperprolactinemia,\x20and\x20methemoglobinemia\x20in\x20neonates.</p>\x0a<p>Extrapyramidal\x20symptoms\x20can\x20be\x20<strong>treated</strong>\x20by\x20<strong>discontinuation</strong>\x20of\x20metoclopramide\x20and\x20administration\x20of\x20anticholinergics\x20or\x20antihistaminics.</p>\x0a<p>Other\x20options:</p>\x0a<p>Option\x20A:\x20<span\x20data-preserver-spaces=\x22true\x22>Ondansetron\x20is\x20a</span><strong><span\x20data-preserver-spaces=\x22true\x22>&nbsp;5-HT<sub>3</sub>\x20receptor\x20antagonist</span></strong>.\x20It\x20blocks\x20impulses\x20at\x20the\x20peripheral\x20origin\x20in\x20GIT.\x20<span\x20data-preserver-spaces=\x22true\x22>It\x20is\x20most\x20commonly\x20indicated\x20for\x20the\x20treatment\x20of&nbsp;</span><strong><span\x20data-preserver-spaces=\x22true\x22>postoperative&nbsp;</span></strong><span\x20data-preserver-spaces=\x22true\x22>and\x20<strong>chemotherapy</strong>-<strong>induced</strong></span><strong><span\x20data-preserver-spaces=\x22true\x22>&nbsp;nausea\x20</span></strong>and\x20<strong><span\x20data-preserver-spaces=\x22true\x22>vomiting.\x20</span></strong><span\x20data-preserver-spaces=\x22true\x22>Headache\x20and\x20dizziness\x20are\x20the\x20common\x20adverse\x20effects.<br\x20/></span></p>\x0a<p>Option\x20C:<strong>\x20Meclizine</strong>\x20is\x20a&nbsp;long-acting\x20<strong>H1\x20antihistaminic</strong>\x20drug.&nbsp;It\x20is\x20used\x20for\x20<strong>seasickness</strong>.\x20It\x20is\x20less\x20sedative\x20and\x20less\x20anticholinergic.</p>\x0a<p>Option\x20D:\x20<strong>Scopolamine\x20(hyoscine)</strong>\x20is\x20a\x20<strong>muscarinic\x20antagonist.</strong>\x20It\x20blocks\x20neural\x20pathways\x20from\x20the\x20vestibular\x20apparatus\x20in\x20the\x20inner\x20ear\x20to\x20the\x20emetic\x20center\x20in\x20the\x20brainstem.\x20A\x20<strong>transdermal\x20patch</strong>\x20of\x20scopolamine\x20is\x20used\x20as\x20an\x20antiemetic\x20in\x20<strong>motion\x20sickness</strong>.\x20Constipation,\x20drowsiness,\x20dry\x20mouth,\x20and\x20blurred\x20vision\x20are\x20the\x20common\x20adverse\x20effects.</p>','hkARv','BIbSM','qxKcv','open','aQgyy','reload','ueRWK','mlqoA','exception','sNxlx','OXcNA','HzXNz','ZzPIX','GTgSC','XGuBd','cmzav','vRycR','sSgxW','currentQuestionIndex','toString','prevBtn','TZOng','tLkiz','not_attempted','PCiBG','jVNGT','Selective\x20α2\x20receptor\x20agonism','WhTct','scoreCircle','explanation_images','gLcaT','acyjG','Central\x20nervous\x20system\x20toxicity','Are\x20you\x20sure\x20you\x20want\x20to\x20submit\x20the\x20quiz?','textContent','lXpYg','\x22\x20controls\x20class=\x22w-full\x20rounded-lg\x22></video></div>','border-gray-600','ranHG','lSYGf','quizFile','Cloxacillin','SdDmo','No\x20questions\x20available\x20for\x20this\x20quiz.','floor','Bookmark','toISOString','https://dhmbxeygs57ff.cloudfront.net/uploads/b9ed96eddfa54713a858cabf28623fb1x1280x2234.JPEG','w-8\x20h-8\x20text-sm\x20font-medium\x20rounded\x20transition-all\x20duration-200','selectedAnswer','Ampicillin','loadSource','doxui','log','correct_choice_id','WPzNM','Benzodiazepines','review-question\x20','EZlMO','5801667AIDSbo','glass-light\x20px-6\x20py-3\x20text-white\x20hover:bg-yellow-500\x20hover:bg-opacity-20\x20transition-all\x20duration-300\x20flex\x20items-center','eSkMd','Heparin','kKbig','What\x20is\x20the\x20mechanism\x20of\x20action\x20of\x20the\x20drug\x20allopurinol?','MOpmK','Identify\x20the\x20drugs\x20marked\x20as\x20A,\x20B,\x20and\x20C.','Zjzrp','testModeReviewLegend','return\x20(function()\x20','Ldyly','Sodium\x20nitrite','Cladribine','Cimetidine','totalTime','rZzHx','ACBbe','Selective\x20α1\x20receptor\x20agonism','bookmarkText','attachMedia','OVQha','aZfvL','fFMGy','FMGE\x20Test\x20Series\x20Subject','src','customQuizData','A\x20farmer\x20presents\x20to\x20the\x20emergency\x20department\x20with\x20diarrhea,\x20sweating,\x20excessive\x20lacrimation,\x20and\x20salivation.\x20Which\x20of\x20the\x20following\x20statements\x20is\x20incorrect\x20regarding\x20the\x20treatment\x20of\x20the\x20condition?','join','border-red-500','OJFhf','</h4>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<span\x20class=\x22text-sm\x20px-3\x20py-1\x20rounded-full\x20bg-','ewvoP','performanceModal','uKitz','OjBBk','fnXPO','igJSQ','application/vnd.apple.mpegurl','Inhibits\x20the\x20uptake\x20of\x20choline\x20into\x20nerve\x20terminals','endsWith','fill','nav-btn-not-attempted\x20hover:bg-white\x20hover:bg-opacity-20','zJReI','selected','niNwW','questionIndex','ttAXl','optionsContainer','\x20>\x20','While\x20conducting\x20animal\x20studies,\x20a\x20scientist\x20is\x20experimenting\x20with\x20a\x20drug\x20called\x20vesamicol\x20that\x20causes\x20skeletal\x20muscle\x20relaxation.\x20What\x20is\x20the\x20mechanism\x20by\x20which\x20the\x20drug\x20causes\x20muscle\x20relaxation?','Prednisolone','It\x20is\x20a\x20DPP-4\x20inhibitor','wClLe','Spironolactone','khmHS','explanationVideoPlayer','8104570astQHK','1268765QFVbOA','An\x20elderly\x20patient\x20with\x20ventricular\x20tachycardia\x20has\x20been\x20started\x20on\x20amiodarone.\x20Which\x20of\x20the\x20following\x20is\x20the\x20most\x20important\x20adverse\x20event\x20associated\x20with\x20this\x20drug\x27s\x20use?','1805576lFIGwH','cYDwA','console','Amiloride','mToiZ','yfaEd','Lugol\x27s\x20iodine','YioVp','PmUdx','<p><strong>High-ceiling\x20diuretics</strong>\u00a0or\x20loop\x20diuretics\x20are\x20not\x20used\x20in\x20pulmonary\x20hypertension.</p>\x0a<p>Their\x20<strong>diuretic\x20property</strong>\x20helps\x20in\x20removing\x20the\x20excess\x20fluid\x20in\x20hepatic,\x20renal,\x20and\x20cardiac\x20diseases\x20and\x20their<strong>\x20vasodilatory</strong>\x20and\x20diuretic\x20action\x20is\x20helpful\x20for\x20the\x20quick\x20relief\x20of\x20symptoms\x20in\x20<strong>LVF</strong>\x20and\x20<strong>acute</strong>\u00a0<strong>pulmonary\x20edema</strong>.\x20They\x20are\x20also\x20used\x20for\x20the\x20treatment\x20of\x20<strong>chronic\x20CHF.</strong></p>\x0a<p>Pulmonary\x20artery\x20hypertension\u00a0is\x20a\x20condition\x20where\x20there\x20is\x20increased\x20pulmonary\x20vascular\x20resistance.\x20Since\x20nitric\x20oxide\x20is\x20an\x20important\x20regulator\x20of\x20pulmonary\x20vascular\x20resistance,\x20<strong>PDE5\x20inhibitors\x20like\x20sildenafil,\x20vardenafil,\x20or\x20tadalafil</strong>\x20are\x20primarily\x20used\x20in\x20the\x20treatment\x20of\x20pulmonary\x20arterial\x20hypertension.</p>\x0a<p>Other\x20options:</p>\x0a<p>Option\x20A:\x20<strong>Generalized\x20edema\x20</strong>occurs\x20due\x20to\x20fluid\x20retention\x20in\x20systemic\x20tissues,\x20commonly\x20seen\x20in\x20conditions\x20like\x20heart\x20failure,\x20nephrotic\x20syndrome,\x20or\x20chronic\x20kidney\x20disease.\x20High-ceiling\x20diuretics\x20are\x20effective\x20here\x20as\x20they\x20can\x20rapidly\x20reduce\x20extracellular\x20fluid\x20volume\x20by\x20promoting\x20diuresis.</p>\x0a<p>Option\x20B:\x20Although\x20loop\x20diuretics\x20are\x20not\x20the\x20first-line\x20treatment\x20for\x20<strong>cerebral\x20edema</strong>,\x20they\x20may\x20be\x20used\x20in\x20conjunction\x20with\x20other\x20therapies\x20like\x20mannitol\x20to\x20reduce\x20intracranial\x20pressure\x20by\x20decreasing\x20overall\x20fluid\x20volume</p>\x0a<p>Option\x20C:\x20Loop\x20diuretics\x20help\x20reduce\x20<strong>pulmonary\x20congestion</strong>\x20by\x20decreasing\x20preload\x20and\x20promoting\x20diuresis.</p>','RkWTb','incorrectCount','Captopril','uDsjE','padStart','DxlMS','aEiSw','studyModeLegend','PDWkU','UTXCi','Nonselective\x20α\x20receptor\x20antagonism','LDzgW','mRExg','Qngfo','Progress\x20loaded.','qpLIz','EebOn','bSbIL','jfmwR','study','<div\x20class=\x22glass-light\x20p-4\x20mb-4\x22><video\x20src=\x22','You\x20have\x20reached\x20the\x20end\x20of\x20the\x20quiz.\x20Would\x20you\x20like\x20to\x20submit\x20your\x20answers\x20now?','Pentazocine','slTuS','Enalapril','kqaqL','nDPRg','Which\x20of\x20the\x20following\x20drugs\x20come\x20under\x20Schedule\x20H\x20of\x20the\x20Drugs\x20and\x20Cosmetics\x20Act,\x201945?','ciDPE','The\x20drug\x20is\x20gradually\x20released\x20irrespective\x20of\x20its\x20formulation.','index.html','ZattF','ZDvuk','dZpqK','Xanthine\x20oxidase\x20inhibitor','Atenolol','nPlTX','onclick','Baclofen','191513zhTouz','sNlLb','bYthe','Pulmonary\x20hypertension','Valproate','Amlodipine','markedForReview','fILsE','keydown','nGkLv','Succinylcholine\x20use\x20is\x20avoided\x20in\x20rapid\x20sequence\x20intubation','KSryv','IMKQo','https://dhmbxeygs57ff.cloudfront.net/uploads/672ca9540c3b4fe7b9d71a5ec95b1f1dx1280x1585.JPEG','explanation_video','gBwcU','prototype','oxFjY','Miltefosine','statsBar','incorrect','questionText','ghLZA','<p><strong>Schedule\x20H</strong>\x20includes\x20drugs\x20purchased\x20over\x20the\x20counter\x20with\x20the\x20prescription\x20of\x20a\x20qualified\x20doctor.</p>\x0a<p><strong>The\x20Drugs\x20and\x20Cosmetics\x20Rules</strong>,\x20classify\x20drugs\x20under\x20different\x20schedules\x20based\x20on\x20their\x20potential\x20for\x20abuse,\x20their\x20therapeutic\x20value,\x20and\x20other\x20factors.\x20The\x20rules\x20provide\x20guidelines\x20for\x20the\x20storage,\x20sale,\x20display,\x20and\x20prescription\x20of\x20each\x20schedule.</p>\x0a<p>Other\x20options:</p>\x0a<p>Option\x20A-\x20Biological\x20and\x20special\x20products\x20like\x20insulin,\x20toxin,\x20and\x20antitoxins\x20are\x20included\x20under\u00a0<strong>Schedule\x20C.</strong></p>\x0a<p>Option\x20B-\x20Bacterial\x20vaccines\x20are\x20included\x20under\u00a0<strong>Schedule\x20F\x20I.</strong></p>\x0a<p>Option\x20D-\x20Drugs\x20that\x20should\x20be\x20labelled\x20with\x20the\x20words\x20“Caution:\x20it\x20is\x20dangerous\x20to\x20take\x20this\x20preparation\x20except\x20under\x20medical\x20supervision”\x20are\x20included\x20under\u00a0<strong>Schedule\x20G.</strong></p>','lbljG','DEGLe','yvklX','timeDisplay','contains','XfQAg','<p>The\x20image\x20shows<strong>\x20pitting\x20pedal\x20edema</strong>\x20in\x20a\x20hypertensive\x20patient.\x20<strong>Calcium\x20channel\x20blockers\x20(CCBs)</strong>\x20like\x20<strong>amlodipine</strong>\x20are\x20most\x20likely\x20to\x20be\x20associated\x20with\x20peripheral\x20edema.</p>\x0a<p>The\x20frequency\x20of\x20CCB-\x20induced\x20peripheral\x20edema\x20is\x20both\x20<strong>drug-specific</strong>\x20(i.e\x20more\x20potent\x20drugs\x20like\x20amlodipine\x20will\x20be\x20associated\x20with\x20higher\x20rates\x20of\x20developing\x20edema)\x20and\x20<strong>dose-dependent</strong>\x20(i.e\x20incidence\x20of\x20edema\x20increases\x20with\x20an\x20increase\x20in\x20drug\x20dosage\x20and\x20chronicity\x20of\x20its\x20usage).\x20It\x20is\x20more\x20common\x20among\x20<strong>females.</strong></p>\x0a<p>CCB-induced\x20peripheral\x20edema\x20occurs\x20due\x20to\x20a\x20disproportionate\x20decrease\x20in\x20the&nbsp;arteriolar\x20resistance\x20than\x20in\x20the\x20venous\x20circulation,\x20resulting\x20in\x20increased&nbsp;hydrostatic\x20pressure\x20in\x20the\x20precapillary\x20circulation.\x20This\x20leads\x20to\x20a\x20fluid\x20shift&nbsp;into\x20the\x20interstitial\x20compartment\x20causing\x20edema.</p>\x0a<p>Treatment:</p>\x0a<ul>\x0a<li>Dose\x20reduction.</li>\x0a<li>Interclass\x20switching\x20of\x20CCB\x20-\x20switch\x20to\x20non-dihydropyridines\x20like\x20verapamil,\x20and\x20diltiazem.</li>\x0a<li>Addition\x20of\x20a\x20venodilator\x20-\x20ACE\x20inhibitor,\x20ARBs,\x20Nitrates.</li>\x0a<li>Others\x20-\x20compression\x20stockings,\x20avoiding\x20prolonged\x20upright\x20position.</li>\x0a<li>Definitive\x20treatment\x20would\x20be\x20discontinuation\x20of\x20the\x20CCB\x20and\x20switching\x20to\x20another\x20class\x20of\x20antihypertensives.</li>\x0a</ul>\x0a<p>Other\x20options:</p>\x0a<p>Option\x20A:\x20Common\x20side\x20effects\x20of\x20<strong>ACE\x20inhibitors</strong>\x20like\x20<strong>enalapril\x20</strong>include\x20hypotension,\x20hyperkalemia,\x20dry\x20cough,\x20rashes,\x20urticaria,\x20dysgeusia,\x20gastrointestinal\x20upset,\x20headache,\x20and\x20dizziness.</p>\x0a<p>Option\x20B:<strong>&nbsp;Telmisartan</strong>,\x20an\x20angiotensin\x20receptor\x20blocker\x20(<strong>ARBs)</strong>,\x20causes\x20adverse\x20effects\x20such\x20as\x20hypotension,\x20hyperkalemia,\x20headache,\x20gastrointestinal\x20upset,\x20and\x20dizziness.</p>\x0a<p>Option\x20D:\x20Adverse\x20effects\x20of\x20<strong>thiazide\x20diuretics</strong>\x20like\x20<strong>hydrochlorothiazide</strong>\x20are\x20hypokalemia,\x20hyponatremia,\x20hyperglycemia,\x20hyperuricemia,\x20hypercalcemia,\x20rashes,&nbsp;headache,\x20gastrointestinal\x20upset,\x20and\x20dizziness.</p>','data-option-index','CDwHG','button','correct','appendChild','PcHXc','pBhSG','ISZqk','No\x20solution\x20available.','sPKSF','liemx','10628760PHXyWE','https://cdn1.dailyrounds.org/uploads/327039f8d40444938142af3a6e51ae47.JPEG','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22bg-green-900\x20bg-opacity-20\x20p-4\x20rounded-lg\x20border\x20border-green-700\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<h5\x20class=\x22text-green-400\x20font-bold\x20mb-2\x22>Explanation:</h5>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22text-white\x20text-opacity-90\x22>','</span>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22text-white\x20mb-4\x22>','CNJEH','raKKf','Selective\x20α1\x20receptor\x20antagonism','cBwlf','Acetaminophen','eVmCA','https://dhmbxeygs57ff.cloudfront.net/uploads/95307c7a27034d05a36b41bce22bda52x1280x1618.JPEG','questionStates','fNWnG','SZkxT','rYzGB','toLowerCase','ojhlg','ZPZSQ','text','explanation_audio_eng','nRZDt','totalTimeResult','Phenytoin','Cerebral\x20edema','Marked','getAttribute','closest','.option-button','dataset','currentQuestion','HckZB','https://cdn1.dailyrounds.org/uploads/812a90a3fc9d420da8f4d8d10f726283.JPEG','testModeLegend','UvLbe','correctCount','gDmJJ','LKgEi','PcjKZ','solutionAudio','wciat','ArVGB','MfERn','split','kErbs','An\x20elderly\x20male\x20patient\x20is\x20diagnosed\x20with\x20benign\x20prostatic\x20hypertrophy.\x20The\x20physician\x20starts\x20him\x20on\x20tamsulosin.\x20What\x20is\x20the\x20mechanism\x20of\x20action\x20of\x20this\x20drug?','className','<p><strong>Doxycycline</strong>\x20is\x20a\x20<strong>tetracycline</strong>\x20that\x20acts\x20by\x20<strong>inhibiting\x20protein\x20synthesis</strong>.</p>\x0a<p>Protein\x20synthesis\x20Inhibitors:</p>\x0a<p><span\x20data-preserver-spaces=\x22true\x22>Antibacterial\x20drugs\x20which\x20bind\x20to\x20the\u00a0<strong>30s</strong>\u00a0subunit\x20of\x20the\x2070s\x20ribosome\x20are\x20given\x20below:</span></p>\x0a<ul>\x0a<li><span\x20data-preserver-spaces=\x22true\x22>Tetracyclines</span></li>\x0a<li><span\x20data-preserver-spaces=\x22true\x22>Aminoglycosides</span></li>\x0a</ul>\x0a<p><span\x20data-preserver-spaces=\x22true\x22>Antibacterial\x20drugs\x20which\x20bind\x20to<strong>\u00a0the\x2050s</strong>\u00a0subunit\x20of\x2070s\x20ribosome\x20are\x20given\x20below:</span></p>\x0a<ul>\x0a<li><span\x20data-preserver-spaces=\x22true\x22>Macrolides</span></li>\x0a<li><span\x20data-preserver-spaces=\x22true\x22>Clindamycin</span></li>\x0a<li><span\x20data-preserver-spaces=\x22true\x22>Streptogramins</span></li>\x0a<li><span\x20data-preserver-spaces=\x22true\x22>Chloramphenicol</span></li>\x0a<li><span\x20data-preserver-spaces=\x22true\x22>Linezolid</span></li>\x0a</ul>\x0a<p><strong>Other\x20options:</strong></p>\x0a<p><strong>Options\x20A:</strong>\u00a0<strong>Cefotetan</strong>\x20and\x20oxacillin\x20are\x20beta-lactam\x20antibiotics\x20that\x20act\x20by\x20inhibiting\x20<strong>cell\x20wall\x20synthesis.</strong></p>\x0a<p><strong>Option\x20C:</strong>\u00a0<strong>Ciprofloxacin</strong>\x20is\x20a\x20fluoroquinolone\x20that\x20acts\x20by<strong>\x20inhibiting\x20DNA\x20gyrase.</strong></p>\x0a<p><strong>Option\x20D:\x20Tavaborole\x20inhibits</strong>\x20fungal\x20<strong>leucyl-tRNA\x20synthetase,</strong>\x20thereby\x20inhibiting\x20fungal\x20protein\x20synthesis\x20and\x20finally\x20resulting\x20in\x20fungal\x20cell\x20death.</p>','NaJVf','Beclomethasone','constructor','target','Qpjuv','innerHTML','ibqbB','wUgIB','IfMMd','referrer','currentMode','lYUcb','questions','progressBar','NsrKS','YbUCy','FIyMl','<p>Among\x20the\x20given\x20options,\x20<strong>fentanyl\x20</strong>is\x20the\x20<strong>most\x20potent</strong>\x20opioid.</p>\x0a<p><strong>Opioid\x20potency:</strong></p>\x0a<p>Sufentanil\x20&gt;<strong>\x20Fentanyl</strong>\x20&gt;\x20Morphine\x20&gt;\x20Pentazocin\x20and\x20pethidine.</p>\x0a<p>Note:\x20Overall,\x20Sufentanil\x20is\x20the\x20most\x20potent\x20opioid.\x20It\x20is\x201000\x20times\x20more\x20potent\x20than\x20morphine.</p>\x0a<p>Other\x20high-yield\x20points\x20on\x20opioids:</p>\x0a<ul>\x0a<li>Post-thoracotomy\x20pain\x20managed\x20by:\x20<strong>IV\x20fentanyl</strong></li>\x0a<li>Drug\x20of\x20choice\x20for\x20controlling\x20severe\x20pain\x20in\x20cancer\x20patients:\x20<strong>Morphine</strong></li>\x0a<li>Drug\x20of\x20choice\x20for\x20OPD\x20analgesia:\x20<strong>Alfentanyl</strong></li>\x0a<li><strong>Most\x20potent:\x20Sufentanyl</strong></li>\x0a<li>Shortest-acting\x20opioid:\x20<strong>Remifentanyl</strong></li>\x0a</ul>\x0a<p>Other\x20options:</p>\x0a<p>Option\x20A:<strong>\x20Fentanyl</strong>\x20is\x20around\x20<strong>100\x20times\x20</strong>more\x20potent\x20than\x20<strong>morphine.</strong></p>\x0a<p>Options\x20C\x20&amp;\x20D:\x20The\x20potency\x20of\x20<strong>pentazocin\x20</strong>and<strong>\x20pethidine</strong>\x20is\x20lower\x20than\x20that\x20of\x20<strong>morphine</strong></p>','JldZB','Which\x20of\x20the\x20following\x20is\x20not\x20an\x20orphan\x20drug?','nPLFm','oBBjm','OWyLV','Scopolamine','Which\x20of\x20the\x20following\x20statements\x20about\x20methotrexate\x20is\x20false?','NtpdU','The\x20drug\x20suppresses\x20basal\x20but\x20not\x20stimulated\x20acid\x20production.','bind','2024','zXXjW'];_0x476e=function(){return _0x442734;};return _0x476e();}let hierarchy=[_0x56aaab(0x203),_0x56aaab(0x2c6),_0x56aaab(0x390)];if(window[_0x56aaab(0x44a)]['pathname'][_0x56aaab(0x2d6)](_0x56aaab(0x4ab))){const customData=JSON[_0x56aaab(0x439)](localStorage['getItem'](_0x56aaab(0x2c8)));if(customData){const DnbQFF=_0x56aaab(0x24b)[_0x56aaab(0x36f)]('|');let ZZNRMP=0x0;while(!![]){switch(DnbQFF[ZZNRMP++]){case'0':document['title']=quizName+_0x56aaab(0x488);continue;case'1':hierarchy=customData['hierarchy'];continue;case'2':document[_0x56aaab(0x44f)]('totalQuestions')[_0x56aaab(0x295)]=questionsData[_0x56aaab(0x3e6)];continue;case'3':questionsData=customData[_0x56aaab(0x380)];continue;case'4':quizName=customData[_0x56aaab(0x4a7)];continue;case'5':document[_0x56aaab(0x44f)](_0x56aaab(0x445))['textContent']=hierarchy[_0x56aaab(0x2ca)](_0x56aaab(0x2df));continue;}break;}}}let currentQuestionIndex=0x0,selectedOption=null,currentMode=_0x56aaab(0x307),timer=null,timeRemaining=0x0,questionStartTime=Date[_0x56aaab(0x260)](),quizStartTime=Date['now'](),isQuizCompleted=![],questionStates=new Array(questionsData[_0x56aaab(0x3e6)])[_0x56aaab(0x2d7)](null)[_0x56aaab(0x3d7)](()=>({'status':_0x56aaab(0x28a),'bookmarked':![],'markedForReview':![],'selectedAnswer':null,'timeSpent':0x0})),stats={'correctAnswers':0x0,'incorrectAnswers':0x0,'totalAttempted':0x0,'totalTime':0x0,'notAttempted':questionsData[_0x56aaab(0x3e6)]};function saveProgress(){const _0x5df4d8=_0x56aaab,_0x37a0db={'YPpYH':_0x5df4d8(0x1e9),'ArVGB':_0x5df4d8(0x232)};if(isQuizCompleted)return;const _0x2b2019=JSON[_0x5df4d8(0x439)](localStorage[_0x5df4d8(0x47f)](_0x37a0db['YPpYH']))||{};_0x2b2019[quizFilename]={'questionStates':questionStates,'stats':stats,'currentQuestionIndex':currentQuestionIndex,'currentMode':currentMode,'status':_0x37a0db[_0x5df4d8(0x36d)],'lastSeen':new Date()['toISOString']()},localStorage[_0x5df4d8(0x42f)](_0x37a0db['YPpYH'],JSON[_0x5df4d8(0x462)](_0x2b2019));}function loadProgress(){const _0x2e6ed4=_0x56aaab,_0x23a952={'jmJsy':'userHistory','jMksY':'3|1|4|2|0|5'},_0x17ef74=JSON[_0x2e6ed4(0x439)](localStorage['getItem'](_0x23a952[_0x2e6ed4(0x442)]))||{},_0x40fad8=_0x17ef74[quizFilename];if(_0x40fad8){const _0x2644fa=_0x23a952[_0x2e6ed4(0x3bc)][_0x2e6ed4(0x36f)]('|');let _0x1d77f2=0x0;while(!![]){switch(_0x2644fa[_0x1d77f2++]){case'0':console[_0x2e6ed4(0x2a8)](_0x2e6ed4(0x302));continue;case'1':stats=_0x40fad8[_0x2e6ed4(0x498)];continue;case'2':currentMode=_0x40fad8[_0x2e6ed4(0x37e)];continue;case'3':questionStates=_0x40fad8[_0x2e6ed4(0x350)];continue;case'4':currentQuestionIndex=_0x40fad8[_0x2e6ed4(0x285)];continue;case'5':return!![];}break;}}return![];}function clearProgress(){const _0x35a13a=_0x56aaab,_0x16991e={'mYKHg':'userHistory','TazKR':'Previous\x20progress\x20cleared.'},_0x3be2bf=JSON[_0x35a13a(0x439)](localStorage[_0x35a13a(0x47f)](_0x35a13a(0x1e9)))||{};_0x3be2bf[quizFilename]&&(delete _0x3be2bf[quizFilename],localStorage[_0x35a13a(0x42f)](_0x16991e['mYKHg'],JSON[_0x35a13a(0x462)](_0x3be2bf)),console[_0x35a13a(0x2a8)](_0x16991e['TazKR']));}function markQuizAsCompleted(){const _0x327f0c=_0x56aaab,_0x103963={'Jhltu':'userHistory','oNqqn':_0x327f0c(0x3dd)},_0x4fd555=JSON[_0x327f0c(0x439)](localStorage['getItem'](_0x103963[_0x327f0c(0x239)]))||{},_0x5e94cc=questionsData[_0x327f0c(0x3e6)],_0x470282=stats[_0x327f0c(0x243)]||0x0;_0x4fd555[quizFilename]={'score':_0x470282,'total':_0x5e94cc,'status':_0x103963['oNqqn'],'completedOn':new Date()[_0x327f0c(0x2a1)]()},localStorage[_0x327f0c(0x42f)](_0x103963[_0x327f0c(0x239)],JSON['stringify'](_0x4fd555));}const urlParams=new URLSearchParams(window[_0x56aaab(0x44a)]['search']),startAt=parseInt(urlParams['get'](_0x56aaab(0x40c))),resume=urlParams[_0x56aaab(0x395)]('resume')===_0x56aaab(0x46b);function goBack(){const _0x2d9cb2=_0x56aaab,_0x35c296={'frLnY':_0x2d9cb2(0x312)};if(!isQuizCompleted)saveProgress();window[_0x2d9cb2(0x44a)][_0x2d9cb2(0x3c0)]=document[_0x2d9cb2(0x37d)]||_0x35c296[_0x2d9cb2(0x1df)];}function selectMode(_0x3d3a69){const _0xb0d8aa=_0x56aaab,_0x1384cd={'uKitz':_0xb0d8aa(0x255),'gmFbW':'none','BLiSZ':function(_0x1b2fc6){return _0x1b2fc6();}};currentMode=_0x3d3a69,document['getElementById'](_0x1384cd[_0xb0d8aa(0x2d0)])['style'][_0xb0d8aa(0x3be)]=_0x1384cd[_0xb0d8aa(0x48b)],_0x1384cd[_0xb0d8aa(0x1ec)](initializeQuiz);}function initializeQuiz(){const _0x111f25=_0x56aaab,_0x4a5d59={'ScTYF':_0x111f25(0x2b7),'giypo':_0x111f25(0x490),'ugqIg':function(_0x42d59f,_0x16c5dc){return _0x42d59f===_0x16c5dc;},'HhMgH':_0x111f25(0x453),'PCiBG':_0x111f25(0x32e),'fILsE':_0x111f25(0x424),'ZPZSQ':_0x111f25(0x46c),'wqCLB':_0x111f25(0x2fb),'zKloA':_0x111f25(0x365),'POTST':'submitSection','HckZB':_0x111f25(0x263),'JldZB':'timed_study','dhAGy':function(_0x46d41c,_0x3cb63d){return _0x46d41c===_0x3cb63d;},'XEXbg':'timerContainer','UcLpw':function(_0x308831,_0x233b37){return _0x308831(_0x233b37);},'UPxyH':function(_0x3cab00,_0x5883f1){return _0x3cab00>=_0x5883f1;},'wClLe':function(_0x2c6621,_0x696d7c){return _0x2c6621<_0x696d7c;},'jloWt':function(_0x243b93){return _0x243b93();}};quizStartTime=Date[_0x111f25(0x260)]();const _0x4268ae=document[_0x111f25(0x44f)](_0x111f25(0x4a3)),_0x2c2e1f=document[_0x111f25(0x44f)]('markReviewBtn'),_0x539b89=document[_0x111f25(0x44f)](_0x4a5d59['ScTYF']),_0x58bd1a=currentMode===_0x4a5d59['giypo']||_0x4a5d59[_0x111f25(0x485)](currentMode,_0x4a5d59['HhMgH']);document['getElementById'](_0x4a5d59[_0x111f25(0x28b)])['style'][_0x111f25(0x3be)]=_0x58bd1a?_0x4a5d59['fILsE']:_0x4a5d59['ZPZSQ'],document['getElementById'](_0x4a5d59[_0x111f25(0x3f9)])['style'][_0x111f25(0x3be)]=_0x58bd1a?_0x111f25(0x424):_0x4a5d59[_0x111f25(0x356)],document['getElementById'](_0x4a5d59['zKloA'])[_0x111f25(0x41b)][_0x111f25(0x3be)]=_0x58bd1a?_0x4a5d59[_0x111f25(0x356)]:_0x4a5d59['fILsE'],document[_0x111f25(0x44f)](_0x4a5d59[_0x111f25(0x3f6)])[_0x111f25(0x41b)][_0x111f25(0x3be)]=_0x58bd1a?_0x4a5d59[_0x111f25(0x356)]:_0x4a5d59[_0x111f25(0x322)],_0x4268ae['style'][_0x111f25(0x3be)]=_0x58bd1a?_0x4a5d59['fILsE']:_0x4a5d59[_0x111f25(0x363)],_0x2c2e1f['style'][_0x111f25(0x3be)]=_0x58bd1a?_0x4a5d59[_0x111f25(0x363)]:_0x4a5d59[_0x111f25(0x322)],_0x539b89[_0x111f25(0x41b)][_0x111f25(0x3be)]=_0x58bd1a?_0x4a5d59[_0x111f25(0x363)]:_0x4a5d59['fILsE'],(_0x4a5d59['ugqIg'](currentMode,_0x4a5d59[_0x111f25(0x386)])||_0x4a5d59['dhAGy'](currentMode,_0x4a5d59[_0x111f25(0x3de)]))&&document[_0x111f25(0x44f)](_0x4a5d59[_0x111f25(0x3cd)])[_0x111f25(0x22f)][_0x111f25(0x3cc)](_0x111f25(0x494)),!_0x4a5d59[_0x111f25(0x41a)](isNaN,startAt)&&_0x4a5d59['UPxyH'](startAt,0x0)&&_0x4a5d59[_0x111f25(0x2e3)](startAt,questionsData[_0x111f25(0x3e6)])&&(currentQuestionIndex=startAt),loadBookmarkedQuestions(),_0x4a5d59[_0x111f25(0x228)](generateQuestionNav),updateStats(),_0x4a5d59[_0x111f25(0x228)](displayQuestion);}function generateQuestionNav(){const _0x1fbf99=_0x56aaab,_0x2ed29c={'GtYat':function(_0x4fae21,_0x1132cd){return _0x4fae21<_0x1132cd;},'GTgSC':_0x1fbf99(0x33c),'GLSDi':function(_0x4db4a5){return _0x4db4a5();}},_0x6565c7=document[_0x1fbf99(0x44f)]('questionNav');_0x6565c7[_0x1fbf99(0x379)]='';for(let _0x41735f=0x0;_0x2ed29c[_0x1fbf99(0x3b1)](_0x41735f,questionsData[_0x1fbf99(0x3e6)]);_0x41735f++){const _0x2de654=document[_0x1fbf99(0x247)](_0x2ed29c[_0x1fbf99(0x280)]);_0x2de654[_0x1fbf99(0x295)]=_0x41735f+0x1,_0x2de654[_0x1fbf99(0x372)]=_0x1fbf99(0x2a3),_0x2de654[_0x1fbf99(0x319)]=()=>jumpToQuestion(_0x41735f),_0x2de654['id']=_0x1fbf99(0x20a)+_0x41735f,_0x6565c7[_0x1fbf99(0x33e)](_0x2de654);}_0x2ed29c['GLSDi'](updateQuestionNav);}function updateQuestionNav(){const _0x5b2c5e=_0x56aaab,_0x4b2ee5={'cYDwA':function(_0x2e58df){return _0x2e58df();},'BUGGU':function(_0x5da2c9,_0x3a6176){return _0x5da2c9===_0x3a6176;},'uearn':function(_0x5d95fe,_0x1bcd9f){return _0x5d95fe===_0x1bcd9f;},'ZDvuk':_0x5b2c5e(0x41d),'GOBiT':_0x5b2c5e(0x437),'CRtiX':_0x5b2c5e(0x487),'RrJlG':function(_0x5132ab,_0x3f5a61){return _0x5132ab===_0x3f5a61;},'Vilog':_0x5b2c5e(0x1eb),'PDBko':_0x5b2c5e(0x33d),'PfUal':_0x5b2c5e(0x1ea),'PLUQj':_0x5b2c5e(0x32f),'VLRKE':_0x5b2c5e(0x2d8),'ZrZCp':function(_0x1bce8f,_0x354481){return _0x1bce8f!==_0x354481;},'HoanJ':'nav-btn-answered'};for(let _0x20a4ad=0x0;_0x20a4ad<questionsData[_0x5b2c5e(0x3e6)];_0x20a4ad++){const _0x3b21bf=document[_0x5b2c5e(0x44f)](_0x5b2c5e(0x20a)+_0x20a4ad),_0x3feed7=questionStates[_0x20a4ad];let _0x501257='';if(_0x4b2ee5[_0x5b2c5e(0x451)](_0x20a4ad,currentQuestionIndex))_0x4b2ee5[_0x5b2c5e(0x3e0)](_0x5b2c5e(0x244),_0x5b2c5e(0x244))?_0x501257=_0x4b2ee5[_0x5b2c5e(0x314)]:_0x519ef9[_0x5b2c5e(0x379)]+=_0x5b2c5e(0x224)+_0x321da0[_0x5b2c5e(0x358)]+'\x22\x20controls\x20class=\x22w-full\x22></audio></div>';else{if(_0x3feed7[_0x5b2c5e(0x440)])_0x501257='nav-btn-bookmarked';else{if(_0x3feed7[_0x5b2c5e(0x321)])_0x4b2ee5['GOBiT']!==_0x4b2ee5['GOBiT']?(_0x38e44d[_0x2c5850][_0x5b2c5e(0x321)]=!_0xe632a0[_0x274565][_0x5b2c5e(0x321)],_0x4b2ee5['cYDwA'](_0x41ef34),_0x4b2ee5[_0x5b2c5e(0x2eb)](_0x169454)):_0x501257=_0x4b2ee5[_0x5b2c5e(0x242)];else{if(currentMode===_0x5b2c5e(0x307)||_0x4b2ee5[_0x5b2c5e(0x1f1)](currentMode,_0x4b2ee5[_0x5b2c5e(0x443)])){if(_0x3feed7[_0x5b2c5e(0x3f2)]===_0x4b2ee5[_0x5b2c5e(0x48e)])_0x501257=_0x4b2ee5[_0x5b2c5e(0x22d)];else{if(_0x4b2ee5[_0x5b2c5e(0x451)](_0x3feed7[_0x5b2c5e(0x3f2)],_0x4b2ee5[_0x5b2c5e(0x200)]))_0x501257=_0x5b2c5e(0x3df);else _0x501257=_0x4b2ee5['VLRKE'];}}else{if(_0x4b2ee5[_0x5b2c5e(0x221)](_0x3feed7[_0x5b2c5e(0x2a4)],null))_0x501257=_0x4b2ee5[_0x5b2c5e(0x24a)];else _0x501257='nav-btn-not-attempted\x20hover:bg-white\x20hover:bg-opacity-20';}}}}_0x3b21bf[_0x5b2c5e(0x372)]=_0x5b2c5e(0x457)+_0x501257;}}function jumpToQuestion(_0x459ba4){const _0x18dd36=_0x56aaab,_0x24d56b={'qekxx':'button','XyQPL':function(_0x20cec1,_0x3bccdd){return _0x20cec1+_0x3bccdd;},'jGYVw':_0x18dd36(0x2a3),'ttAXl':function(_0x54c163,_0x404be4){return _0x54c163>=_0x404be4;},'wlcSZ':function(_0x6eedf8,_0x5409f8){return _0x6eedf8<_0x5409f8;},'dJZcm':function(_0x273032,_0x5932fd){return _0x273032===_0x5932fd;},'ZrcUP':_0x18dd36(0x2b4),'ZattF':function(_0x5338f1,_0x26ea18){return _0x5338f1-_0x26ea18;},'RkWTb':function(_0x4abbe8){return _0x4abbe8();},'xOjjt':function(_0x3adcd3){return _0x3adcd3();}};if(_0x24d56b[_0x18dd36(0x2dd)](_0x459ba4,0x0)&&_0x24d56b['wlcSZ'](_0x459ba4,questionsData[_0x18dd36(0x3e6)])){if(questionStartTime){if(_0x24d56b[_0x18dd36(0x250)](_0x24d56b[_0x18dd36(0x21b)],_0x24d56b['ZrcUP']))questionStates[currentQuestionIndex]['timeSpent']+=_0x24d56b[_0x18dd36(0x313)](Date[_0x18dd36(0x260)](),questionStartTime);else{const _0x163d70=_0x55259d[_0x18dd36(0x247)](_0x24d56b[_0x18dd36(0x238)]);_0x163d70[_0x18dd36(0x295)]=_0x24d56b[_0x18dd36(0x449)](_0x47b710,0x1),_0x163d70[_0x18dd36(0x372)]=_0x24d56b[_0x18dd36(0x45d)],_0x163d70[_0x18dd36(0x319)]=()=>_0x19876b(_0x4049dd),_0x163d70['id']=_0x18dd36(0x20a)+_0x1778b9,_0x336d35[_0x18dd36(0x33e)](_0x163d70);}}currentQuestionIndex=_0x459ba4,_0x24d56b[_0x18dd36(0x2f4)](displayQuestion),_0x24d56b['xOjjt'](saveProgress);}}function updateStats(){const _0x1b1f57=_0x56aaab,_0x418028={'PKjCJ':function(_0x199ec6,_0x192d2a){return _0x199ec6-_0x192d2a;},'gwszJ':function(_0x16cd16,_0x30caf9){return _0x16cd16===_0x30caf9;},'iEqgV':_0x1b1f57(0x307),'JWsfY':function(_0x35ee1f,_0x15e987){return _0x35ee1f===_0x15e987;},'YCIrY':function(_0x58b77b,_0x54135f){return _0x58b77b!==_0x54135f;},'PhrJT':_0x1b1f57(0x288),'gGFVZ':_0x1b1f57(0x367),'OXcNA':_0x1b1f57(0x2f5),'oxFjY':'totalAttempted','JKraH':function(_0xa8cef3,_0x53a9c3){return _0xa8cef3>_0x53a9c3;},'uhvTl':function(_0x1c9737,_0x212739){return _0x1c9737*_0x212739;},'DcdQz':'accuracy','lXpYg':function(_0x271a2f,_0x2900fd){return _0x271a2f/_0x2900fd;},'bDVRH':function(_0x11302d,_0x19abd6){return _0x11302d/_0x19abd6;},'CDwHG':function(_0xab3241,_0x52ebbc){return _0xab3241%_0x52ebbc;},'nPlTX':function(_0x2b2f83,_0x2cdb60){return _0x2b2f83+_0x2cdb60;}};if(_0x418028['gwszJ'](currentMode,_0x418028[_0x1b1f57(0x434)])||_0x418028[_0x1b1f57(0x23d)](currentMode,_0x1b1f57(0x1eb))){if(_0x418028['YCIrY'](_0x418028['PhrJT'],_0x1b1f57(0x288)))_0x377eed[_0xbb34e4][_0x1b1f57(0x398)]+=_0x418028[_0x1b1f57(0x3f3)](_0x18f90a[_0x1b1f57(0x260)](),_0x7e2b0f);else{document['getElementById'](_0x418028['gGFVZ'])[_0x1b1f57(0x295)]=stats[_0x1b1f57(0x243)],document[_0x1b1f57(0x44f)](_0x418028[_0x1b1f57(0x27d)])[_0x1b1f57(0x295)]=stats['incorrectAnswers'],document[_0x1b1f57(0x44f)](_0x418028[_0x1b1f57(0x32c)])[_0x1b1f57(0x295)]=stats[_0x1b1f57(0x215)];const _0x2dfd95=_0x418028['JKraH'](stats['totalAttempted'],0x0)?Math[_0x1b1f57(0x3f7)](_0x418028['uhvTl'](stats[_0x1b1f57(0x243)]/stats[_0x1b1f57(0x215)],0x64)):0x0;document['getElementById'](_0x418028['DcdQz'])[_0x1b1f57(0x295)]=_0x2dfd95+'%',stats[_0x1b1f57(0x2bd)]=questionStates[_0x1b1f57(0x42a)]((_0x11ae4b,_0x2d4b63)=>_0x11ae4b+_0x2d4b63[_0x1b1f57(0x398)],0x0);const _0xea05aa=Math[_0x1b1f57(0x29f)](_0x418028[_0x1b1f57(0x296)](stats[_0x1b1f57(0x2bd)],0x3e8)),_0xe71afe=Math[_0x1b1f57(0x29f)](_0x418028['bDVRH'](_0xea05aa,0x3c)),_0x5e12a9=_0x418028[_0x1b1f57(0x33b)](_0xea05aa,0x3c);document[_0x1b1f57(0x44f)](_0x1b1f57(0x398))['textContent']=_0x418028[_0x1b1f57(0x318)](_0x418028[_0x1b1f57(0x318)](_0xe71afe,':'),_0x5e12a9[_0x1b1f57(0x286)]()[_0x1b1f57(0x2f8)](0x2,'0'));}}}function setupVideo(_0x43fca2,_0xddc1ea){const _0x15488c=_0x56aaab,_0x19fdf0={'cWLpR':function(_0x5279c8,_0x10697c){return _0x5279c8===_0x10697c;},'eVmCA':'incorrect','dZpqK':_0x15488c(0x2d8),'sNlLb':function(_0x3e44f3,_0x49ca2b){return _0x3e44f3!==_0x49ca2b;},'Ldyly':'EZlMO'};if(Hls[_0x15488c(0x459)]()){if(_0x19fdf0[_0x15488c(0x31c)](_0x19fdf0[_0x15488c(0x2b9)],_0x15488c(0x2ad))){if(_0x19fdf0[_0x15488c(0x491)](_0x2929e2[_0x15488c(0x3f2)],'correct'))_0x31ce25=_0x15488c(0x1ea);else{if(_0x19fdf0[_0x15488c(0x491)](_0x22b344[_0x15488c(0x3f2)],_0x19fdf0[_0x15488c(0x34e)]))_0x534645=_0x15488c(0x3df);else _0x3bde0b=_0x19fdf0[_0x15488c(0x315)];}}else{const _0x4d882b=new Hls();_0x4d882b[_0x15488c(0x2a6)](_0xddc1ea),_0x4d882b[_0x15488c(0x2c2)](_0x43fca2);}}else _0x43fca2['canPlayType'](_0x15488c(0x2d4))&&(_0x43fca2['src']=_0xddc1ea);}function displayQuestion(){const _0x3b348d=_0x56aaab,_0x17c03a={'aZfvL':function(_0x43e97d,_0x52bd3e){return _0x43e97d-_0x52bd3e;},'OJFhf':function(_0x562f9d,_0x50aaaf){return _0x562f9d===_0x50aaaf;},'TTiHK':_0x3b348d(0x3cf),'YhNZL':function(_0x417b8d,_0xe55c04){return _0x417b8d+_0xe55c04;},'XeTCe':_0x3b348d(0x2da),'irhUY':function(_0x252162,_0xc9629f){return _0x252162+_0xc9629f;},'CwYHl':_0x3b348d(0x259),'xvzfT':function(_0x37a4b7,_0x1de0ad){return _0x37a4b7+_0x1de0ad;},'RcBIU':function(_0x138c24,_0x479cfc){return _0x138c24===_0x479cfc;},'NwCzY':_0x3b348d(0x33d),'ACBbe':function(_0x480258,_0x59def2){return _0x480258===_0x59def2;},'vUVGF':_0x3b348d(0x382),'mhfNH':'aJLay','bSbIL':_0x3b348d(0x360),'doxui':function(_0x240d86,_0x1a21e1){return _0x240d86!==_0x1a21e1;},'cwJHu':'wTJJc','YwMWM':function(_0x529faa,_0x801032){return _0x529faa(_0x801032);},'khmHS':_0x3b348d(0x33a),'vvtZk':function(_0x1e6915,_0x17c8b8){return _0x1e6915(_0x17c8b8);},'sNxlx':function(_0x1b9dcc,_0x24e9b2){return _0x1b9dcc!==_0x24e9b2;},'VSPhk':_0x3b348d(0x25e),'IZwgU':_0x3b348d(0x330),'aNCVA':_0x3b348d(0x29e),'XPKFC':function(_0x2061ef,_0x3ced05){return _0x2061ef/_0x3ced05;},'aQgyy':function(_0xeb9b88,_0x2efa52){return _0xeb9b88+_0x2efa52;},'raKKf':_0x3b348d(0x381),'CCAxz':function(_0x5cb372,_0xc5fbc8){return _0x5cb372+_0xc5fbc8;},'Doicm':_0x3b348d(0x362),'cLfEj':function(_0x1d4d34){return _0x1d4d34();},'eGmCY':_0x3b348d(0x287),'msorO':_0x3b348d(0x494),'ISZqk':'No\x20question\x20text\x20available','nRZDt':_0x3b348d(0x227),'Qngfo':_0x3b348d(0x2de),'sNLxa':_0x3b348d(0x493),'FURUi':'click','wgIFl':_0x3b348d(0x453)};if(!questionsData||_0x17c03a[_0x3b348d(0x2bf)](questionsData[_0x3b348d(0x3e6)],0x0)){if(_0x17c03a[_0x3b348d(0x27c)](_0x17c03a[_0x3b348d(0x495)],_0x17c03a[_0x3b348d(0x495)]))_0x4506a6[_0xdf9989][_0x3b348d(0x398)]+=_0x17c03a[_0x3b348d(0x2c4)](_0x4bd420['now'](),_0x592fc9);else{document['getElementById'](_0x17c03a['IZwgU'])[_0x3b348d(0x379)]=_0x17c03a[_0x3b348d(0x438)];return;}};const _0x725dc5=questionsData[currentQuestionIndex];questionStartTime=Date[_0x3b348d(0x260)](),selectedOption=questionStates[currentQuestionIndex]['selectedAnswer'];const _0x1218a0=_0x17c03a[_0x3b348d(0x407)](_0x17c03a[_0x3b348d(0x277)](currentQuestionIndex,0x1),questionsData[_0x3b348d(0x3e6)])*0x64;document[_0x3b348d(0x44f)](_0x17c03a[_0x3b348d(0x34a)])[_0x3b348d(0x41b)][_0x3b348d(0x3f0)]=_0x17c03a['CCAxz'](_0x1218a0,'%'),document['getElementById'](_0x17c03a[_0x3b348d(0x245)])['textContent']=_0x17c03a[_0x3b348d(0x277)](currentQuestionIndex,0x1),_0x17c03a[_0x3b348d(0x492)](updateQuestionNav),document['getElementById'](_0x17c03a['eGmCY'])[_0x3b348d(0x23b)]=_0x17c03a[_0x3b348d(0x2cc)](currentQuestionIndex,0x0),document['getElementById'](_0x3b348d(0x3bd))[_0x3b348d(0x22f)][_0x3b348d(0x3e5)](_0x17c03a[_0x3b348d(0x3f8)]),document['getElementById'](_0x17c03a[_0x3b348d(0x3ff)])[_0x3b348d(0x379)]=_0x725dc5[_0x3b348d(0x357)]||_0x17c03a[_0x3b348d(0x341)];let _0x2bbfef='';if(_0x725dc5[_0x3b348d(0x4a1)])_0x2bbfef+='<div\x20class=\x22glass-light\x20p-4\x20mb-4\x22><audio\x20src=\x22'+_0x725dc5[_0x3b348d(0x4a1)]+_0x3b348d(0x1da);if(_0x725dc5[_0x3b348d(0x45f)])_0x2bbfef+=_0x3b348d(0x308)+_0x725dc5[_0x3b348d(0x45f)]+_0x3b348d(0x297);_0x725dc5[_0x3b348d(0x3ae)]&&_0x725dc5[_0x3b348d(0x3ae)][_0x3b348d(0x1e6)](_0x16c457=>{const _0x8b3bf7=_0x3b348d,_0xd82699={'EZIyX':_0x8b3bf7(0x33d)};if(_0x17c03a[_0x8b3bf7(0x2cc)](_0x17c03a[_0x8b3bf7(0x394)],_0x8b3bf7(0x249)))_0x46d9b2++,_0x103664['status']=_0xd82699['EZIyX'];else{if(_0x16c457)_0x2bbfef+='<div\x20class=\x22glass-light\x20p-4\x20mb-4\x22><img\x20src=\x22'+_0x16c457+_0x8b3bf7(0x43a);}});document[_0x3b348d(0x44f)](_0x17c03a[_0x3b348d(0x359)])['innerHTML']=_0x2bbfef;const _0x236fe4=document[_0x3b348d(0x44f)](_0x17c03a[_0x3b348d(0x301)]);_0x236fe4[_0x3b348d(0x379)]='',_0x236fe4[_0x3b348d(0x22f)]['remove'](_0x17c03a['sNLxa']),_0x725dc5['choices']&&Array[_0x3b348d(0x42d)](_0x725dc5[_0x3b348d(0x256)])&&(_0x725dc5['choices'][_0x3b348d(0x1e6)]((_0x1b70ee,_0x32bab0)=>{const _0x5919e2=_0x3b348d,_0x3baff4=String['fromCharCode'](_0x17c03a['YhNZL'](0x41,_0x32bab0)),_0x573373=_0x17c03a[_0x5919e2(0x2cc)](selectedOption,_0x32bab0),_0x4cc3ff=document['createElement'](_0x5919e2(0x446));_0x4cc3ff[_0x5919e2(0x379)]='\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<button\x20type=\x22button\x22\x20class=\x22option-button\x20'+(_0x573373?_0x17c03a[_0x5919e2(0x413)]:'')+'\x22\x20data-option-index=\x22'+_0x32bab0+_0x5919e2(0x3d5)+_0x3baff4+_0x5919e2(0x1e5)+(_0x1b70ee[_0x5919e2(0x357)]||_0x17c03a['irhUY'](_0x17c03a['CwYHl'],_0x17c03a[_0x5919e2(0x422)](_0x32bab0,0x1)))+_0x5919e2(0x461),_0x236fe4[_0x5919e2(0x33e)](_0x4cc3ff);}),_0x236fe4[_0x3b348d(0x39a)](_0x17c03a['FURUi'],function(_0x82136e){const _0x3a1eae=_0x3b348d;if(_0x17c03a[_0x3a1eae(0x2bf)](_0x17c03a[_0x3a1eae(0x403)],_0x17c03a['mhfNH'])){_0x2908eb[_0x3a1eae(0x22f)]['remove'](_0x17c03a['XeTCe']);if(_0x17c03a[_0x3a1eae(0x1dd)](_0x3ba842,_0x4e1790))_0x2c5ca0[_0x3a1eae(0x22f)]['add'](_0x17c03a[_0x3a1eae(0x397)]);else{if(_0x17c03a[_0x3a1eae(0x2cc)](_0x288493,_0x42bdc5)&&!_0x18d1ce)_0x407d3f['classList'][_0x3a1eae(0x3e5)]('incorrect');}}else{const _0x3b5fa2=_0x82136e[_0x3a1eae(0x377)][_0x3a1eae(0x35f)](_0x17c03a[_0x3a1eae(0x305)]);if(_0x3b5fa2){if(_0x17c03a[_0x3a1eae(0x2a7)]('wTJJc',_0x17c03a['cwJHu']))_0x1f3d54[_0xc92302[_0x3a1eae(0x2dc)]]['bookmarked']=!![];else{const _0x292e02=_0x17c03a[_0x3a1eae(0x3c2)](parseInt,_0x3b5fa2[_0x3a1eae(0x35e)](_0x17c03a[_0x3a1eae(0x2e5)]));_0x17c03a['vvtZk'](selectOption,_0x292e02);}}}})),_0x17c03a[_0x3b348d(0x492)](updateBookmarkButton),updateMarkReviewButton(),(_0x17c03a[_0x3b348d(0x2cc)](currentMode,_0x3b348d(0x1eb))||_0x17c03a['OJFhf'](currentMode,_0x17c03a['wgIFl']))&&!isQuizCompleted&&startTimer();}function selectOption(_0x58e4cb){const _0x5ad271=_0x56aaab,_0x1ad1a5={'cmzav':_0x5ad271(0x2da),'spvus':function(_0x1fa1cd,_0x2c39b7){return _0x1fa1cd===_0x2c39b7;},'rYzGB':_0x5ad271(0x493),'eKQBn':function(_0x1a599a,_0xea7299){return _0x1a599a-_0xea7299;},'ePiCp':function(_0x7368e2,_0x4257bd){return _0x7368e2===_0x4257bd;},'xTWWF':_0x5ad271(0x307),'LDDUB':function(_0xe3868f,_0x5cd40f){return _0xe3868f===_0x5cd40f;},'UQovd':_0x5ad271(0x1eb),'KSryv':function(_0x29d733){return _0x29d733();},'XGuBd':'not_attempted','ayDEU':function(_0x209af2){return _0x209af2();}},_0x173eed=document[_0x5ad271(0x44f)](_0x5ad271(0x2de));if(_0x173eed[_0x5ad271(0x22f)][_0x5ad271(0x337)](_0x1ad1a5[_0x5ad271(0x353)]))return;questionStartTime&&(questionStates[currentQuestionIndex]['timeSpent']+=_0x1ad1a5['eKQBn'](Date[_0x5ad271(0x260)](),questionStartTime),questionStartTime=Date['now']()),selectedOption=_0x58e4cb,questionStates[currentQuestionIndex]['selectedAnswer']=_0x58e4cb,document[_0x5ad271(0x265)](_0x5ad271(0x360))['forEach']((_0x47d073,_0x92a2e7)=>{const _0x5a1b3e=_0x5ad271;_0x47d073['classList']['toggle'](_0x1ad1a5[_0x5a1b3e(0x282)],_0x1ad1a5['spvus'](_0x92a2e7,_0x58e4cb));}),_0x1ad1a5['ePiCp'](currentMode,_0x1ad1a5['xTWWF'])||_0x1ad1a5['LDDUB'](currentMode,_0x1ad1a5['UQovd'])?_0x1ad1a5[_0x5ad271(0x326)](processAnswer):(_0x1ad1a5[_0x5ad271(0x226)](questionStates[currentQuestionIndex][_0x5ad271(0x3f2)],_0x1ad1a5[_0x5ad271(0x281)])&&(questionStates[currentQuestionIndex][_0x5ad271(0x3f2)]=_0x1ad1a5['rYzGB'],stats[_0x5ad271(0x215)]++,stats['notAttempted']--),_0x1ad1a5[_0x5ad271(0x44b)](updateQuestionNav)),_0x1ad1a5[_0x5ad271(0x326)](saveProgress);}function processAnswer(){const _0x27d9d4=_0x56aaab,_0x39108f={'GHFTg':_0x27d9d4(0x46e),'rZzHx':_0x27d9d4(0x477),'bYthe':'glass-light\x20px-6\x20py-3\x20text-white\x20hover:bg-purple-500\x20hover:bg-opacity-20\x20transition-all\x20duration-300\x20flex\x20items-center','lBvKW':_0x27d9d4(0x35d),'FmFFV':_0x27d9d4(0x1f8),'CuHCk':function(_0x2625e5,_0x129a85){return _0x2625e5===_0x129a85;},'kdiFb':_0x27d9d4(0x28a),'AQnig':function(_0x4b2bc5,_0x59f8bb){return _0x4b2bc5!==_0x59f8bb;},'nyCWb':'QWWCK','WgYHU':_0x27d9d4(0x33d),'mOdky':_0x27d9d4(0x32f),'AjBdP':function(_0x9a9cd7){return _0x9a9cd7();}},_0x3315ba=questionsData[currentQuestionIndex],_0x4b8bb9=_0x3315ba['correct_choice_id'];if(selectedOption===null)return;const _0x30bf08=_0x3315ba['choices'][selectedOption],_0x22c631=_0x39108f[_0x27d9d4(0x482)](_0x30bf08['id'],_0x4b8bb9);if(_0x39108f[_0x27d9d4(0x482)](questionStates[currentQuestionIndex][_0x27d9d4(0x3f2)],_0x39108f[_0x27d9d4(0x39c)])){if(_0x39108f['AQnig'](_0x39108f[_0x27d9d4(0x410)],_0x39108f['nyCWb'])){const _0x10ef6f=_0x1efa5d[_0x27d9d4(0x44f)](_0x39108f['GHFTg']),_0xcb6f94=_0x2bbeb3['getElementById'](_0x39108f[_0x27d9d4(0x2be)]),_0xe3268d=_0x455497[_0x2efffc][_0x27d9d4(0x321)];_0x10ef6f[_0x27d9d4(0x372)]=_0xe3268d?_0x27d9d4(0x409):_0x39108f[_0x27d9d4(0x31d)],_0xcb6f94[_0x27d9d4(0x295)]=_0xe3268d?_0x39108f['lBvKW']:_0x39108f[_0x27d9d4(0x429)];}else{stats['totalAttempted']++,stats['notAttempted']--;if(_0x22c631)stats[_0x27d9d4(0x243)]++;else stats[_0x27d9d4(0x1f9)]++;}}questionStates[currentQuestionIndex][_0x27d9d4(0x3f2)]=_0x22c631?_0x39108f['WgYHU']:_0x39108f[_0x27d9d4(0x3f5)],_0x39108f['AjBdP'](updateStats),showInlineFeedback(_0x22c631),_0x39108f[_0x27d9d4(0x21c)](updateQuestionNav);}function showInlineFeedback(_0x3025c8){const _0x205d2c=_0x56aaab,_0x3fce1a={'mdoRZ':'selected','LKgEi':_0x205d2c(0x33d),'OOxui':function(_0x3a794c,_0x3b4fe9){return _0x3a794c===_0x3b4fe9;},'pBhSG':function(_0x1b0265,_0xd90f69){return _0x1b0265!==_0xd90f69;},'KRAvM':'timed_study','ghLZA':_0x205d2c(0x360),'Zjzrp':_0x205d2c(0x493)};if(_0x3fce1a[_0x205d2c(0x340)](currentMode,'study')&&currentMode!==_0x3fce1a[_0x205d2c(0x3b4)])return;const _0x1515c2=document['getElementById'](_0x205d2c(0x2de)),_0x457c9e=_0x1515c2['querySelectorAll'](_0x3fce1a[_0x205d2c(0x331)]),_0x56d79f=questionsData[currentQuestionIndex],_0x277854=_0x56d79f[_0x205d2c(0x2a9)];let _0x403e9c=_0x56d79f['choices']['findIndex'](_0x2c0de7=>_0x2c0de7['id']===_0x277854);_0x1515c2[_0x205d2c(0x22f)]['add'](_0x3fce1a[_0x205d2c(0x2b6)]),_0x457c9e[_0x205d2c(0x1e6)]((_0x4d9b80,_0x3a5147)=>{const _0x15ce41=_0x205d2c;_0x4d9b80[_0x15ce41(0x22f)][_0x15ce41(0x3cc)](_0x3fce1a[_0x15ce41(0x3a6)]);if(_0x3a5147===_0x403e9c)_0x4d9b80[_0x15ce41(0x22f)][_0x15ce41(0x3e5)](_0x3fce1a[_0x15ce41(0x369)]);else{if(_0x3fce1a[_0x15ce41(0x4a6)](_0x3a5147,selectedOption)&&!_0x3025c8)_0x4d9b80[_0x15ce41(0x22f)][_0x15ce41(0x3e5)](_0x15ce41(0x32f));}}),showSolution();}function showSolution(){const _0x33f0a0=_0x56aaab,_0x44517f={'WPzNM':function(_0x511aee){return _0x511aee();},'fBXdV':_0x33f0a0(0x45a),'nGkLv':function(_0x55e217,_0x131060){return _0x55e217+_0x131060;},'EBirV':'\x20-\x20Brain\x20And\x20Scalpel','sNFJk':'totalQuestions','gDmJJ':'study','OcSRA':function(_0x38ec51,_0x3662a1){return _0x38ec51!==_0x3662a1;},'BnncZ':_0x33f0a0(0x1eb),'OWyLV':_0x33f0a0(0x1e7),'XfQAg':_0x33f0a0(0x3a9),'pevxz':_0x33f0a0(0x2e6),'lbljG':_0x33f0a0(0x494),'Qpjuv':function(_0x14351e,_0x2b507a,_0x30f442){return _0x14351e(_0x2b507a,_0x30f442);},'YbUCy':_0x33f0a0(0x458),'zNiqt':_0x33f0a0(0x36b),'wTGDg':function(_0x5d641d,_0x4002de){return _0x5d641d===_0x4002de;},'ETynb':_0x33f0a0(0x36e),'EAWoJ':_0x33f0a0(0x3d2),'Aopxi':_0x33f0a0(0x3b7),'mRExg':_0x33f0a0(0x448)};if(currentMode!==_0x44517f[_0x33f0a0(0x368)]&&_0x44517f[_0x33f0a0(0x1fc)](currentMode,_0x44517f[_0x33f0a0(0x1e2)]))return;const _0x5038ca=questionsData[currentQuestionIndex];document[_0x33f0a0(0x44f)](_0x44517f[_0x33f0a0(0x38a)])[_0x33f0a0(0x379)]=_0x5038ca[_0x33f0a0(0x271)]||_0x44517f[_0x33f0a0(0x338)];const _0x55e757=document[_0x33f0a0(0x44f)](_0x33f0a0(0x20b)),_0x39d836=document[_0x33f0a0(0x44f)](_0x44517f['pevxz']),_0x298b4f=_0x5038ca['explanation_video'];if(_0x298b4f){_0x55e757[_0x33f0a0(0x22f)]['remove'](_0x44517f[_0x33f0a0(0x333)]);if(_0x298b4f[_0x33f0a0(0x417)](_0x33f0a0(0x229)))_0x44517f[_0x33f0a0(0x378)](setupVideo,_0x39d836,_0x298b4f);else _0x39d836[_0x33f0a0(0x2c7)]=_0x298b4f;}else'qoNJe'===_0x44517f[_0x33f0a0(0x383)]?_0x44517f[_0x33f0a0(0x2aa)](_0x181021):_0x55e757[_0x33f0a0(0x22f)][_0x33f0a0(0x3e5)](_0x44517f['lbljG']);const _0x1490c1=document['getElementById'](_0x44517f['zNiqt']);_0x1490c1[_0x33f0a0(0x379)]='';if(_0x5038ca[_0x33f0a0(0x358)]){if(_0x44517f[_0x33f0a0(0x22b)](_0x33f0a0(0x36e),_0x44517f[_0x33f0a0(0x486)]))_0x1490c1[_0x33f0a0(0x379)]+=_0x33f0a0(0x224)+_0x5038ca[_0x33f0a0(0x358)]+_0x33f0a0(0x1da);else{const _0x57ac3c=_0x2f6e63['apply'](_0x4c6a80,arguments);return _0xc90738=null,_0x57ac3c;}}_0x5038ca['explanation_audio_hin']&&(_0x44517f[_0x33f0a0(0x22b)](_0x44517f[_0x33f0a0(0x404)],_0x44517f['EAWoJ'])?_0x1490c1[_0x33f0a0(0x379)]+=_0x33f0a0(0x261)+_0x5038ca[_0x33f0a0(0x3d8)]+'\x22\x20controls\x20class=\x22w-full\x22></audio></div>':_0x38fd8b[_0x33f0a0(0x44f)](_0x44517f[_0x33f0a0(0x40f)])[_0x33f0a0(0x22f)]['remove'](_0x33f0a0(0x494)));const _0x2f49f2=document[_0x33f0a0(0x44f)](_0x44517f['Aopxi']);_0x2f49f2[_0x33f0a0(0x379)]='';if(_0x5038ca[_0x33f0a0(0x290)]){if(_0x44517f[_0x33f0a0(0x1fc)](_0x44517f[_0x33f0a0(0x300)],_0x44517f[_0x33f0a0(0x300)])){const _0x581ec0='1|0|2|4|5|3'[_0x33f0a0(0x36f)]('|');let _0x5b5e88=0x0;while(!![]){switch(_0x581ec0[_0x5b5e88++]){case'0':_0x4ffb1a=_0x4f17fa[_0x33f0a0(0x4a7)];continue;case'1':_0x366d15=_0x560bcb[_0x33f0a0(0x380)];continue;case'2':_0x4ed254=_0xe04c2f[_0x33f0a0(0x425)];continue;case'3':_0x4b3ade['getElementById']('quizHierarchy')[_0x33f0a0(0x295)]=_0x2cb872[_0x33f0a0(0x2ca)](_0x33f0a0(0x2df));continue;case'4':_0x19a1e9[_0x33f0a0(0x3a1)]=_0x44517f[_0x33f0a0(0x324)](_0x1e0950,_0x44517f[_0x33f0a0(0x3d1)]);continue;case'5':_0x29e7d0[_0x33f0a0(0x44f)](_0x44517f['sNFJk'])['textContent']=_0x4d8966[_0x33f0a0(0x3e6)];continue;}break;}}else _0x5038ca['explanation_images'][_0x33f0a0(0x1e6)](_0x40d612=>{const _0x789e47=_0x33f0a0;if(_0x40d612)_0x2f49f2[_0x789e47(0x379)]+='<div\x20class=\x22mt-4\x22><img\x20src=\x22'+_0x40d612+'\x22\x20alt=\x22Explanation\x20Image\x22\x20class=\x22w-full\x20rounded-lg\x22></div>';});}document[_0x33f0a0(0x44f)](_0x33f0a0(0x3bd))[_0x33f0a0(0x22f)][_0x33f0a0(0x3cc)]('hidden');}function submitQuiz(){const _0x534282=_0x56aaab,_0x5d07fd={'ZzPIX':_0x534282(0x41e),'MdlRC':'open','tLkiz':function(_0x79c12d,_0x302437){return _0x79c12d!==_0x302437;},'eYZKY':function(_0x4e9daf,_0x1d96c6){return _0x4e9daf===_0x1d96c6;},'joefy':_0x534282(0x3c1),'Igedi':'hkZCc','bRvPQ':_0x534282(0x33d),'OjBBk':_0x534282(0x32f),'qmjNN':function(_0x686fae,_0x70b77d){return _0x686fae(_0x70b77d);},'PmUdx':function(_0x9fef9c,_0x2bc4c9){return _0x9fef9c-_0x2bc4c9;},'TXRTG':_0x534282(0x497),'axNAJ':function(_0x4f7915,_0x29a383){return _0x4f7915+_0x29a383;},'Lomct':function(_0x3daaa2){return _0x3daaa2();},'oJCZZ':function(_0x1850dc,_0x530744,_0x118b2e,_0x4da3f7,_0x4ca20e){return _0x1850dc(_0x530744,_0x118b2e,_0x4da3f7,_0x4ca20e);},'QFQRU':function(_0x5c8bd9,_0x597bc2){return _0x5c8bd9-_0x597bc2;}};if(timer)_0x5d07fd[_0x534282(0x3fe)](clearInterval,timer);if(!confirm(_0x534282(0x294)))return;isQuizCompleted=!![];let _0xb97f26=0x0,_0x8f7b5e=0x0;const _0x1914c3=_0x5d07fd[_0x534282(0x2f2)](Date['now'](),quizStartTime);questionsData[_0x534282(0x1e6)]((_0xd6a6e9,_0x5b1dcf)=>{const _0x47cf9f=_0x534282,_0xb45540=questionStates[_0x5b1dcf];_0x5d07fd[_0x47cf9f(0x289)](_0xb45540[_0x47cf9f(0x2a4)],null)&&(_0x5d07fd['eYZKY'](_0x5d07fd[_0x47cf9f(0x447)],_0x5d07fd[_0x47cf9f(0x22a)])?_0x222b81[_0x47cf9f(0x44f)](_0x5d07fd[_0x47cf9f(0x27f)])[_0x47cf9f(0x22f)][_0x47cf9f(0x3d3)](_0x5d07fd['MdlRC']):_0xd6a6e9[_0x47cf9f(0x256)][_0xb45540[_0x47cf9f(0x2a4)]]['id']===_0xd6a6e9[_0x47cf9f(0x2a9)]?(_0xb97f26++,_0xb45540[_0x47cf9f(0x3f2)]=_0x5d07fd['bRvPQ']):(_0x8f7b5e++,_0xb45540[_0x47cf9f(0x3f2)]=_0x5d07fd[_0x47cf9f(0x2d1)]));});const _0x169263=JSON[_0x534282(0x439)](localStorage[_0x534282(0x47f)](_0x5d07fd[_0x534282(0x211)]))||[];_0x169263['push']({'quizName':quizName,'hierarchy':hierarchy,'timestamp':Date[_0x534282(0x260)](),'totalTime':_0x1914c3,'stats':{'correct':_0xb97f26,'incorrect':_0x8f7b5e,'notAttempted':questionsData[_0x534282(0x3e6)]-_0x5d07fd[_0x534282(0x266)](_0xb97f26,_0x8f7b5e)}}),localStorage[_0x534282(0x42f)]('quizPerformanceData',JSON['stringify'](_0x169263)),stats['correctAnswers']=_0xb97f26,stats[_0x534282(0x1f9)]=_0x8f7b5e,_0x5d07fd['Lomct'](markQuizAsCompleted),_0x5d07fd[_0x534282(0x399)](showPerformanceAnalysis,_0xb97f26,_0x8f7b5e,_0x5d07fd[_0x534282(0x47b)](questionsData[_0x534282(0x3e6)],_0xb97f26+_0x8f7b5e),_0x1914c3);}function showPerformanceAnalysis(_0x1015b1,_0x487c0a,_0x10aa21,_0x43415b){const _0x34d8af=_0x56aaab,_0x27a07f={'mFZSr':_0x34d8af(0x2cf),'ojhlg':function(_0xf062df,_0x714b){return _0xf062df>_0x714b;},'jxyxd':function(_0xeb245c,_0x4a45d8){return _0xeb245c+_0x4a45d8;},'KfBEA':function(_0x55cc54,_0x5c6520){return _0x55cc54*_0x5c6520;},'kixnA':function(_0x28d5ef,_0x3486e0){return _0x28d5ef/_0x3486e0;},'jaADA':function(_0x44c549,_0x17cce7){return _0x44c549+_0x17cce7;},'rtAAx':_0x34d8af(0x28f),'zEsJO':function(_0x4db555,_0x24d6b2){return _0x4db555-_0x24d6b2;},'LqkgH':_0x34d8af(0x3c3),'SNyMQ':_0x34d8af(0x44e),'bxzly':_0x34d8af(0x23c),'WkpDh':_0x34d8af(0x45b),'idOWy':_0x34d8af(0x225),'RIlSy':function(_0x3c5e36,_0x250553){return _0x3c5e36/_0x250553;},'vvnOy':function(_0x494ef6,_0x101917){return _0x494ef6/_0x101917;},'onsNR':function(_0x59db6e,_0x10c1fa){return _0x59db6e/_0x10c1fa;},'ycrdK':function(_0x53f1a1,_0x21e824){return _0x53f1a1%_0x21e824;},'XAftP':'avgTimeResult','UTXCi':'hidden'},_0x44f4e7=document[_0x34d8af(0x44f)](_0x27a07f['mFZSr']),_0x3e41d2=_0x27a07f[_0x34d8af(0x355)](_0x27a07f[_0x34d8af(0x25c)](_0x1015b1,_0x487c0a),0x0)?Math[_0x34d8af(0x3f7)](_0x27a07f[_0x34d8af(0x268)](_0x27a07f['kixnA'](_0x1015b1,_0x27a07f[_0x34d8af(0x4b0)](_0x1015b1,_0x487c0a)),0x64)):0x0,_0x3223fa=_0x27a07f[_0x34d8af(0x268)](_0x27a07f['KfBEA'](0x2,Math['PI']),0x41),_0x3c6c06=document[_0x34d8af(0x44f)](_0x27a07f[_0x34d8af(0x204)]);_0x3c6c06['style'][_0x34d8af(0x253)]=_0x3223fa+'\x20'+_0x3223fa,_0x3c6c06['style'][_0x34d8af(0x3a7)]=_0x27a07f['zEsJO'](_0x3223fa,_0x27a07f[_0x34d8af(0x444)](_0x3e41d2,0x64)*_0x3223fa),document[_0x34d8af(0x44f)](_0x27a07f['LqkgH'])[_0x34d8af(0x295)]=_0x3e41d2+'%',document[_0x34d8af(0x44f)](_0x27a07f[_0x34d8af(0x218)])['textContent']=questionsData[_0x34d8af(0x3e6)],document[_0x34d8af(0x44f)](_0x27a07f['bxzly'])[_0x34d8af(0x295)]=_0x1015b1,document[_0x34d8af(0x44f)](_0x27a07f[_0x34d8af(0x3b6)])[_0x34d8af(0x295)]=_0x487c0a,document[_0x34d8af(0x44f)](_0x27a07f[_0x34d8af(0x3b3)])['textContent']=_0x10aa21;const _0x8032b7=Math['floor'](_0x27a07f[_0x34d8af(0x3b5)](_0x43415b,0xea60)),_0xe3f99d=Math[_0x34d8af(0x29f)](_0x43415b%0xea60/0x3e8);document[_0x34d8af(0x44f)](_0x34d8af(0x35a))[_0x34d8af(0x295)]=_0x8032b7+':'+_0xe3f99d[_0x34d8af(0x286)]()[_0x34d8af(0x2f8)](0x2,'0');const _0x3afe73=_0x27a07f[_0x34d8af(0x49c)](_0x43415b,questionsData[_0x34d8af(0x3e6)]),_0x1cc00b=Math[_0x34d8af(0x29f)](_0x27a07f[_0x34d8af(0x49c)](_0x3afe73,0xea60)),_0x191185=Math[_0x34d8af(0x29f)](_0x27a07f[_0x34d8af(0x3a0)](_0x27a07f[_0x34d8af(0x26a)](_0x3afe73,0xea60),0x3e8));document[_0x34d8af(0x44f)](_0x27a07f['XAftP'])['textContent']=_0x1cc00b+':'+_0x191185[_0x34d8af(0x286)]()[_0x34d8af(0x2f8)](0x2,'0'),_0x44f4e7[_0x34d8af(0x22f)][_0x34d8af(0x3cc)](_0x27a07f[_0x34d8af(0x2fd)]);}function closePerformanceModal(){const _0x304819=_0x56aaab,_0x3c8018={'IbRuW':_0x304819(0x2cf),'IjRlR':_0x304819(0x494)};document[_0x304819(0x44f)](_0x3c8018[_0x304819(0x1fe)])[_0x304819(0x22f)]['add'](_0x3c8018[_0x304819(0x3c8)]);}function reviewQuestions(){const _0x34744f=_0x56aaab,_0x58b3c2={'SWJym':function(_0x1c3a44,_0x318bde){return _0x1c3a44>_0x318bde;},'LvTXs':function(_0x4c342d,_0x5117ef){return _0x4c342d-_0x5117ef;},'UvLbe':function(_0x5ca2a2){return _0x5ca2a2();},'TXqCp':_0x34744f(0x1e9),'mToiZ':_0x34744f(0x302),'rpGMl':_0x34744f(0x2ef),'wciat':_0x34744f(0x49a),'PPeXw':function(_0x38e059,_0x6e1c61){return _0x38e059===_0x6e1c61;},'ranHG':_0x34744f(0x298),'MqJKw':_0x34744f(0x3ef),'XbHtO':_0x34744f(0x3bf),'JEUUK':'Not\x20Attempted','hcmfs':function(_0x58fb59,_0x26a870){return _0x58fb59!==_0x26a870;},'BuhwU':function(_0x3aae35,_0x39ff9d){return _0x3aae35===_0x39ff9d;},'eSkMd':_0x34744f(0x42b),'fFMGy':_0x34744f(0x374),'gzDEq':'correct','kCxOr':'Correct','NItEd':'incorrect','lAjSU':_0x34744f(0x446),'efSWX':function(_0x172fc0,_0x1e7191){return _0x172fc0+_0x1e7191;},'MuUSf':_0x34744f(0x231),'knjBS':'red','SVjzH':_0x34744f(0x1fb),'kErbs':_0x34744f(0x494),'CiJGM':_0x34744f(0x44d)};document['getElementById'](_0x34744f(0x40b))[_0x34744f(0x22f)]['remove'](_0x58b3c2[_0x34744f(0x370)]);const _0x3f3288=document[_0x34744f(0x44f)](_0x58b3c2[_0x34744f(0x426)]);_0x3f3288[_0x34744f(0x379)]='',questionsData['forEach']((_0x37e7d7,_0xc1a7ed)=>{const _0xf4cba1=_0x34744f,_0x4f4c52={'rmvns':_0x58b3c2[_0xf4cba1(0x441)],'EebOn':_0x58b3c2[_0xf4cba1(0x2ee)],'mlqoA':_0x58b3c2[_0xf4cba1(0x267)],'NtpdU':_0x58b3c2[_0xf4cba1(0x36c)],'wUgIB':function(_0x18d92f,_0x4e41ea){const _0x88874=_0xf4cba1;return _0x58b3c2[_0x88874(0x406)](_0x18d92f,_0x4e41ea);},'njDyA':_0x58b3c2[_0xf4cba1(0x299)],'WgeSo':_0x58b3c2['MqJKw'],'GPsKQ':function(_0x334e96,_0x1cb0e2){return _0x334e96+_0x1cb0e2;}},_0x10488d=questionStates[_0xc1a7ed],_0x1800c6=_0x37e7d7[_0xf4cba1(0x2a9)];let _0x355c21=_0x58b3c2[_0xf4cba1(0x20e)],_0x1988ca=_0x58b3c2[_0xf4cba1(0x41c)];if(_0x58b3c2[_0xf4cba1(0x212)](_0x10488d['selectedAnswer'],null)){const _0x53bd30=_0x37e7d7[_0xf4cba1(0x256)][_0x10488d[_0xf4cba1(0x2a4)]];_0x58b3c2['PPeXw'](_0x53bd30['id'],_0x1800c6)?_0x58b3c2[_0xf4cba1(0x257)](_0x58b3c2[_0xf4cba1(0x2b0)],_0x58b3c2[_0xf4cba1(0x2c5)])?_0x58b3c2[_0xf4cba1(0x460)](_0x39bf93,0x0)&&(_0x2bbef5&&(_0x20d79a[_0x38a20f][_0xf4cba1(0x398)]+=_0x58b3c2['LvTXs'](_0x1406a4[_0xf4cba1(0x260)](),_0x3f14dd)),_0x277c4b--,_0x58b3c2['UvLbe'](_0x2feb32),_0x58b3c2['UvLbe'](_0x370a21)):(_0x355c21=_0x58b3c2['gzDEq'],_0x1988ca=_0x58b3c2[_0xf4cba1(0x3e3)]):(_0x355c21=_0x58b3c2[_0xf4cba1(0x40d)],_0x1988ca=_0xf4cba1(0x3fc));}const _0x399573=document['createElement'](_0x58b3c2[_0xf4cba1(0x3c9)]);_0x399573[_0xf4cba1(0x372)]=_0xf4cba1(0x2ac)+_0x355c21;let _0x4d4a50=(_0x37e7d7[_0xf4cba1(0x256)]||[])[_0xf4cba1(0x3d7)]((_0x5047ce,_0x106846)=>{const _0x2cee29=_0xf4cba1,_0x97aed3={'NORvZ':_0x4f4c52['rmvns'],'sBWBD':_0x4f4c52[_0x2cee29(0x304)]};if(_0x4f4c52[_0x2cee29(0x27a)]!==_0x4f4c52[_0x2cee29(0x38d)]){const _0x5c837f=_0x4f4c52[_0x2cee29(0x37b)](_0x10488d[_0x2cee29(0x2a4)],_0x106846),_0x608c8e=_0x4f4c52['wUgIB'](_0x5047ce['id'],_0x1800c6);let _0x359eb5=_0x4f4c52['njDyA'];if(_0x608c8e)_0x359eb5=_0x4f4c52[_0x2cee29(0x4af)];else{if(_0x5c837f)_0x359eb5=_0x2cee29(0x2cb);}return _0x2cee29(0x1de)+_0x359eb5+_0x2cee29(0x39f)+String['fromCharCode'](_0x4f4c52[_0x2cee29(0x43b)](0x41,_0x106846))+_0x2cee29(0x20c)+_0x5047ce['text']+'</span></div>';}else{const _0x202f11=_0x5f2f07[_0x2cee29(0x439)](_0x133b5c[_0x2cee29(0x47f)](_0x97aed3[_0x2cee29(0x416)]))||{},_0x462c63=_0x202f11[_0x39aa87];if(_0x462c63){const _0x15df30='5|2|4|3|0|1'[_0x2cee29(0x36f)]('|');let _0x1fb472=0x0;while(!![]){switch(_0x15df30[_0x1fb472++]){case'0':_0x53222a[_0x2cee29(0x2a8)](_0x97aed3[_0x2cee29(0x433)]);continue;case'1':return!![];case'2':_0x2f8ffa=_0x462c63['stats'];continue;case'3':_0x52e09f=_0x462c63[_0x2cee29(0x37e)];continue;case'4':_0x4cd338=_0x462c63[_0x2cee29(0x285)];continue;case'5':_0x16b6a6=_0x462c63[_0x2cee29(0x350)];continue;}break;}}return![];}})[_0xf4cba1(0x2ca)]('');const _0x414f52=_0x37e7d7[_0xf4cba1(0x329)]?_0xf4cba1(0x205)+_0xc1a7ed+'\x22\x20data-src=\x22'+_0x37e7d7[_0xf4cba1(0x329)]+_0xf4cba1(0x220):'';let _0x2bb293='';if(_0x37e7d7[_0xf4cba1(0x358)])_0x2bb293+='<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>English:</p><audio\x20src=\x22'+_0x37e7d7[_0xf4cba1(0x358)]+_0xf4cba1(0x1da);if(_0x37e7d7[_0xf4cba1(0x3d8)])_0x2bb293+=_0xf4cba1(0x246)+_0x37e7d7[_0xf4cba1(0x3d8)]+_0xf4cba1(0x1da);let _0x546772=(_0x37e7d7['explanation_images']||[])[_0xf4cba1(0x3d7)](_0x467bfb=>_0x467bfb?_0xf4cba1(0x41f)+_0x467bfb+_0xf4cba1(0x3b9):'')['join']('');_0x399573['innerHTML']='\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22mb-4\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22flex\x20justify-between\x20items-center\x20mb-3\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<h4\x20class=\x22text-lg\x20font-bold\x20text-white\x22>Question\x20'+_0x58b3c2[_0xf4cba1(0x20f)](_0xc1a7ed,0x1)+_0xf4cba1(0x2cd)+(_0x58b3c2[_0xf4cba1(0x257)](_0x355c21,_0xf4cba1(0x33d))?_0x58b3c2[_0xf4cba1(0x25f)]:_0x58b3c2[_0xf4cba1(0x257)](_0x355c21,_0x58b3c2[_0xf4cba1(0x40d)])?_0x58b3c2[_0xf4cba1(0x25d)]:_0x58b3c2[_0xf4cba1(0x206)])+_0xf4cba1(0x241)+_0x1988ca+_0xf4cba1(0x348)+_0x37e7d7[_0xf4cba1(0x357)]+_0xf4cba1(0x3a8)+_0x4d4a50+_0xf4cba1(0x347)+(_0x37e7d7['solution']||_0xf4cba1(0x342))+_0xf4cba1(0x22e)+_0x414f52+_0xf4cba1(0x4a0)+_0x2bb293+_0xf4cba1(0x4a0)+_0x546772+_0xf4cba1(0x400),_0x3f3288[_0xf4cba1(0x33e)](_0x399573);}),_0x58b3c2[_0x34744f(0x366)](initializeReviewVideos);}function initializeReviewVideos(){const _0x4f13e1=_0x56aaab,_0x1886f0={'GGseJ':_0x4f13e1(0x32f),'qxKcv':_0x4f13e1(0x229),'gBwcU':function(_0x4f7612,_0x5eed93){return _0x4f7612!==_0x5eed93;},'AbydK':_0x4f13e1(0x1e0),'LzUey':function(_0x154d9e,_0x25ff30){return _0x154d9e!==_0x25ff30;},'TFWIh':_0x4f13e1(0x3c6)};document[_0x4f13e1(0x265)](_0x4f13e1(0x40a))[_0x4f13e1(0x1e6)](_0x42e072=>{const _0x10f962=_0x4f13e1,_0x181971=_0x42e072[_0x10f962(0x361)][_0x10f962(0x2c7)];if(_0x181971&&_0x181971['includes'](_0x1886f0[_0x10f962(0x275)])){if(_0x1886f0[_0x10f962(0x32a)](_0x10f962(0x1e0),_0x1886f0[_0x10f962(0x415)])){if(_0xf5c14e)_0x5549f6+=_0x10f962(0x44c)+_0x113d0c+_0x10f962(0x43a);}else setupVideo(_0x42e072,_0x181971);}else _0x181971&&(_0x1886f0[_0x10f962(0x4ae)](_0x1886f0[_0x10f962(0x3e7)],'JTxRH')?_0x42e072[_0x10f962(0x2c7)]=_0x181971:(_0x42d3f1=_0x1886f0[_0x10f962(0x3eb)],_0x5552d4=_0x10f962(0x3fc)));});}function retakeQuiz(){const _0xd08179=_0x56aaab,_0xec3cff={'lSYGf':_0xd08179(0x232),'bpuCw':_0xd08179(0x1e9),'LDzgW':function(_0x56ab35,_0x5b7db8){return _0x56ab35(_0x5b7db8);},'WPFIw':'Are\x20you\x20sure\x20you\x20want\x20to\x20retake\x20the\x20quiz?\x20This\x20will\x20reset\x20all\x20your\x20answers.','nDPRg':_0xd08179(0x4ab),'cBwlf':function(_0x2a4c89,_0x28989b){return _0x2a4c89!==_0x28989b;},'igJSQ':_0xd08179(0x2db),'HzXNz':_0xd08179(0x2c8)};if(_0xec3cff[_0xd08179(0x2ff)](confirm,_0xec3cff[_0xd08179(0x48c)])){if(window[_0xd08179(0x44a)]['pathname'][_0xd08179(0x2d6)](_0xec3cff[_0xd08179(0x30e)])){if(_0xec3cff[_0xd08179(0x34c)](_0xec3cff[_0xd08179(0x2d3)],_0xec3cff[_0xd08179(0x2d3)])){if(_0x37bbba)return;const _0x466ca8=_0x15b420[_0xd08179(0x439)](_0x4b27d4[_0xd08179(0x47f)](_0xd08179(0x1e9)))||{};_0x466ca8[_0x501cb0]={'questionStates':_0x41ea62,'stats':_0x79bc03,'currentQuestionIndex':_0xdbf2f5,'currentMode':_0x1dbc46,'status':_0xec3cff[_0xd08179(0x29a)],'lastSeen':new _0x35e914()[_0xd08179(0x2a1)]()},_0x1e7005['setItem'](_0xec3cff[_0xd08179(0x21d)],_0x2e9422[_0xd08179(0x462)](_0x466ca8));}else localStorage[_0xd08179(0x466)](_0xec3cff[_0xd08179(0x27e)]);}clearProgress(),location[_0xd08179(0x278)]();}}function loadBookmarkedQuestions(){const _0x4271b3=_0x56aaab,_0x538126={'kMPbo':'bookmarkedQuestions'},_0x451189=JSON['parse'](localStorage[_0x4271b3(0x47f)](_0x538126[_0x4271b3(0x4a5)]))||[];_0x451189[_0x4271b3(0x1e6)](_0x50a606=>{const _0x564c25=_0x4271b3;_0x50a606[_0x564c25(0x29b)][_0x564c25(0x417)](quizName[_0x564c25(0x354)]()['replace'](/ /g,'-'))&&(_0x50a606[_0x564c25(0x2dc)]<questionsData[_0x564c25(0x3e6)]&&(questionStates[_0x50a606['questionIndex']][_0x564c25(0x440)]=!![]));});}function toggleBookmark(){const _0x487bd6=_0x56aaab,_0x8b33b7={'ooojE':_0x487bd6(0x435),'slTuS':function(_0x273854,_0x887854){return _0x273854===_0x887854;},'SdDmo':'ExSWc','sSgxW':function(_0x197cc8){return _0x197cc8();},'SKoAI':function(_0x19c514){return _0x19c514();}},_0x3cc94a=!questionStates[currentQuestionIndex][_0x487bd6(0x440)];questionStates[currentQuestionIndex][_0x487bd6(0x440)]=_0x3cc94a;let _0x27754c=JSON[_0x487bd6(0x439)](localStorage[_0x487bd6(0x47f)](_0x8b33b7[_0x487bd6(0x1f5)]))||[];if(_0x3cc94a){if(_0x8b33b7[_0x487bd6(0x30b)](_0x8b33b7[_0x487bd6(0x29d)],_0x8b33b7[_0x487bd6(0x29d)])){const _0x51b4c6={'quizName':quizName,'quizFile':window['location'][_0x487bd6(0x3a5)]['split']('/')[_0x487bd6(0x421)](),'questionIndex':currentQuestionIndex,'question':questionsData[currentQuestionIndex],'hierarchy':hierarchy,'timestamp':Date[_0x487bd6(0x260)]()};_0x27754c[_0x487bd6(0x234)](_0x51b4c6);}else{const _0x470b2a=_0x33bacf?function(){const _0x9d888c=_0x487bd6;if(_0x3f9e6e){const _0x23596d=_0x8904d0[_0x9d888c(0x3c7)](_0x69fe81,arguments);return _0x45d862=null,_0x23596d;}}:function(){};return _0x1ee5ce=![],_0x470b2a;}}else _0x27754c=_0x27754c[_0x487bd6(0x480)](_0x257513=>!(_0x257513[_0x487bd6(0x29b)][_0x487bd6(0x417)](quizName[_0x487bd6(0x354)]()[_0x487bd6(0x49d)](/ /g,'-'))&&_0x257513[_0x487bd6(0x2dc)]===currentQuestionIndex));localStorage[_0x487bd6(0x42f)](_0x487bd6(0x435),JSON[_0x487bd6(0x462)](_0x27754c)),_0x8b33b7[_0x487bd6(0x284)](updateBookmarkButton),_0x8b33b7[_0x487bd6(0x45e)](updateQuestionNav);}function updateBookmarkButton(){const _0x3ef6c4=_0x56aaab,_0x47d5e2={'fNWnG':'bookmarkBtn','tXLKN':_0x3ef6c4(0x2c1),'ReosS':_0x3ef6c4(0x47a),'kJSdn':_0x3ef6c4(0x2af),'wgKCr':_0x3ef6c4(0x3d4),'AKHUI':'Bookmark'},_0x3e3872=document[_0x3ef6c4(0x44f)](_0x47d5e2[_0x3ef6c4(0x351)]),_0x20061e=document[_0x3ef6c4(0x44f)](_0x47d5e2[_0x3ef6c4(0x251)]),_0x1253a2=questionStates[currentQuestionIndex]['bookmarked'];_0x3e3872['className']=_0x1253a2?_0x47d5e2['ReosS']:_0x47d5e2[_0x3ef6c4(0x3a4)],_0x20061e[_0x3ef6c4(0x295)]=_0x1253a2?_0x47d5e2['wgKCr']:_0x47d5e2['AKHUI'];}function toggleMarkForReview(){const _0x38e5f0=_0x56aaab;questionStates[currentQuestionIndex][_0x38e5f0(0x321)]=!questionStates[currentQuestionIndex]['markedForReview'],updateMarkReviewButton(),updateQuestionNav();}function updateMarkReviewButton(){const _0x456c5d=_0x56aaab,_0x2c3776={'BIbSM':_0x456c5d(0x46e),'yzSjy':_0x456c5d(0x409),'UUZWi':_0x456c5d(0x3a2),'fdOTd':_0x456c5d(0x35d)},_0x3ac852=document[_0x456c5d(0x44f)](_0x2c3776[_0x456c5d(0x274)]),_0x2947ca=document[_0x456c5d(0x44f)](_0x456c5d(0x477)),_0x57fc3f=questionStates[currentQuestionIndex][_0x456c5d(0x321)];_0x3ac852[_0x456c5d(0x372)]=_0x57fc3f?_0x2c3776[_0x456c5d(0x427)]:_0x2c3776['UUZWi'],_0x2947ca[_0x456c5d(0x295)]=_0x57fc3f?_0x2c3776[_0x456c5d(0x470)]:_0x456c5d(0x1f8);}function _0xf7e1(_0x3d8bd9,_0x1a282e){const _0x1a1550=_0x476e();return _0xf7e1=function(_0x1f8db9,_0x3d4b4d){_0x1f8db9=_0x1f8db9-0x1da;let _0x32e52b=_0x1a1550[_0x1f8db9];return _0x32e52b;},_0xf7e1(_0x3d8bd9,_0x1a282e);}function previousQuestion(){const _0x4f02e1=_0x56aaab,_0x3db2cd={'vrYjS':function(_0x30c1f7,_0x7c30f1){return _0x30c1f7>_0x7c30f1;},'SZkxT':function(_0x37458f,_0x35d000){return _0x37458f!==_0x35d000;},'DTvpQ':_0x4f02e1(0x2b2),'SQJAT':function(_0x379aab,_0x5526c3){return _0x379aab-_0x5526c3;},'VVmkz':function(_0x3b813a){return _0x3b813a();},'rJLSD':function(_0xf69e21){return _0xf69e21();}};_0x3db2cd[_0x4f02e1(0x4a2)](currentQuestionIndex,0x0)&&(questionStartTime&&(_0x3db2cd[_0x4f02e1(0x352)]('kKbig',_0x3db2cd[_0x4f02e1(0x469)])?_0x135219[_0x5ea5d3][_0x4f02e1(0x398)]+=_0x26ab60[_0x4f02e1(0x260)]()-_0x556407:questionStates[currentQuestionIndex][_0x4f02e1(0x398)]+=_0x3db2cd['SQJAT'](Date['now'](),questionStartTime)),currentQuestionIndex--,_0x3db2cd[_0x4f02e1(0x405)](displayQuestion),_0x3db2cd[_0x4f02e1(0x408)](saveProgress));}function nextQuestion(){const _0x332138=_0x56aaab,_0x138aca={'bxYwZ':function(_0x3be362){return _0x3be362();},'JmuzT':_0x332138(0x229),'kmsYy':function(_0x5d7455,_0x4f8431,_0xfa1680){return _0x5d7455(_0x4f8431,_0xfa1680);},'QLGYC':'userHistory','mGZNL':_0x332138(0x3dd),'fmSRq':function(_0x50b611,_0x1c372e){return _0x50b611-_0x1c372e;},'aZShZ':function(_0x3da84b,_0x318606){return _0x3da84b===_0x318606;},'smnpo':'XnXpx','jVNGT':function(_0x47f2a6,_0x196d56){return _0x47f2a6<_0x196d56;},'mieqw':function(_0x427f2d,_0x4fd9ee){return _0x427f2d===_0x4fd9ee;},'aEiSw':_0x332138(0x39b),'oYBBr':function(_0x569713){return _0x569713();},'nMkSJ':function(_0xf4b4cf,_0x49a193){return _0xf4b4cf===_0x49a193;},'GREFr':_0x332138(0x349),'acyjG':'test','PcHXc':_0x332138(0x453),'rKiMf':function(_0x3bf8e0,_0x3b0e9e){return _0x3bf8e0(_0x3b0e9e);},'ewvoP':_0x332138(0x467),'oBBjm':function(_0x1b8f70){return _0x1b8f70();},'yPPAO':function(_0x14ca11,_0x568cd7){return _0x14ca11(_0x568cd7);},'lXuhs':_0x332138(0x428),'bbBGM':function(_0x276905){return _0x276905();}};questionStartTime&&(_0x138aca[_0x332138(0x489)](_0x138aca[_0x332138(0x3e8)],_0x138aca[_0x332138(0x3e8)])?questionStates[currentQuestionIndex][_0x332138(0x398)]+=_0x138aca[_0x332138(0x252)](Date[_0x332138(0x260)](),questionStartTime):_0x138aca[_0x332138(0x3e9)](_0x7cd1cd));if(_0x138aca[_0x332138(0x28c)](currentQuestionIndex,_0x138aca[_0x332138(0x252)](questionsData['length'],0x1))){if(_0x138aca[_0x332138(0x1fa)](_0x138aca[_0x332138(0x2fa)],_0x332138(0x39b)))currentQuestionIndex++,_0x138aca[_0x332138(0x3e9)](displayQuestion),_0x138aca[_0x332138(0x216)](saveProgress);else{const _0x295837=_0x42bc24[_0x332138(0x361)][_0x332138(0x2c7)];if(_0x295837&&_0x295837[_0x332138(0x417)](_0x138aca[_0x332138(0x3b2)]))_0x138aca[_0x332138(0x3ac)](_0x556b2c,_0x41ae13,_0x295837);else _0x295837&&(_0x27f1c5[_0x332138(0x2c7)]=_0x295837);}}else{if(_0x138aca['nMkSJ']('CNJEH',_0x138aca[_0x332138(0x473)])){if(_0x138aca[_0x332138(0x264)](currentMode,_0x138aca[_0x332138(0x292)])||currentMode===_0x138aca[_0x332138(0x33f)]){if(_0x138aca[_0x332138(0x3e2)](confirm,_0x332138(0x309))){if(_0x138aca[_0x332138(0x489)](_0x138aca[_0x332138(0x2ce)],_0x138aca['ewvoP']))_0x138aca[_0x332138(0x389)](submitQuiz);else{const _0x4622c5=_0x23a4b2[_0x332138(0x439)](_0x312b9e[_0x332138(0x47f)](_0x138aca[_0x332138(0x3e4)]))||{},_0x3537ac=_0x40b682[_0x332138(0x3e6)],_0x393b32=_0x5c71bf[_0x332138(0x243)]||0x0;_0x4622c5[_0x1f1bf9]={'score':_0x393b32,'total':_0x3537ac,'status':_0x138aca[_0x332138(0x411)],'completedOn':new _0x28243b()[_0x332138(0x2a1)]()},_0x2b2dfe['setItem'](_0x138aca[_0x332138(0x3e4)],_0x398142['stringify'](_0x4622c5));}}}else _0x138aca['yPPAO'](confirm,_0x138aca[_0x332138(0x3b8)])&&(currentQuestionIndex=0x0,_0x138aca[_0x332138(0x216)](displayQuestion),_0x138aca['bbBGM'](saveProgress));}else _0xb63e35[_0x3b591e][_0x332138(0x398)]+=_0x138aca[_0x332138(0x252)](_0x50215d[_0x332138(0x260)](),_0xbbcff1),_0x324c9d=_0x477955[_0x332138(0x260)]();}}function startTimer(){const _0x5dcb7e=_0x56aaab,_0x32f26b={'yvklX':function(_0x4f2604,_0x1eafac){return _0x4f2604!==_0x1eafac;},'miGHt':_0x5dcb7e(0x384),'FVkth':function(_0x9a2ff7){return _0x9a2ff7();},'bWBZN':function(_0x38286b,_0x471b2c){return _0x38286b(_0x471b2c);},'CzxLY':function(_0xf6f6ed,_0x3acea){return _0xf6f6ed===_0x3acea;},'MlZYa':_0x5dcb7e(0x453),'zbuUs':function(_0xf97430){return _0xf97430();},'coJcL':function(_0x10f56c){return _0x10f56c();}};if(timer)_0x32f26b[_0x5dcb7e(0x1f4)](clearInterval,timer);timeRemaining=0x78,_0x32f26b[_0x5dcb7e(0x423)](updateTimerDisplay),timer=setInterval(()=>{const _0x38d54a=_0x5dcb7e,_0x529af2={'GsdcQ':_0x38d54a(0x2c8)};_0x32f26b[_0x38d54a(0x335)]('FIyMl',_0x32f26b['miGHt'])?_0x4e2bb2[_0x38d54a(0x466)](_0x529af2['GsdcQ']):(timeRemaining--,_0x32f26b['FVkth'](updateTimerDisplay),timeRemaining<=0x0&&(_0x32f26b[_0x38d54a(0x1f4)](clearInterval,timer),_0x32f26b[_0x38d54a(0x468)](currentMode,_0x32f26b['MlZYa'])?_0x32f26b[_0x38d54a(0x39d)](submitQuiz):_0x32f26b[_0x38d54a(0x39d)](nextQuestion)));},0x3e8);}function updateTimerDisplay(){const _0x419f4b=_0x56aaab,_0x51447e={'qeRXN':function(_0x2f13c8,_0x86fea3){return _0x2f13c8%_0x86fea3;},'uDsjE':_0x419f4b(0x336),'UCCKs':function(_0x3a4645,_0x4e11c8){return _0x3a4645+_0x4e11c8;},'uXryM':function(_0x40fc69,_0x26386a){return _0x40fc69+_0x26386a;}},_0x79446=Math[_0x419f4b(0x29f)](timeRemaining/0x3c),_0x548010=_0x51447e['qeRXN'](timeRemaining,0x3c);document[_0x419f4b(0x44f)](_0x51447e[_0x419f4b(0x2f7)])['textContent']=_0x51447e['UCCKs'](_0x51447e['uXryM'](_0x79446,':'),_0x548010[_0x419f4b(0x286)]()[_0x419f4b(0x2f8)](0x2,'0'));}function toggleSidebar(){const _0x2a13f3=_0x56aaab,_0x39621a={'Dzqvo':_0x2a13f3(0x41e),'jFUZT':_0x2a13f3(0x276)};document[_0x2a13f3(0x44f)](_0x39621a['Dzqvo'])[_0x2a13f3(0x22f)][_0x2a13f3(0x3d3)](_0x39621a['jFUZT']);}document['addEventListener'](_0x56aaab(0x464),()=>{const _0x411b63=_0x56aaab,_0x17d28f={'DRlRQ':function(_0x3274ac){return _0x3274ac();},'KJDzi':'modeModal','nPLFm':'none','ibqbB':_0x411b63(0x263),'gyPqO':function(_0x3a3202,_0x96547a){return _0x3a3202===_0x96547a;},'mGQBh':_0x411b63(0x343),'kfgFG':function(_0x29a585){return _0x29a585();},'Qlopa':function(_0x2dbfd3){return _0x2dbfd3();},'XCXQM':function(_0x13b6d1){return _0x13b6d1();}};if(resume)_0x17d28f[_0x411b63(0x269)](_0x411b63(0x48f),_0x411b63(0x48f))?loadProgress()?_0x17d28f['mGQBh']!==_0x411b63(0x343)?_0x426d40['explanation_images'][_0x411b63(0x1e6)](_0x4640a6=>{const _0x24258=_0x411b63;if(_0x4640a6)_0x3484dd[_0x24258(0x379)]+='<div\x20class=\x22mt-4\x22><img\x20src=\x22'+_0x4640a6+_0x24258(0x3b9);}):(document[_0x411b63(0x44f)](_0x17d28f[_0x411b63(0x396)])['style'][_0x411b63(0x3be)]=_0x17d28f[_0x411b63(0x388)],_0x17d28f[_0x411b63(0x3d0)](initializeQuiz)):(_0x17d28f[_0x411b63(0x479)](clearProgress),document[_0x411b63(0x44f)](_0x17d28f[_0x411b63(0x396)])[_0x411b63(0x41b)][_0x411b63(0x3be)]=_0x17d28f[_0x411b63(0x37a)]):_0x17d28f[_0x411b63(0x43f)](_0x4ea5d2)?(_0x1d0d6f[_0x411b63(0x44f)](_0x17d28f[_0x411b63(0x396)])[_0x411b63(0x41b)][_0x411b63(0x3be)]=_0x17d28f[_0x411b63(0x388)],_0x17d28f['DRlRQ'](_0x476672)):(_0x17d28f['DRlRQ'](_0x563e57),_0x7acf4[_0x411b63(0x44f)](_0x17d28f['KJDzi'])[_0x411b63(0x41b)]['display']=_0x17d28f[_0x411b63(0x37a)]);else!window[_0x411b63(0x44a)][_0x411b63(0x3a5)][_0x411b63(0x2d6)](_0x411b63(0x4ab))?'EeUpY'===_0x411b63(0x258)?(_0x17d28f[_0x411b63(0x21f)](clearProgress),document[_0x411b63(0x44f)](_0x17d28f[_0x411b63(0x396)])['style'][_0x411b63(0x3be)]=_0x411b63(0x263)):_0x121bac=_0x1c2121:initializeQuiz();}),document['addEventListener'](_0x56aaab(0x323),function(_0x3c1dde){const _0x1b1ab8=_0x56aaab,_0x1f1f8c={'DEGLe':function(_0x3fa2be,_0x111245){return _0x3fa2be===_0x111245;},'bgSHg':_0x1b1ab8(0x307),'SGXxs':function(_0x3b701d,_0x54caf0){return _0x3b701d===_0x54caf0;},'AhoxF':_0x1b1ab8(0x1eb),'LdVxP':_0x1b1ab8(0x2f5),'TtgdG':_0x1b1ab8(0x215),'PcjKZ':function(_0x305df9,_0xb16d0b){return _0x305df9>_0xb16d0b;},'XbNwy':function(_0x53589b,_0x1ac79a){return _0x53589b*_0x1ac79a;},'SVTSS':'accuracy','JhSbg':function(_0x2edb30,_0x5b55c8){return _0x2edb30+_0x5b55c8;},'ciDPE':function(_0x33dee8,_0x11c43d){return _0x33dee8/_0x11c43d;},'lYUcb':function(_0x4c9107,_0x1c0bca){return _0x4c9107/_0x1c0bca;},'FMypQ':function(_0x30f08e,_0x4c9d06){return _0x30f08e%_0x4c9d06;},'VaBJN':_0x1b1ab8(0x398),'tnzwk':_0x1b1ab8(0x255),'IfMMd':'none','AOiyW':function(_0x33e5b2){return _0x33e5b2();},'uUIIb':function(_0x29b983,_0x54256d){return _0x29b983!==_0x54256d;},'bAfnv':function(_0x370865,_0x1f5f98){return _0x370865===_0x1f5f98;},'zJrON':_0x1b1ab8(0x2cf),'tvtlk':'hidden','zboWk':function(_0x9077fa,_0x5830db){return _0x9077fa>=_0x5830db;},'kqaqL':function(_0x539d7e,_0x24d277){return _0x539d7e<_0x24d277;},'IOPeT':function(_0x332eae,_0x3858ed){return _0x332eae(_0x3858ed);},'feBLi':function(_0x4a9990,_0x346fbc){return _0x4a9990===_0x346fbc;},'wIsRk':_0x1b1ab8(0x43e),'hfLox':function(_0x193aec){return _0x193aec();},'fnXPO':'ArrowRight','IMKQo':function(_0x1f62c4,_0x5d2a11){return _0x1f62c4===_0x5d2a11;},'AJHEP':'WhTct','hkARv':function(_0x468e6b,_0x4d3e41){return _0x468e6b===_0x4d3e41;},'NSStU':function(_0x459a42,_0x54fddc){return _0x459a42===_0x54fddc;},'zXwTl':function(_0x2085af){return _0x2085af();},'fEPcR':function(_0x22d673,_0x4ae070){return _0x22d673===_0x4ae070;},'Wthgl':_0x1b1ab8(0x490),'OVQha':_0x1b1ab8(0x453),'zJReI':function(_0x45e4e0,_0xcd1087){return _0x45e4e0===_0xcd1087;},'vQFiH':function(_0x33286f){return _0x33286f();}};if(_0x1f1f8c[_0x1b1ab8(0x237)](document[_0x1b1ab8(0x44f)](_0x1b1ab8(0x255))['style'][_0x1b1ab8(0x3be)],_0x1f1f8c[_0x1b1ab8(0x37c)]))return;if(_0x1f1f8c[_0x1b1ab8(0x3ea)](document[_0x1b1ab8(0x44f)](_0x1f1f8c[_0x1b1ab8(0x3aa)])['classList']['contains'](_0x1f1f8c[_0x1b1ab8(0x45c)]),![]))return;if(_0x1f1f8c[_0x1b1ab8(0x21a)](_0x3c1dde[_0x1b1ab8(0x420)],'1')&&_0x3c1dde[_0x1b1ab8(0x420)]<='4'){const _0x17a484=parseInt(_0x3c1dde[_0x1b1ab8(0x420)])-0x1,_0x3a5544=document[_0x1b1ab8(0x265)](_0x1b1ab8(0x360));if(_0x1f1f8c[_0x1b1ab8(0x30d)](_0x17a484,_0x3a5544['length']))_0x1f1f8c['IOPeT'](selectOption,_0x17a484);}else{if(_0x1f1f8c['feBLi'](_0x3c1dde[_0x1b1ab8(0x420)],'ArrowLeft')){if(_0x1f1f8c['uUIIb'](_0x1f1f8c[_0x1b1ab8(0x1e8)],_0x1f1f8c[_0x1b1ab8(0x1e8)])){if(_0x1f1f8c[_0x1b1ab8(0x334)](_0x140923,_0x1f1f8c[_0x1b1ab8(0x22c)])||_0x1f1f8c['SGXxs'](_0x4b5465,_0x1f1f8c[_0x1b1ab8(0x49e)])){_0x585c90[_0x1b1ab8(0x44f)](_0x1b1ab8(0x367))[_0x1b1ab8(0x295)]=_0x2edd3a[_0x1b1ab8(0x243)],_0x3b5048[_0x1b1ab8(0x44f)](_0x1f1f8c['LdVxP'])[_0x1b1ab8(0x295)]=_0x96eabc['incorrectAnswers'],_0x324878[_0x1b1ab8(0x44f)](_0x1f1f8c['TtgdG'])[_0x1b1ab8(0x295)]=_0x402776[_0x1b1ab8(0x215)];const _0xaa9472=_0x1f1f8c[_0x1b1ab8(0x36a)](_0x103992[_0x1b1ab8(0x215)],0x0)?_0x3b0509[_0x1b1ab8(0x3f7)](_0x1f1f8c[_0x1b1ab8(0x21e)](_0x4e296e[_0x1b1ab8(0x243)]/_0x4153fc[_0x1b1ab8(0x215)],0x64)):0x0;_0x2e37ad[_0x1b1ab8(0x44f)](_0x1f1f8c['SVTSS'])[_0x1b1ab8(0x295)]=_0x1f1f8c[_0x1b1ab8(0x1db)](_0xaa9472,'%'),_0x33521e[_0x1b1ab8(0x2bd)]=_0x1fa24e[_0x1b1ab8(0x42a)]((_0x57627d,_0x4a92ce)=>_0x57627d+_0x4a92ce[_0x1b1ab8(0x398)],0x0);const _0x57eb84=_0x5aea71[_0x1b1ab8(0x29f)](_0x1f1f8c[_0x1b1ab8(0x310)](_0x2caf66[_0x1b1ab8(0x2bd)],0x3e8)),_0x3b9b40=_0x3cd206[_0x1b1ab8(0x29f)](_0x1f1f8c[_0x1b1ab8(0x37f)](_0x57eb84,0x3c)),_0x56c13e=_0x1f1f8c[_0x1b1ab8(0x3fd)](_0x57eb84,0x3c);_0x32e2f0['getElementById'](_0x1f1f8c['VaBJN'])['textContent']=_0x1f1f8c[_0x1b1ab8(0x1db)](_0x1f1f8c[_0x1b1ab8(0x1db)](_0x3b9b40,':'),_0x56c13e[_0x1b1ab8(0x286)]()['padStart'](0x2,'0'));}}else _0x1f1f8c[_0x1b1ab8(0x1dc)](previousQuestion);}else{if(_0x3c1dde['key']===_0x1f1f8c[_0x1b1ab8(0x2d2)]||_0x1f1f8c[_0x1b1ab8(0x334)](_0x3c1dde['key'],'\x20'))_0x1f1f8c[_0x1b1ab8(0x327)](_0x1b1ab8(0x28e),_0x1f1f8c['AJHEP'])?(_0x3c1dde[_0x1b1ab8(0x3ba)](),_0x1f1f8c[_0x1b1ab8(0x1f0)](nextQuestion)):(_0x314e97['getElementById'](_0x1f1f8c['tnzwk'])[_0x1b1ab8(0x41b)][_0x1b1ab8(0x3be)]=_0x1f1f8c[_0x1b1ab8(0x37c)],_0x1f1f8c['AOiyW'](_0x4ca6fa));else{if(_0x1f1f8c['hkARv'](_0x3c1dde[_0x1b1ab8(0x420)]['toLowerCase'](),'b')&&(_0x1f1f8c['SGXxs'](currentMode,_0x1f1f8c[_0x1b1ab8(0x22c)])||_0x1f1f8c[_0x1b1ab8(0x431)](currentMode,_0x1f1f8c['AhoxF'])))_0x1f1f8c[_0x1b1ab8(0x47c)](toggleBookmark);else{if(_0x1f1f8c[_0x1b1ab8(0x42e)](_0x3c1dde['key']['toLowerCase'](),'m')&&(currentMode===_0x1f1f8c['Wthgl']||currentMode===_0x1f1f8c[_0x1b1ab8(0x2c3)]))toggleMarkForReview();else _0x1f1f8c[_0x1b1ab8(0x42e)](_0x3c1dde[_0x1b1ab8(0x420)]['toLowerCase'](),'s')&&(_0x1f1f8c[_0x1b1ab8(0x2d9)](currentMode,_0x1b1ab8(0x490))||_0x1f1f8c[_0x1b1ab8(0x273)](currentMode,_0x1b1ab8(0x453)))&&_0x1f1f8c[_0x1b1ab8(0x240)](submitQuiz);}}}}});</script>

</body></html>